<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">80317</article-id><article-id pub-id-type="doi">10.7554/eLife.80317</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Chromosomes and Gene Expression</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group></article-categories><title-group><article-title>An atrial fibrillation-associated regulatory region modulates cardiac <italic>Tbx5</italic> levels and arrhythmia susceptibility</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-280175"><name><surname>Bosada</surname><given-names>Fernanda M</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9817-7370</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-160858"><name><surname>van Duijvenboden</surname><given-names>Karel</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5691-8097</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-300525"><name><surname>Giovou</surname><given-names>Alexandra E</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-280176"><name><surname>Rivaud</surname><given-names>Mathilde R</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0680-3483</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-280177"><name><surname>Uhm</surname><given-names>Jae-Sun</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-177204"><name><surname>Verkerk</surname><given-names>Arie O</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2140-834X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-180297"><name><surname>Boukens</surname><given-names>Bastiaan J</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6449-145X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-178004"><name><surname>Christoffels</surname><given-names>Vincent M</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4131-2636</contrib-id><email>v.m.christoffels@amsterdamumc.nl</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04dkp9463</institution-id><institution>Department of Medical Biology, Amsterdam Cardiovascular Sciences, Amsterdam Reproduction and Development, Amsterdam University Medical Centers, University of Amsterdam</institution></institution-wrap><addr-line><named-content content-type="city">Amsterdam</named-content></addr-line><country>Netherlands</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04dkp9463</institution-id><institution>Department of Experimental Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, University of Amsterdam</institution></institution-wrap><addr-line><named-content content-type="city">Amsterdam</named-content></addr-line><country>Netherlands</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01wjejq96</institution-id><institution>Department of Cardiology, Severance Hospital, College of Medicine, Yonsei University</institution></institution-wrap><addr-line><named-content content-type="city">Seoul</named-content></addr-line><country>Republic of Korea</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02d9ce178</institution-id><institution>Department of Physiology, University of Maastricht, Cardiovascular Research Institute Maastricht, Maastricht University Medical Center</institution></institution-wrap><addr-line><named-content content-type="city">Maastricht</named-content></addr-line><country>Netherlands</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Shivkumar</surname><given-names>Kalyanam</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01d88se56</institution-id><institution>UCLA Health</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Barton</surname><given-names>Matthias</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02crff812</institution-id><institution>University of Zurich</institution></institution-wrap><country>Switzerland</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>30</day><month>01</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>12</volume><elocation-id>e80317</elocation-id><history><date date-type="received" iso-8601-date="2022-05-27"><day>27</day><month>05</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2023-01-29"><day>29</day><month>01</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2022-05-14"><day>14</day><month>05</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.05.14.491627"/></event></pub-history><permissions><copyright-statement>Â© 2023, Bosada et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Bosada et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-80317-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-80317-figures-v2.pdf"/><abstract><p>Heart development and rhythm control are highly Tbx5 dosage-sensitive. <italic>TBX5</italic> haploinsufficiency causes congenital conduction disorders, whereas increased expression levels of <italic>TBX5</italic> in human heart samples has been associated with atrial fibrillation (AF). We deleted the conserved mouse orthologues of two independent AF-associated genomic regions in the <italic>Tbx5</italic> locus, one intronic (RE(int)) and one downstream (RE(down)) of <italic>Tbx5</italic>. In both lines, we observed a modest (30%) increase of <italic>Tbx5</italic> in the postnatal atria. To gain insight into the effects of slight dosage increase in vivo, we investigated the atrial transcriptional, epigenetic and electrophysiological properties of both lines. Increased atrial <italic>Tbx5</italic> expression was associated with induction of genes involved in development, ion transport and conduction, with increased susceptibility to atrial arrhythmias, and increased action potential duration of atrial cardiomyocytes. We identified an AF-associated variant in the human RE(int) that increases its transcriptional activity. Expression of the AF-associated transcription factor <italic>Prrx1</italic> was induced in <italic>Tbx5<sup>RE(int)KO</sup></italic> cardiomyocytes. We found that some of the transcriptional and functional changes in the atria caused by increased <italic>Tbx5</italic> expression were normalized when reducing cardiac <italic>Prrx1</italic> expression in <italic>Tbx5<sup>RE(int)KO</sup></italic> mice, indicating an interaction between these two AF genes. We conclude that modest increases in expression of dose-dependent transcription factors, caused by common regulatory variants, significantly impact on the cardiac gene regulatory network and disease susceptibility.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>atrial fibrillation</kwd><kwd>gene expression</kwd><kwd>regulation</kwd><kwd>genetically altered</kwd><kwd>transgenic models</kwd><kwd>epigenetics</kwd><kwd>arrhythmias</kwd><kwd>genetic variation</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution>CardioVasculair Onderzoek Nederland</institution></institution-wrap></funding-source><award-id>Project 2014-18 CONCOR-genes Young Talent Program</award-id><principal-award-recipient><name><surname>Bosada</surname><given-names>Fernanda M</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001674</institution-id><institution>Fondation Leducq</institution></institution-wrap></funding-source><award-id>14CVD01</award-id><principal-award-recipient><name><surname>Christoffels</surname><given-names>Vincent M</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100018890</institution-id><institution>Dutch Cardiovascular Alliance</institution></institution-wrap></funding-source><award-id>OUTREACH</award-id><principal-award-recipient><name><surname>Christoffels</surname><given-names>Vincent M</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001826</institution-id><institution>ZonMw</institution></institution-wrap></funding-source><award-id>TOP 91217061</award-id><principal-award-recipient><name><surname>Christoffels</surname><given-names>Vincent M</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003246</institution-id><institution>Dutch Research Council</institution></institution-wrap></funding-source><award-id>OCENW.GROOT.2019.029</award-id><principal-award-recipient><name><surname>Christoffels</surname><given-names>Vincent M</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Modest changes in expression of interacting dose-dependent transcription factors <italic>Tbx5</italic> and <italic>Prrx1</italic>, caused by disease-associated common regulatory variants, significantly impact on the cardiac gene regulatory network and disease susceptibility.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The lifetime risk of developing a common disease, such as cardiovascular or neurodegenerative conditions, is influenced by genetic predisposition resulting from large numbers of inherited common genetic variants (single-nucleotide polymorphisms, SNPs). Disease-associated variants are typically found in noncoding genomic regions and are thought to affect the functionality of regulatory elements (REs) such as enhancers or elements involved in chromatin conformation (<xref ref-type="bibr" rid="bib14">Degtyareva et al., 2021</xref>; <xref ref-type="bibr" rid="bib15">Deplancke et al., 2016</xref>; <xref ref-type="bibr" rid="bib26">Hormozdiari et al., 2018</xref>; <xref ref-type="bibr" rid="bib43">Maurano et al., 2012</xref>; <xref ref-type="bibr" rid="bib63">Schaub et al., 2012</xref>). These regulatory variants are pleiotropic and their effects on target gene expression are often specific to particular cell-types, conditions or stages of development (<xref ref-type="bibr" rid="bib22">GTEx Consortium, 2020</xref>; <xref ref-type="bibr" rid="bib67">Sobreira et al., 2021</xref>; <xref ref-type="bibr" rid="bib70">Strober et al., 2019</xref>; <xref ref-type="bibr" rid="bib86">Watanabe et al., 2019</xref>). It remains challenging to identify the causal variants among the many associated variants in a disease-associated noncoding DNA region and the REs that are affected by such variants (<xref ref-type="bibr" rid="bib25">Hormozdiari et al., 2017</xref>). Moreover, common variants typically have a small effect on phenotype, and the different functional variants may act additively, synergistically, or oppositely. As a consequence, very few biological mechanisms linking disease-associated variant(s) to phenotype have been uncovered (<xref ref-type="bibr" rid="bib34">Lappalainen and MacArthur, 2021</xref>; <xref ref-type="bibr" rid="bib72">Timpson et al., 2018</xref>; <xref ref-type="bibr" rid="bib84">Visscher et al., 2017</xref>). Here, we set out to investigate how particular noncoding regions harboring clustered variants associated with a common disease modulate expression of a disease-associated transcription factor gene in a tissue-specific manner, and how this expression change affects phenotype in vivo.</p><p>Genome-wide association studies (GWAS) have identified many common variants in over 100 genetic loci associated with atrial fibrillation (AF) risk, the most prevalent arrhythmia associated with high comorbidity and increased mortality risk (<xref ref-type="bibr" rid="bib11">Christophersen et al., 2017</xref>; <xref ref-type="bibr" rid="bib12">Chugh et al., 2014</xref>; <xref ref-type="bibr" rid="bib39">Low et al., 2017</xref>; <xref ref-type="bibr" rid="bib51">Nielsen et al., 2018</xref>; <xref ref-type="bibr" rid="bib58">Roselli et al., 2018</xref>; <xref ref-type="bibr" rid="bib68">Staerk et al., 2017</xref>). The identification of functional variants, REs, and target genes underlying AF will provide important insights into the molecular mechanisms of disease (<xref ref-type="bibr" rid="bib78">van Ouwerkerk et al., 2020</xref>). AF-associated variants have been identified in loci harboring transcription factor-encoding genes, including <italic>PITX2</italic>, <italic>TBX5,</italic> and <italic>PRRX1</italic>, suggesting that altered expression levels of such factors cause imbalances in gene regulatory networks that control heart rhythm and function (<xref ref-type="bibr" rid="bib78">van Ouwerkerk et al., 2020</xref>). Indeed, using mouse models, insufficiency of these transcriptional regulators was shown to cause arrhythmia susceptibility (<xref ref-type="bibr" rid="bib6">Bosada et al., 2021</xref>; <xref ref-type="bibr" rid="bib13">Dai et al., 2019</xref>; <xref ref-type="bibr" rid="bib32">Kirchhof et al., 2011</xref>; <xref ref-type="bibr" rid="bib33">Laforest et al., 2019</xref>; <xref ref-type="bibr" rid="bib50">Nadadur et al., 2016</xref>; <xref ref-type="bibr" rid="bib71">Tao et al., 2014</xref>; <xref ref-type="bibr" rid="bib73">Tucker et al., 2017</xref>; <xref ref-type="bibr" rid="bib85">Wang et al., 2010</xref>; <xref ref-type="bibr" rid="bib88">Zhang et al., 2019</xref>). Heterozygous loss- or gain of function variants in <italic>TBX5</italic> can cause Holt-Oram syndrome in humans, characterized by congenital heart defects and cardiac conduction anomalies, as a result of profound changes in the gene regulatory networks controlling heart development and function (<xref ref-type="bibr" rid="bib4">Basson et al., 1997</xref>; <xref ref-type="bibr" rid="bib7">Bruneau et al., 1999</xref>; <xref ref-type="bibr" rid="bib29">Kathiriya et al., 2021</xref>; <xref ref-type="bibr" rid="bib36">Li et al., 1997</xref>; <xref ref-type="bibr" rid="bib47">Mori et al., 2006</xref>; <xref ref-type="bibr" rid="bib48">Moskowitz et al., 2004</xref>). Interestingly, duplications of TBX5 as well as intragenic duplications have been reported in families with (atypical) Holt-Oram syndrome including cardiac defects (<xref ref-type="bibr" rid="bib10">Cenni et al., 2021</xref>; <xref ref-type="bibr" rid="bib31">Kimura et al., 2015</xref>; <xref ref-type="bibr" rid="bib54">Patel et al., 2012</xref>). Furthermore, a gain-of-function pathological missense variant in <italic>TBX5</italic> causes paroxysmal AF (<xref ref-type="bibr" rid="bib55">Postma et al., 2008</xref>; <xref ref-type="bibr" rid="bib79">van Ouwerkerk et al., 2022</xref>). Moreover, a previous study uncovered a 30% increase, rather than a reduction, in cardiac <italic>TBX5</italic> expression in human heart tissues has been associated with AF (<xref ref-type="bibr" rid="bib58">Roselli et al., 2018</xref>). The effects of small but potentially physiologically relevant dosage increase in transcriptional regulators such as TBX5 are not well characterized.</p><p>We deleted the mouse orthologues of two AF variant-rich regions in the human <italic>TBX5</italic> locus to investigate how variant regions associated with a common disease modulate phenotype in a tissue- and developmental stage-specific manner. Each deletion caused a modest 30% increase in <italic>Tbx5</italic> expression in different heart compartments and at different stages of life. We report the relatively large effect of this modest increase in <italic>Tbx5</italic> expression on atrial function including arrhythmia susceptibility, and on the gene regulatory network. Decreased expression of <italic>Prrx1</italic> has been associated with AF in human and mouse models (<xref ref-type="bibr" rid="bib58">Roselli et al., 2018</xref>; <xref ref-type="bibr" rid="bib6">Bosada et al., 2021</xref>; <xref ref-type="bibr" rid="bib73">Tucker et al., 2017</xref>). We observed a genetic interaction between <italic>Tbx5</italic> and <italic>Prrx1</italic>, and found that some of the transcriptional and functional changes in the atria caused by increased <italic>Tbx5</italic> expression were rescued by reducing cardiac <italic>Prrx1</italic> expression.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Identification of two AF-associated regulatory regions in the <italic>TBX5</italic> locus</title><p>The topologically associated domain (<xref ref-type="bibr" rid="bib16">Dixon et al., 2012</xref>; <xref ref-type="bibr" rid="bib52">Nora et al., 2012</xref>) harboring <italic>Tbx5</italic> shows very limited contact with the adjacent domains harboring <italic>Tbx3</italic> and <italic>Rbm19</italic>, respectively (<xref ref-type="bibr" rid="bib80">van Weerd et al., 2014</xref>). Because all AF-associated variants in this locus are found within the topologically associated domain of <italic>TBX5</italic> (<xref ref-type="fig" rid="fig1">Figure 1A</xref>), we anticipate that REs affected by the risk variants modulate the expression of <italic>TBX5</italic> only. Promoter capture Hi-C maps from iPSC-derived cardiomyocytes (<xref ref-type="bibr" rid="bib46">Montefiori et al., 2018</xref>) show distinct contacts between the promoter of <italic>Tbx5</italic> and distal AF-associated regions, including the region in the last intron of <italic>TBX5</italic> (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). To identify possible regulatory elements within the AF-associated regions, we analyzed epigenomic datasets in both human (<xref ref-type="bibr" rid="bib20">Gilsbach et al., 2018</xref>; <xref ref-type="bibr" rid="bib77">van Ouwerkerk et al., 2019</xref>) and mouse orthologous region (<xref ref-type="fig" rid="fig1">Figure 1AâB</xref>). We selected two regions: the first situated in the last intron (RE(int)), and the second immediately downstream (RE(down)) of <italic>Tbx5</italic>. Both fragments contain evolutionary conserved regions, and RE(int) harbors accessible chromatin sites in the left atria and ventricles, and EMERGE enhancer prediction signal (<xref ref-type="bibr" rid="bib75">van Duijvenboden et al., 2019</xref>; <xref ref-type="bibr" rid="bib77">van Ouwerkerk et al., 2019</xref>). Additionally, RE(int) and RE(down) contain regions associated with cardiac H3K4me1, and RE(int) with H3K27ac (<xref ref-type="bibr" rid="bib19">Gilsbach et al., 2014</xref>; <xref ref-type="fig" rid="fig1">Figure 1B</xref>). The SNPs in the last intron and those downstream of the gene are clustered into two distinct haplotypes, suggesting that these two regions are independently inherited (<xref ref-type="fig" rid="fig1s1">Figure 1âfigure supplement 1</xref>; <xref ref-type="bibr" rid="bib41">Machiela and Chanock, 2015</xref>). Using CRISPR/Cas9 genome editing, we deleted these candidate REs from the mouse genome to test their function in vivo.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>AF-associated noncoding variants are found in the <italic>TBX5</italic> locus.</title><p>(<bold>A</bold>) Hi-C heatmap from human lymphoblastoid line GM12878 shows AF-associated variants are found in the regulatory domain of <italic>TBX5</italic>. Zoom-in of the AF-associated region overlaid with promoter capture Hi-C (red arcs), regions of open chromatin in whole left atria (ATACseq LA), H3K27ac and H3K4me1 ChIPseq signatures in cardiomyocytes. (<bold>B</bold>) Mouse orthologue of the human region including ATACseq from left atrial and ventricular CMs, H3K27ac ChIPseq from whole juvenile hearts, EMERGE, and conservation tracks. CRISPR/Cas9-generated deletions in light gray (REint), and dark gray (REdown).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80317-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1âfigure supplement 1.</label><caption><title>AF-associated variants near <italic>TBX5</italic> are grouped into distinct haplotypes.</title><p>Linkage disequilibrium (LD) matrix plot of SNPs located at the <italic>TBX5</italic> locus associated with AF. The SNPs found in the last intron and downstream of the gene are clustered into two distinct haplotypes based on minimum linkage disequilibrium r2 of 0.1. The plot was generated using the LD matrix tool al <ext-link ext-link-type="uri" xlink:href="https://ldlink.nci.nih.gov/">ldlink.nci.nih.gov</ext-link>. Scale bar depicted above and below gene.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80317-fig1-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-2"><title><italic>Tbx5</italic> expression and arrhythmia predisposition are increased in atria of <italic>Tbx5<sup>RE(int)KO</sup></italic> and <italic>Tbx5<sup>RE(down)KO</sup></italic> mice</title><p>Before birth, expression of <italic>Tbx5</italic> in the atria was not different between genotypes (<xref ref-type="fig" rid="fig2s1">Figure 2âfigure supplement 1A</xref>). However, in juvenile atria of RE(int) KO mice (p=0.001), <italic>Tbx5</italic> expression was slightly increased compared to controls (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Expression of <italic>Rbm19</italic>, <italic>Tbx3,</italic> and <italic>Med13l</italic>, which neighbor <italic>Tbx5</italic>, remained unchanged in atria or ventricles of both mutants (<xref ref-type="fig" rid="fig2s1">Figure 2âfigure supplement 1</xref>). Both atria of <italic>Tbx5<sup>RE(int)KO</sup></italic> adult mice expressed approximately 30% more <italic>Tbx5</italic>, whereas only the left atrium and lungs of <italic>Tbx5<sup>RE(down)KO</sup></italic> adult mice expressed more <italic>Tbx5</italic> (<xref ref-type="fig" rid="fig2">Figure 2BâC</xref>). While we were not able to assess quantitative differences in protein expression, we observed that Tbx5 protein was selectively present in PCM-1 +cardiomyocyte nuclei in left and right atria of both control and of <italic>Tbx5<sup>RE(int)KO</sup></italic> mice (<xref ref-type="fig" rid="fig2s2">Figure 2âfigure supplement 2</xref>). We confirmed absence of aberrant splicing caused by the intronic deletion in <italic>Tbx5<sup>RE(int)KO</sup></italic> (<xref ref-type="fig" rid="fig2s3">Figure 2âfigure supplement 3</xref>). Interestingly, eQTL analysis indicated that AF is associated with a statistically significant 30% increase in <italic>TBX5</italic> expression in cardiac tissue (<xref ref-type="bibr" rid="bib58">Roselli et al., 2018</xref>). This suggests that AF-associated variants in the corresponding human regions may mediate the increase in <italic>TBX5</italic> expression observed in patients with risk variants.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Deletion of AF-associated regions results in increased <italic>Tbx5</italic> in adult atrial tissue.</title><p>(<bold>A</bold>) <italic>Tbx5</italic> expression in atria, ventricles, and lungs from P21 control, <italic>Tbx5<sup>RE(int)KO</sup></italic>, and <italic>Tbx5<sup>RE(down)KO</sup></italic> mice determined by RT-qPCR. (<bold>BâC</bold>) <italic>Tbx5</italic> expression levels in adult control and <italic>Tbx5<sup>RE(int)KO</sup></italic> (<bold>B</bold>) or <italic>Tbx5<sup>RE(down)KO</sup></italic> (<bold>C</bold>) left and right atria. (<bold>D</bold>) UCSC browser view of the human intronic region (gray) and tested fragments containing AF-associated SNPs (blue) overlaid with chromatin conformation, EMERGE, and conservation tracks. (<bold>E</bold>) Luciferase assay (n=6) shows enhancer activity differences between non-risk (dark gray) or risk (gray) alleles (Kruskal-Wallis p=0.0019). Statistical significance within each tissue type was determined with ANOVA followed by pairwise comparisons using Dunnettâs T3 multiple comparison test in A, unpaired t-tests in B, C, and Kruskal-Wallis tests followed by pairwise unpaired t-tests (p values shown in figure) in E.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80317-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2âfigure supplement 1.</label><caption><title>No difference in transcript levels of genes adjacent to <italic>Tbx5</italic> in deletion mutants.</title><p>(<bold>A</bold>) Fetal (E14.5) expression levels of <italic>Tbx5</italic> were normalized to controls within each litter. (<bold>B</bold>) Reference gene-corrected expression levels of <italic>Rbm19</italic>, <italic>Tbx3</italic>, and <italic>Med13l</italic> in juvenile whole atria (left) and ventricles (right) in <italic>WT</italic> (n=5), <italic>Tbx5<sup>RE(int)KO</sup></italic> (n=6), and <italic>Tbx5<sup>RE(down)KO</sup></italic> (n=6). Statistical significance within each gene and tissue type was determined with Kruskal-Wallis tests.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80317-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2âfigure supplement 2.</label><caption><title>Tbx5 is selectively expressed in cardiomyocyte nuclei in atria of <italic>WT</italic> and <italic>Tbx5<sup>RE(int)KO</sup></italic> mice.</title><p>(<bold>A</bold>) Immunoflourescence staining on paraffin sections of adult left atria for Tbx5 (red), PCM-1 which marks cardiomyocytes nuclei (green), and DAPI (blue). Red arrowheads point to non-cardiomyocyte (Tbx5-negative, PCM-1-negative) nuclei, and yellow arrowheads point to Tbx5 +cardiomyocytes. Scale bar is 50 Âµm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80317-fig2-figsupp2-v2.tif"/></fig><fig id="fig2s3" position="float" specific-use="child-fig"><label>Figure 2âfigure supplement 3.</label><caption><title><italic>Tbx5</italic> splicing is not affected in deletion mutants.</title><p>(<bold>A</bold>) UCSC browser view shows exon read coverage including the ones flanking the intronic deletion is similar across genotypes. (<bold>B</bold>) RTq-PCR of <italic>WT</italic> and <italic>Tbx5<sup>RE(int)KO</sup></italic> (HOM) left and right atria using primers spanning exons 6â8 and 8â9. (<bold>C</bold>) Resulting amplicon sizes are not different in homozygous mice.</p><p><supplementary-material id="fig2s3sdata1"><label>Figure 2âfigure supplement 3âsource data 1.</label><caption><title>Raw gel for <xref ref-type="fig" rid="fig2s3">Figure 2âfigure supplement 3</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-80317-fig2-figsupp3-data1-v2.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80317-fig2-figsupp3-v2.tif"/></fig></fig-group><p>To identify functional AF-associated variants within the human intronic RE region, we tested enhancer activity of five fragments containing an AF-associated SNPs (p&lt;10<sup>â6</sup>) (<xref ref-type="bibr" rid="bib58">Roselli et al., 2018</xref>) using luciferase assays in the atrial cardiomyocyte-like cell line HL-1 (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). Of the tested fragments, the fragment containing rs7312625 showed increased enhancer activity, and the fragment containing rs4767237 showed minimal decreased activity (<xref ref-type="fig" rid="fig2">Figure 2E</xref>). Comparative TF motif analysis between the regions containing the major (A) or minor (G) allele of rs7312625 revealed that the minor (G) allele causes disruption of motifs for <italic>Arabidopsis</italic> SOL1/2 (TCX/TCX2) (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>), which are homologues of animal LIN54 (<xref ref-type="bibr" rid="bib42">Marceau et al., 2016</xref>; <xref ref-type="bibr" rid="bib64">Simmons et al., 2019</xref>), a DNA-binding component of the DREAM complex regulating cell cycle-dependent transcription (<xref ref-type="bibr" rid="bib61">Sadasivam and DeCaprio, 2013</xref>). We also observed gain of a <italic>sine oculis</italic> (SIX) homeodomain transcription factor binding motif (<xref ref-type="bibr" rid="bib44">Meurer et al., 2021</xref>; <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). Lin54 and both Six4 and Six5 are expressed in atrial tissue of mice (see <xref ref-type="supplementary-material" rid="supp2 supp3">Supplementary files 2 and 3</xref>).</p><p>Next, we recorded in vivo electrocardiograms (ECGs) to determine the functional consequences of such a modest increase in <italic>Tbx5</italic>. Both <italic>Tbx5<sup>RE(int)KO</sup></italic> and <italic>Tbx5<sup>RE(down)KO</sup></italic> mice had slower and more variable heart rates (R-R interval (RR); standard deviation of normal to normal R-R intervals (SDNN)) (<xref ref-type="fig" rid="fig3">Figure 3A and B</xref>). Additionally, we detected instances of sinus pauses and inverted P waves in mice with both deletions (<xref ref-type="fig" rid="fig3s1">Figure 3âfigure supplement 1A</xref>). PR interval was significantly increased in <italic>Tbx5<sup>RE(int)KO</sup></italic> mice, but remained unaffected in <italic>Tbx5<sup>RE(down)KO</sup></italic> mice (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). Other ECG parameters were not affected (<xref ref-type="fig" rid="fig3s1">Figure 3âfigure supplement 1</xref>). Heart rate corrected sinus node recovery time (cSNRT) and Wenckebach cycle length (WBCL) measured during transesophageal pacing (<xref ref-type="bibr" rid="bib6">Bosada et al., 2021</xref>; <xref ref-type="bibr" rid="bib81">Verheule et al., 2004</xref>) were increased in both mouse models (<xref ref-type="fig" rid="fig3">Figure 3D and E</xref>), suggesting altered conduction system function. We next tested whether AA could be induced in both mouse lines using in vivo burst pacing (<xref ref-type="fig" rid="fig3">Figure 3G</xref> [typical AA traces]). The total duration of all AA episodes per mouse was greater in both deletion models when compared to control littermates (<xref ref-type="fig" rid="fig3">Figure 3F</xref> [top graph]). Yet, we were able to induce AAs more often in <italic>Tbx5<sup>RE(int)KO</sup></italic>, but not <italic>Tbx5<sup>RE(down)KO</sup></italic> mice compared to controls (<xref ref-type="fig" rid="fig3">Figure 3F</xref> [below graph]).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Increased <italic>Tbx5</italic> in adult atria results in altered in vivo electrophysiology.</title><p>(<bold>AâC</bold>) Graphs show individual and average ECG measurements for heart rate (RR) (<bold>A</bold>), heart rate variation (SDNN) (<bold>B</bold>), and PR-interval (<bold>C</bold>) of adult <italic>wild-type</italic>, <italic>Tbx5<sup>RE(int)KO</sup></italic>, and <italic>Tbx5<sup>RE(down)KO</sup></italic> mice. (<bold>D, E</bold>) Graphs show changes in heart rate-corrected sinus node recovery times at 120ms (cSNRT<sub>120</sub>) (<bold>D</bold>), and Wenckebach cycle length (WBCL) (<bold>E</bold>). (<bold>F</bold>) Bar graph depicts the total time each mouse spent in an atrial arrhythmia (AA) episode after two pacing passes, with the number of mice in which at least one episode lasting &gt;1 s was observed below each bar. (<bold>G</bold>) Representative traces from <italic>wild-type</italic> (top) and two <italic>Tbx5<sup>RE(int)KO</sup></italic> (bottom) individuals showing disappearance of p waves or the start of atrial arrhythmia with variability in ventricular response after pacing stimulus. Significance for in vivo parameters was determined with Kruskal-Wallis test followed by Dunnâs multiple comparison tests in A, B, D, and AA duration in F (top graph), and one-way ANOVA followed by Tukeyâs multiple comparisons test in C and E. AA inducibility significance was determined with pairwise Fisherâs exact test (F bottom of graph).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80317-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3âfigure supplement 1.</label><caption><title>Additional in vivo electrophysiology parameters.</title><p>(<bold>A</bold>) Lead 2 traces of <italic>WT</italic>, <italic>Tbx5<sup>RE(int)KO</sup></italic>, and <italic>Tbx5<sup>RE(down)KO</sup></italic> mice showing slow and variable RR, a sinus pause (arrowhead), or abnormal P waves (asterisk). (<bold>B</bold>) Graph shows no significant change in QRS duration in either mutant. Statistical significance was determined in B with Kruskal-Wallis test.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80317-fig3-figsupp1-v2.tif"/></fig></fig-group><p>To further characterize the electrophysiological phenotypes of <italic>Tbx5<sup>RE(int)KO</sup></italic> mice we analyzed the properties of single isolated left atrial cardiomyocytes using patch-clamp. At 6 Hz stimulation, we observed APD prolongation in mutants at all measured repolarization stages, with no changes in AP upstroke velocity, resting membrane potential and maximal AP amplitude (<xref ref-type="fig" rid="fig4">Figure 4AâC</xref>). APD increase was present at all frequencies measured (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). Because <italic>Tbx5</italic> has important roles in intracellular Ca<sup>2+</sup> handling (<xref ref-type="bibr" rid="bib13">Dai et al., 2019</xref>; <xref ref-type="bibr" rid="bib33">Laforest et al., 2019</xref>; <xref ref-type="bibr" rid="bib89">Zhu et al., 2008</xref>), we measured intracellular Ca<sup>2+</sup> concentration ([Ca<sup>2+</sup>]<sub>i</sub>) in isolated atrial CMs using fluorescent calcium indicator Indo-1. We did not observe any changes in systolic or diastolic [Ca<sup>2+</sup>]<sub>i</sub> concentration (<xref ref-type="fig" rid="fig4">Figure 4E</xref>). Together, our data show that a slight increase in <italic>Tbx5</italic> disturbs atrial function and can predispose to arrhythmia.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Atrial function abnormalities in <italic>Tbx5<sup>RE(int)KO</sup></italic> mice.</title><p>(<bold>A</bold>) Typical action potentials (APs) and upstroke velocity measured at 6 Hz in single left atrial cardiomyocytes using the amphotericin-perforated patch clamp technique. (<bold>B</bold>) Average resting membrane potential (RMP), AP amplitude (APA), and AP upstroke velocity remain unchanged in mutants. (<bold>C</bold>) AP duration at 20, 50, and 90% of repolarization (APD<sub>20</sub>, APD<sub>50</sub>, APD<sub>90</sub>, respectively) is increased in mutants. (<bold>D</bold>) APD<sub>90</sub> was prolonged at all tested frequencies in mutant left atrial cardiomyocytes. Error bars are SD. (<bold>E</bold>) Diastolic and systolic intracellular Ca<sup>2+</sup> concentrations ([Ca<sup>2+</sup>]<sub>i</sub>) were not changed in <italic>Tbx5<sup>RE(int)KO</sup></italic> compared to controls. Statistical significance in B was determined with unpaired t-tests with Welchâs correction, and unpaired t-tests were used in B. Experimental groups were compared using two-way repeated measures ANOVA (<bold>D, E</bold>), followed by pairwise unpaired t-tests (<bold>C</bold>). Error bars are SEM.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80317-fig4-v2.tif"/></fig></sec><sec id="s2-3"><title>Sensitivity of the atrial gene regulatory network to modestly increased <italic>Tbx5</italic> dosage</title><p>To gain insight into the mechanism underlying the changes in electrophysiological properties in mutants, we performed transcriptional profiling of whole left atria. We detected 13790 and 13564 different transcripts in <italic>Tbx5<sup>RE(int)KO</sup></italic> and <italic>Tbx5<sup>RE(down)KO</sup></italic>, respectively, of which 816 were significantly up- and 1235 were downregulated in <italic>Tbx5<sup>RE(int)KO</sup></italic> (<xref ref-type="fig" rid="fig5">Figure 5A</xref>; adjusted p&lt;0.05), and 112 were up- and 123 were downregulated in <italic>Tbx5<sup>RE(down)KO</sup></italic> (<xref ref-type="fig" rid="fig5">Figure 5B</xref>; adjusted p&lt;0.05). Both datasets shared a high proportion of deregulated genes, with fewer significantly deregulated genes observed in <italic>Tbx5<sup>RE(down)KO</sup></italic> compared to <italic>Tbx5<sup>RE(int)KO</sup></italic> (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). These data indicate that transcriptomes in <italic>Tbx5<sup>RE(int)KO</sup></italic> atria and in <italic>Tbx5<sup>RE(down)KO</sup></italic> atria are comparably affected qualitatively, but not quantitatively, consistent with the slightly higher increase in <italic>Tbx5</italic> expression in <italic>Tbx5<sup>RE(int)KO</sup></italic> compared to <italic>Tbx5<sup>RE(down)KO</sup></italic>. Gene Ontology analysis (<xref ref-type="bibr" rid="bib45">Mi et al., 2019</xref>) revealed that processes involved in cellular compartment organization, ion transport, and cardiac conduction characterized the transcripts found in the upregulated genes, and extracellular matrix organization, vasculature development, and actin cytoskeleton organization were found in the downregulated set in both deletions (<xref ref-type="fig" rid="fig5">Figure 5D</xref>). Accordingly, several <italic>Tbx5</italic> target genes known to affect APD or whose deregulation may result in electrophysiological changes, (<xref ref-type="bibr" rid="bib13">Dai et al., 2019</xref>; <xref ref-type="bibr" rid="bib33">Laforest et al., 2019</xref>; <xref ref-type="bibr" rid="bib50">Nadadur et al., 2016</xref>; <xref ref-type="bibr" rid="bib89">Zhu et al., 2008</xref>) were significantly deregulated in one or both deletion lines (<xref ref-type="fig" rid="fig5">Figure 5F</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5âfigure supplement 1</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Transcriptomic analysis of <italic>Tbx5<sup>RE(int)KO</sup></italic> left atria.</title><p>(<bold>A, B</bold>) Volcano plot showing differentially expressed transcripts in <italic>Tbx5<sup>RE(int)KO</sup></italic> (n=3)(<bold>A</bold>) and <italic>Tbx5<sup>RE(down)KO</sup></italic> (n=3) (<bold>B</bold>) from <italic>wild-type</italic> (n=4) left atria. Dark red and light red dots indicate significantly upregulated genes by raw p-value and p-adjusted for multiple testing, respectively. Correspondingly, dark blue and light blue dots indicate downregulated genes. p Values were adjusted for multiple testing using the false discovery rate (FDR) method of Benjamini-Hochberg. (<bold>C</bold>) X-Y plot of all transcripts in <italic>Tbx5<sup>RE(int)KO</sup></italic> (x axis) and <italic>Tbx5<sup>RE(down)KO</sup></italic> (y axis), with deregulated genes common to both deletion mutants in purple, <italic>Tbx5<sup>RE(int)KO</sup></italic> deregulated genes in blue, and <italic>Tbx5<sup>RE(down)KO</sup></italic> deregulated genes in red. (<bold>D</bold>) Gene ontology (GO) analysis of upregulated and downregulated genes in <italic>Tbx5<sup>RE(int)KO</sup></italic> and <italic>Tbx5<sup>RE(down)KO</sup></italic> mutants. (<bold>F</bold>) Graph depicts fold change expression in control and mutant samples of genes known to affect action potential duration. * denotes significantly deregulated in one or both mutant lines.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80317-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5âfigure supplement 1.</label><caption><title>Ion channel expression in left atria of deletion mutants.</title><p>(<bold>A</bold>) Graph depicts differential ion channel expression (fold change) in control and mutant left atria. RPBPL; Reads per (transcript) base pair length.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80317-fig5-figsupp1-v2.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5âfigure supplement 2.</label><caption><title>Comparison of genes differentially expressed between left atria of <italic>Tbx5<sup>RE(int)KO</sup></italic> and control mice, <italic>Tbx5<sup>G125R/+</sup></italic> and control mice and <italic>Tbx5 iKO</italic> and control mice.</title><p>(<bold>AâB</bold>) Scatterplots of Log<sub>2</sub>(Fold Change) of transcripts in <italic>Tbx5<sup>RE(int)KO</sup></italic> (x axis) and (<bold>A</bold>) <italic>Tbx5<sup>G125R/+</sup></italic> or (<bold>B</bold>) <italic>Tbx5 iKO</italic> (y axis), with deregulated genes (Padj &lt;0.05) common to both genotypes in purple, <italic>Tbx5<sup>RE(int)KO</sup></italic> deregulated genes in blue and <italic>Tbx5<sup>G125R/+</sup></italic> or <italic>Tbx5 iKO</italic> deregulated genes in red.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80317-fig5-figsupp2-v2.tif"/></fig><fig id="fig5s3" position="float" specific-use="child-fig"><label>Figure 5âfigure supplement 3.</label><caption><title><italic>Pitx2</italic> expression is not affected in <italic>Tbx5<sup>RE(int)KO</sup></italic> atria.</title><p>(<bold>A</bold>) RT-qPCR on left and right atria of controls and deletion mutants for <italic>Pitx2</italic>. Statistical significance was determined by unpaired t-tests (no significant differences detected).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80317-fig5-figsupp3-v2.tif"/></fig><fig id="fig5s4" position="float" specific-use="child-fig"><label>Figure 5âfigure supplement 4.</label><caption><title>Modest <italic>Tbx5</italic> upregulation minimally alters genome-wide chromatin accessibility.</title><p>(<bold>A</bold>) Heatmaps depicting vertically sorted up or downregulated accessible regions spanning 1500 bp bins (Padj &lt;0.05) in <italic>Tbx5<sup>RE(int)KO</sup></italic> (n=4) vs <italic>WT</italic> (n=4) cardiomyocytes. (<bold>B</bold>) UCSC browser view of the <italic>Tbx5</italic> locus showing differential accessibility profiles in mutants.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80317-fig5-figsupp4-v2.tif"/></fig></fig-group><p>Next, we compared the transcriptional response to increased <italic>Tbx5</italic> in left atria (<italic>Tbx5<sup>RE(int)KO</sup></italic>) to that of a gain-of-function missense mutation (<italic>Tbx5<sup>G125R/+</sup></italic>) (<xref ref-type="bibr" rid="bib79">van Ouwerkerk et al., 2022</xref>), and noticed that it was unexpectedly divergent, with only 80 transcripts significantly deregulated in the same direction in both datasets (<xref ref-type="fig" rid="fig5s2">Figure 5âfigure supplement 2A</xref>, <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>). In contrast, comparison with left atria of inducible adult-specific <italic>Tbx5</italic> deletion (<italic>Tbx5iKO</italic>) (<xref ref-type="bibr" rid="bib50">Nadadur et al., 2016</xref>) revealed that the majority of significantly deregulated genes common to both datasets were changed in opposite direction (<xref ref-type="fig" rid="fig5s2">Figure 5âfigure supplement 2B</xref>, <xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref>), thus indicating the <italic>Tbx5</italic>-dependent regulatory network responds in opposite direction to increased- or decreased <italic>Tbx5</italic> dosage, respectively. <italic>PITX2</italic> is strongly associated with AF and functionally implicated in atrial rhythm control (<xref ref-type="bibr" rid="bib32">Kirchhof et al., 2011</xref>; <xref ref-type="bibr" rid="bib71">Tao et al., 2014</xref>; <xref ref-type="bibr" rid="bib85">Wang et al., 2010</xref>; <xref ref-type="bibr" rid="bib88">Zhang et al., 2019</xref>), and was previously found to be a Tbx5 target in the left atrium (<xref ref-type="bibr" rid="bib50">Nadadur et al., 2016</xref>). However, we did not detect a change in <italic>Pitx2</italic> expression in either the left or right atria of <italic>Tbx5<sup>RE(int)KO</sup></italic> mice (<xref ref-type="fig" rid="fig5s3">Figure 5âfigure supplement 3</xref>).</p><p>To determine whether a slight increase in <italic>Tbx5</italic> expression in cardiomyocytes results in changes in chromatin accessibility, we performed ATAC-sequencing profiling (ATACseq) of <italic>Tbx5<sup>RE(int)KO</sup></italic> left atrial cardiomyocytes (<xref ref-type="bibr" rid="bib9">Buenrostro et al., 2015</xref>). After peak-calling, we found a total of 85,569 accessible sites common to both genotypes, and only 15 sites of increased accessibility and 32 of decreased accessibility in mutants (<xref ref-type="fig" rid="fig5s4">Figure 5âfigure supplement 4A</xref>). Two of the sites with decreased accessibility were found in the locus of <italic>Tbx5</italic> (one of which caused by the deletion of the intronic genomic fragment in <italic>Tbx5<sup>RE(int)KO</sup></italic> mice), suggestive for increased direct transcriptional autoregulation in <italic>Tbx5<sup>RE(int)KO</sup></italic> mice (<xref ref-type="fig" rid="fig5s4">Figure 5âfigure supplement 4B</xref>). The very minor changes in chromatin accessibility indicate that a modest increase in <italic>Tbx5</italic> expression does not significantly change transcription factor occupancy or epigenetic state.</p></sec><sec id="s2-4"><title>An interaction between <italic>Tbx5</italic> and <italic>Prrx1</italic>, two AF-associated genes</title><p>We considered whether the presence of two AF-risk alleles would exacerbate the phenotype(s) consistent with AF. <italic>PRRX1</italic>, encoding the transcription factor Paired Related Homeobox 1, has been linked to AF-predisposition (<xref ref-type="bibr" rid="bib6">Bosada et al., 2021</xref>; <xref ref-type="bibr" rid="bib58">Roselli et al., 2018</xref>; <xref ref-type="bibr" rid="bib73">Tucker et al., 2017</xref>). Reduced <italic>PRRX1</italic> expression in human cardiac tissues has been associated with AF (<xref ref-type="bibr" rid="bib58">Roselli et al., 2018</xref>). We previously deleted the mouse orthologous variant region near <italic>PRRX1</italic> (Prrx1(enh)) to investigate its role in gene regulation and rhythm control (<xref ref-type="bibr" rid="bib6">Bosada et al., 2021</xref>). <italic>Prrx1<sup>(enh)KO</sup></italic> mice express less <italic>Prrx1</italic> specifically in cardiomyocytes compared to controls, and show atrial conduction slowing, lower AP upstroke velocity (indicative for lower Na<sup>+</sup> current densities; <xref ref-type="bibr" rid="bib5">Berecki et al., 2010</xref>), as well as increased systolic and diastolic [Ca<sup>2+</sup>]<sub>i</sub> concentration that culminate in increased susceptibility to atrial arrhythmia induction (<xref ref-type="bibr" rid="bib6">Bosada et al., 2021</xref>). To explore whether and how these two AF-risk genes may interact, we intercrossed <italic>Tbx5<sup>RE(int)KO</sup></italic> with <italic>Prrx1<sup>(enh)KO</sup></italic> mice (decreased <italic>Prrx1</italic> in cardiomyocytes), and investigated cardiac transcriptomes and phenotypes across genotypes. We isolated cardiomyocyte and non-cardiomyocyte nuclei from whole hearts using a PCM-1 antibody and interrogated <italic>Tbx5</italic> and <italic>Prrx1</italic> expression across all genotypes. <italic>Tbx5</italic> was upregulated in <italic>Tbx5<sup>RE(int)KO</sup></italic> cardiomyocytes, as expected, but not deregulated in <italic>Prrx1<sup>(enh)KO</sup></italic> or double mutant cardiomyocytes (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). <italic>Prrx1</italic> levels were increased in <italic>Tbx5<sup>RE(int)KO</sup></italic> cardiomyocytes and decreased in <italic>Prrx1<sup>(enh)KO</sup></italic>, as expected, and also decreased in double mutant cardiomyocytes (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). There were no statistically significant changes detected in the non-cardiomyocyte fractions (<xref ref-type="fig" rid="fig6">Figure 6A and B</xref>). These data indicate that in cardiomyocytes, Tbx5 regulates <italic>Prrx1</italic>, and that a regulatory feedback loop modulates <italic>Tbx5</italic> levels when <italic>Prrx1</italic> expression is reduced due to the Prrx1(enh) deletion.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>A genetic interaction between <italic>Tbx5</italic> and <italic>Prrx1</italic>.</title><p>(<bold>A, B</bold>) Graph shows reference gene-corrected expression of <italic>Tbx5</italic> (<bold>A</bold>), and <italic>Prrx1</italic> (<bold>B</bold>) in PCM1-positive and -negative nuclei fractions of <italic>wild-type</italic>, <italic>Tbx5<sup>RE(int)KO</sup></italic>, <italic>Prrx1<sup>(enh)KO</sup></italic> and <italic>double</italic> mutant whole hearts determined by RT-qPCR. (<bold>C</bold>) Principal component analysis of transcriptomes of <italic>wild-type</italic>, <italic>Tbx5<sup>RE(int)KO</sup></italic> and <italic>Double</italic>KO left atrial samples. (<bold>DâH</bold>) Graphs show individual and average ECG measurements for RR (<bold>D</bold>), heart rate variation (SDNN) (<bold>E</bold>), PR interval (<bold>F</bold>), cSNRT at 120ms pacing (<bold>G</bold>), and WBCL (<bold>H</bold>) of <italic>wild-type</italic>, <italic>Tbx5<sup>RE(int)KO</sup></italic>, <italic>Prrx1<sup>(enh)KO</sup></italic> and <italic>Double</italic>KO mice. (<bold>I</bold>) Bar graph depicts the total time each mouse spent in an AA episode after two pacing passes, with the number of mice in which at least one episode lasting &gt;1 s was observed below each bar. Statistical significance was determined using one-way ANOVA followed by Tukeyâs test for pairwise comparisons in A, B, F, H, Kruskal-Wallis test followed by Dunnâs test for pairwise comparisons in D, E, G, and AA duration in I (top of graph), Fisherâs exact test for pairwise comparisons of AA inducibility in I (bottom of graph).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80317-fig6-v2.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6âfigure supplement 1.</label><caption><title>Comparison of genes differentially expressed between left atria of <italic>Prrx1<sup>(enh)KO</sup></italic> and control mice, <italic>Tbx5<sup>RE(int)KO</sup></italic> and control mice, and <italic>Double homozygous</italic> mutants and control mice.</title><p>(<bold>AâB</bold>) X-Y plot of all transcripts in <italic>Prrx1<sup>(enh)KO</sup></italic> (<bold>A</bold>) or <italic>Tbx5<sup>RE(int)KO</sup></italic> (<bold>B</bold>) (x axis) and <italic>Double homozygous</italic> (y axis), with deregulated genes (Padj &lt;0.05) common to both genotypes in purple, <italic>Prrx1<sup>(enh)KO</sup>,</italic> or <italic>Tbx5<sup>RE(int)KO</sup></italic> deregulated genes in red and <italic>Double homozygous</italic> deregulated genes in blue. (<bold>C</bold>) Plot depicts comparison between <italic>Tbx5<sup>RE(int)KO</sup></italic> (x axis) and <italic>Prrx1<sup>(enh)KO</sup></italic> (y axis). (<bold>D</bold>) Box plots showing differences in Log<sub>2</sub>(Fold Change) distribution of <italic>Prrx1<sup>(enh)KO</sup>, Tbx5<sup>RE(int)KO</sup></italic>, and <italic>Double homozygous</italic> left atria.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-80317-fig6-figsupp1-v2.tif"/></fig></fig-group><p>We next performed transcriptome analysis and found that deregulated genes in left atria of <italic>Tbx5<sup>RE(int)KO</sup>;Prrx1<sup>(enh)KO</sup></italic> double mutants were more similar to the transcript changes found in <italic>Tbx5<sup>RE(int)KO</sup></italic> than the ones found in <italic>Prrx1<sup>(enh)KO</sup></italic>, when comparing all lines to WT, suggesting a dominant contribution of <italic>Tbx5<sup>RE(int)KO</sup></italic> to the transcriptional changes in double mutants (<xref ref-type="fig" rid="fig6s1">Figure 6âfigure supplement 1A-C</xref>, <xref ref-type="supplementary-material" rid="supp6 supp7">Supplementary files 6-7</xref>). Using principal component analysis, we found that transcriptomes clustered according to genotype (<xref ref-type="fig" rid="fig6">Figure 6C</xref>). Compared to atrial transcriptomes of <italic>Tbx5<sup>RE(int)KO</sup></italic> mice, those of <italic>Tbx5<sup>RE(int)KO</sup>;Prrx1<sup>(enh)KO</sup></italic> double homozygous showed less variance with WT atrial transcriptomes (<xref ref-type="fig" rid="fig6">Figure 6C</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6âfigure supplement 1</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). This suggested an interaction between <italic>Tbx5</italic> and <italic>Prrx1</italic>, in which reduced <italic>Prrx1</italic> expression partially normalizes increased Tbx5-induced transcriptomic changes.</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Gene ontology (GO) analysis of upregulated and downregulated genes in <italic>Tbx5<sup>RE(int)KO</sup></italic>, <italic>Prrx1<sup>(enh)KO</sup></italic>, and <italic>Double homozygous</italic> adult left atria.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom"/><th align="left" valign="bottom" colspan="4">Prrx1(enh)KO</th><th align="left" valign="bottom" colspan="4">Tbx5RE(int)KO</th><th align="left" valign="bottom" colspan="4">Double</th></tr></thead><tbody><tr><td align="left" valign="bottom">GO biological process</td><td align="left" valign="bottom">UP/DOWN</td><td align="left" valign="bottom">Fold enrich</td><td align="left" valign="bottom">P-value</td><td align="left" valign="bottom">FDR</td><td align="left" valign="bottom">UP/DOWN</td><td align="left" valign="bottom">Fold enrich</td><td align="left" valign="bottom">P-value</td><td align="left" valign="bottom">FDR</td><td align="left" valign="bottom">UP/DOWN</td><td align="left" valign="bottom">Fold enrich</td><td align="left" valign="bottom">P-value</td><td align="left" valign="bottom">FDR</td></tr><tr><td align="left" valign="bottom">âRegulation of biological quality (GO:0065008)</td><td align="left" valign="bottom">DOWN</td><td align="char" char="." valign="bottom">1.64</td><td align="char" char="hyphen" valign="bottom">1.7E-08</td><td align="char" char="hyphen" valign="bottom">3E-06</td><td align="left" valign="bottom">UP</td><td align="char" char="." valign="bottom">1.55</td><td align="char" char="hyphen" valign="bottom">1.5E-10</td><td align="char" char="hyphen" valign="bottom">8E-07</td><td align="left" valign="bottom">UP</td><td align="char" char="." valign="bottom">1.56</td><td align="char" char="hyphen" valign="bottom">3.4E-08</td><td align="char" char="hyphen" valign="bottom">1.5E-05</td></tr><tr><td align="left" valign="bottom">âLocalization (GO:0051179)</td><td align="left" valign="bottom">DOWN</td><td align="char" char="." valign="bottom">2.11</td><td align="char" char="hyphen" valign="bottom">1.5E-14</td><td align="char" char="hyphen" valign="bottom">1.6E-11</td><td align="left" valign="bottom">UP</td><td align="char" char="." valign="bottom">1.45</td><td align="char" char="hyphen" valign="bottom">1.7E-09</td><td align="char" char="hyphen" valign="bottom">6.5E-06</td><td align="left" valign="bottom">UP</td><td align="char" char="." valign="bottom">1.44</td><td align="char" char="hyphen" valign="bottom">2.9E-07</td><td align="char" char="hyphen" valign="bottom">8E-05</td></tr><tr><td align="left" valign="bottom">âDevelopmental process (GO:0032502)</td><td align="left" valign="bottom">UP</td><td align="char" char="." valign="bottom">2.33</td><td align="char" char="hyphen" valign="bottom">6.1E-20</td><td align="char" char="hyphen" valign="bottom">1.6E-16</td><td align="left" valign="bottom">UP</td><td align="char" char="." valign="bottom">1.39</td><td align="char" char="hyphen" valign="bottom">6.8E-09</td><td align="char" char="hyphen" valign="bottom">2.1E-05</td><td align="left" valign="bottom">UP</td><td align="char" char="." valign="bottom">1.61</td><td align="char" char="hyphen" valign="bottom">1.8E-14</td><td align="char" char="hyphen" valign="bottom">2.9E-10</td></tr><tr><td align="left" valign="bottom">âCellular component organization (GO:0016043)</td><td align="left" valign="bottom">DOWN</td><td align="char" char="." valign="bottom">1.85</td><td align="char" char="hyphen" valign="bottom">4.3E-08</td><td align="char" char="hyphen" valign="bottom">6.9E-06</td><td align="left" valign="bottom">UP</td><td align="char" char="." valign="bottom">1.41</td><td align="char" char="hyphen" valign="bottom">1.4E-08</td><td align="char" char="hyphen" valign="bottom">3.1E-05</td><td align="left" valign="bottom">UP</td><td align="char" char="." valign="bottom">1.54</td><td align="char" char="hyphen" valign="bottom">1.3E-10</td><td align="char" char="hyphen" valign="bottom">2.2E-07</td></tr><tr><td align="left" valign="bottom">âRegulation of ion transport (GO:0043269)</td><td align="left" valign="bottom">DOWN</td><td align="char" char="." valign="bottom">2.68</td><td align="char" char="hyphen" valign="bottom">8.7E-08</td><td align="char" char="hyphen" valign="bottom">1.3E-05</td><td align="left" valign="bottom">UP</td><td align="char" char="." valign="bottom">2.22</td><td align="char" char="hyphen" valign="bottom">1.7E-07</td><td align="char" char="." valign="bottom">0.00018</td><td align="left" valign="bottom">UP</td><td align="char" char="." valign="bottom">2.36</td><td align="char" char="hyphen" valign="bottom">7.6E-07</td><td align="char" char="." valign="bottom">0.00018</td></tr><tr><td align="left" valign="bottom">âRegulation of cell communication (GO:0010646)</td><td align="left" valign="bottom">DOWN</td><td align="char" char="." valign="bottom">2.18</td><td align="char" char="hyphen" valign="bottom">2.8E-18</td><td align="char" char="hyphen" valign="bottom">1.1E-14</td><td align="left" valign="bottom">UP</td><td align="char" char="." valign="bottom">1.48</td><td align="char" char="hyphen" valign="bottom">3.3E-07</td><td align="char" char="." valign="bottom">0.00029</td><td align="left" valign="bottom">UP</td><td align="char" char="." valign="bottom">1.57</td><td align="char" char="hyphen" valign="bottom">3.4E-07</td><td align="char" char="hyphen" valign="bottom">8.9E-05</td></tr><tr><td align="left" valign="bottom">âPositive regulation of cell projection organization (GO:0031346)</td><td align="left" valign="bottom">DOWN</td><td align="char" char="." valign="bottom">2.07</td><td align="char" char="." valign="bottom">0.00033</td><td align="char" char="." valign="bottom">0.0158</td><td align="left" valign="bottom">UP</td><td align="char" char="." valign="bottom">2.44</td><td align="char" char="hyphen" valign="bottom">1.5E-06</td><td align="char" char="." valign="bottom">0.001</td><td align="left" valign="bottom">UP</td><td align="char" char="." valign="bottom">2.08</td><td align="char" char="hyphen" valign="bottom">3.9E-07</td><td align="char" char="." valign="bottom">0.0001</td></tr><tr><td align="left" valign="bottom">âCardiac conduction (GO:0061337)</td><td align="left" valign="bottom">DOWN</td><td align="char" char="." valign="bottom">7.1</td><td align="char" char="." valign="bottom">0.00011</td><td align="char" char="." valign="bottom">0.00597</td><td align="left" valign="bottom">UP</td><td align="char" char="." valign="bottom">6.57</td><td align="char" char="hyphen" valign="bottom">3.6E-06</td><td align="char" char="." valign="bottom">0.00203</td><td align="left" valign="bottom">UP</td><td align="char" char="." valign="bottom">7.36</td><td align="char" char="hyphen" valign="bottom">1E-05</td><td align="char" char="." valign="bottom">0.0015</td></tr><tr><td align="left" valign="bottom">âCell differentiation (GO:0030154)</td><td align="left" valign="bottom">UP</td><td align="char" char="." valign="bottom">2.25</td><td align="char" char="hyphen" valign="bottom">2.8E-11</td><td align="char" char="hyphen" valign="bottom">8.2E-09</td><td align="left" valign="bottom">UP</td><td align="char" char="." valign="bottom">1.39</td><td align="char" char="hyphen" valign="bottom">7.9E-06</td><td align="char" char="." valign="bottom">0.00276</td><td align="left" valign="bottom">UP</td><td align="char" char="." valign="bottom">1.65</td><td align="char" char="hyphen" valign="bottom">4.8E-10</td><td align="char" char="hyphen" valign="bottom">5.8E-07</td></tr><tr><td align="left" valign="bottom">âMetal ion transport (GO:0030001)</td><td align="left" valign="bottom">DOWN</td><td align="char" char="." valign="bottom">3.43</td><td align="char" char="hyphen" valign="bottom">4.5E-08</td><td align="char" char="hyphen" valign="bottom">7.3E-06</td><td align="left" valign="bottom">UP</td><td align="char" char="." valign="bottom">2.18</td><td align="char" char="hyphen" valign="bottom">1E-05</td><td align="char" char="." valign="bottom">0.00342</td><td align="left" valign="bottom">UP</td><td align="char" char="." valign="bottom">2.25</td><td align="char" char="." valign="bottom">0.00069</td><td align="char" char="." valign="bottom">0.049</td></tr><tr><td align="left" valign="bottom">Regulation of cell motility (GO:2000145)</td><td align="left" valign="bottom">UP</td><td align="char" char="." valign="bottom">2.96</td><td align="char" char="hyphen" valign="bottom">2.1E-14</td><td align="char" char="hyphen" valign="bottom">1.2E-11</td><td align="left" valign="bottom">DOWN</td><td align="char" char="." valign="bottom">3.35</td><td align="char" char="hyphen" valign="bottom">2.3E-38</td><td align="char" char="hyphen" valign="bottom">9.1E-35</td><td align="left" valign="bottom">DOWN</td><td align="char" char="." valign="bottom">2.28</td><td align="char" char="hyphen" valign="bottom">2.5E-05</td><td align="char" char="." valign="bottom">0.00564</td></tr><tr><td align="left" valign="bottom">Extracellular matrix organization (GO:0030198)</td><td align="left" valign="bottom">UP</td><td align="char" char="." valign="bottom">7.57</td><td align="char" char="hyphen" valign="bottom">2E-24</td><td align="char" char="hyphen" valign="bottom">3.1E-20</td><td align="left" valign="bottom">DOWN</td><td align="char" char="." valign="bottom">6.12</td><td align="char" char="hyphen" valign="bottom">3.5E-34</td><td align="char" char="hyphen" valign="bottom">4.2E-31</td><td align="left" valign="bottom">DOWN</td><td align="char" char="." valign="bottom">7.87</td><td align="char" char="hyphen" valign="bottom">3.2E-17</td><td align="char" char="hyphen" valign="bottom">5.1E-13</td></tr><tr><td align="left" valign="bottom">Circulatory system development (GO:0072359)</td><td align="left" valign="bottom">UP</td><td align="char" char="." valign="bottom">3.3</td><td align="char" char="hyphen" valign="bottom">2.8E-17</td><td align="char" char="hyphen" valign="bottom">3.7E-14</td><td align="left" valign="bottom">DOWN</td><td align="char" char="." valign="bottom">3.2</td><td align="char" char="hyphen" valign="bottom">3.3E-32</td><td align="char" char="hyphen" valign="bottom">2.5E-29</td><td align="left" valign="bottom">DOWN</td><td align="char" char="." valign="bottom">3.14</td><td align="char" char="hyphen" valign="bottom">2.3E-10</td><td align="char" char="hyphen" valign="bottom">9.1E-07</td></tr><tr><td align="left" valign="bottom">Vasculature development (GO:0001944)</td><td align="left" valign="bottom">UP</td><td align="char" char="." valign="bottom">4.11</td><td align="char" char="hyphen" valign="bottom">4.6E-17</td><td align="char" char="hyphen" valign="bottom">4.8E-14</td><td align="left" valign="bottom">DOWN</td><td align="char" char="." valign="bottom">3.97</td><td align="char" char="hyphen" valign="bottom">1.6E-31</td><td align="char" char="hyphen" valign="bottom">1E-28</td><td align="left" valign="bottom">DOWN</td><td align="char" char="." valign="bottom">3.23</td><td align="char" char="hyphen" valign="bottom">3.2E-07</td><td align="char" char="." valign="bottom">0.00017</td></tr><tr><td align="left" valign="bottom">Regulation of response to stimulus (GO:0048583)</td><td align="left" valign="bottom">UP</td><td align="char" char="." valign="bottom">1.91</td><td align="char" char="hyphen" valign="bottom">1.8E-17</td><td align="char" char="hyphen" valign="bottom">2.6E-14</td><td align="left" valign="bottom">DOWN</td><td align="char" char="." valign="bottom">1.79</td><td align="char" char="hyphen" valign="bottom">1.3E-28</td><td align="char" char="hyphen" valign="bottom">5.8E-26</td><td align="left" valign="bottom">DOWN</td><td align="char" char="." valign="bottom">1.61</td><td align="char" char="hyphen" valign="bottom">2.2E-06</td><td align="char" char="." valign="bottom">0.00072</td></tr><tr><td align="left" valign="bottom">Actin cytoskeleton organization (GO:0030036)</td><td align="left" valign="bottom">DOWN</td><td align="char" char="." valign="bottom">3.17</td><td align="char" char="hyphen" valign="bottom">4.6E-08</td><td align="char" char="hyphen" valign="bottom">7.3E-06</td><td align="left" valign="bottom">DOWN</td><td align="char" char="." valign="bottom">3.91</td><td align="char" char="hyphen" valign="bottom">4.9E-28</td><td align="char" char="hyphen" valign="bottom">1.9E-25</td><td align="left" valign="bottom">DOWN</td><td align="char" char="." valign="bottom">3.26</td><td align="char" char="hyphen" valign="bottom">7.9E-07</td><td align="char" char="." valign="bottom">0.00034</td></tr><tr><td align="left" valign="bottom">Cell adhesion (GO:0007155)</td><td align="left" valign="bottom">UP</td><td align="char" char="." valign="bottom">2.92</td><td align="char" char="hyphen" valign="bottom">3.9E-12</td><td align="char" char="hyphen" valign="bottom">1.5E-09</td><td align="left" valign="bottom">DOWN</td><td align="char" char="." valign="bottom">3.1</td><td align="char" char="hyphen" valign="bottom">1.8E-27</td><td align="char" char="hyphen" valign="bottom">6.6E-25</td><td align="left" valign="bottom">DOWN</td><td align="char" char="." valign="bottom">2.99</td><td align="char" char="hyphen" valign="bottom">1.1E-08</td><td align="char" char="hyphen" valign="bottom">1.9E-05</td></tr><tr><td align="left" valign="bottom">Biological adhesion (GO:0022610)</td><td align="left" valign="bottom">UP</td><td align="char" char="." valign="bottom">2.94</td><td align="char" char="hyphen" valign="bottom">2E-12</td><td align="char" char="hyphen" valign="bottom">8.2E-10</td><td align="left" valign="bottom">DOWN</td><td align="char" char="." valign="bottom">3.06</td><td align="char" char="hyphen" valign="bottom">4.9E-27</td><td align="char" char="hyphen" valign="bottom">1.6E-24</td><td align="left" valign="bottom">DOWN</td><td align="char" char="." valign="bottom">2.95</td><td align="char" char="hyphen" valign="bottom">1.4E-08</td><td align="char" char="hyphen" valign="bottom">2E-05</td></tr><tr><td align="left" valign="bottom">Angiogenesis (GO:0001525)</td><td align="left" valign="bottom">UP</td><td align="char" char="." valign="bottom">4.5</td><td align="char" char="hyphen" valign="bottom">4.9E-12</td><td align="char" char="hyphen" valign="bottom">1.8E-09</td><td align="left" valign="bottom">DOWN</td><td align="char" char="." valign="bottom">4.87</td><td align="char" char="hyphen" valign="bottom">4.9E-27</td><td align="char" char="hyphen" valign="bottom">1.6E-24</td><td align="left" valign="bottom">DOWN</td><td align="char" char="." valign="bottom">4.17</td><td align="char" char="hyphen" valign="bottom">3.7E-07</td><td align="char" char="." valign="bottom">0.00019</td></tr><tr><td align="left" valign="bottom">Animal organ development (GO:0048513)</td><td align="left" valign="bottom">UP</td><td align="char" char="." valign="bottom">2.03</td><td align="char" char="hyphen" valign="bottom">8.4E-17</td><td align="char" char="hyphen" valign="bottom">7.4E-14</td><td align="left" valign="bottom">DOWN</td><td align="char" char="." valign="bottom">1.84</td><td align="char" char="hyphen" valign="bottom">1.3E-23</td><td align="char" char="hyphen" valign="bottom">3.3E-21</td><td align="left" valign="bottom">DOWN</td><td align="char" char="." valign="bottom">1.78</td><td align="char" char="hyphen" valign="bottom">3.4E-07</td><td align="char" char="." valign="bottom">0.00018</td></tr></tbody></table></table-wrap><p>Next, we considered whether the adult electrophysiological changes observed in <italic>Tbx5<sup>RE(int)KO</sup></italic> would also be rescued by the presence of this second AF-risk allele. In vivo ECGs and burst pacing experiments revealed that RR, PR interval, and WBCL were normalized in double homozygous mice, whereas SDNN, cSNRT, and AA inducibility remained unchanged (<xref ref-type="fig" rid="fig6">Figure 6DâI</xref>).</p><p>Taken together, our findings suggest that an interaction between <italic>Tbx5</italic> and <italic>Prrx1</italic> exists; in which <italic>Prrx1</italic> expression is induced by Tbx5, where <italic>Prrx1</italic> is required to induce <italic>Tbx5</italic> expression in <italic>Prrx1<sup>(enh)KO</sup></italic> mice, and increased Tbx5 imposes changes in expression and electrophysiological properties, in part through increasing <italic>Prrx1</italic> expression in cardiomyocytes.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Our study reveals that mouse orthologues of two independent variant regions in the <italic>TBX5</italic> locus modulate <italic>Tbx5</italic> expression in tissue- and stage-specific manners, causing distinct specific phenotypes. While the impact of 50â100% dose reduction of <italic>Tbx5</italic> in humans and model systems has been well-investigated (<xref ref-type="bibr" rid="bib2">Bamshad et al., 1997</xref>; <xref ref-type="bibr" rid="bib8">Bruneau et al., 2001</xref>; <xref ref-type="bibr" rid="bib29">Kathiriya et al., 2021</xref><xref ref-type="bibr" rid="bib36">Li et al., 1997</xref>; <xref ref-type="bibr" rid="bib40">Luna-Zurita et al., 2016</xref>; <xref ref-type="bibr" rid="bib47">Mori et al., 2006</xref>; <xref ref-type="bibr" rid="bib48">Moskowitz et al., 2004</xref>), we here show the effect of physiologically relevant increases in expression of <italic>Tbx5</italic>. This is significant as both decreased and increased expression of genes has been associated with increased AF risk.(<xref ref-type="bibr" rid="bib58">Roselli et al., 2018</xref>). Our study reveals that atrial- and postnatal-specific increase in <italic>Tbx5</italic> levels of only 30% affects postnatal atrial gene regulation, function and arrhythmia propensity. Furthermore, we provide an example of the interaction between the effect of two independent AF-associated variant regions (<italic>TBX5</italic> and <italic>PRRX1</italic>) on phenotype. Our models provide insight into the mechanisms underlying the pleiotropic effects and interactions of disease-associated regulatory variants, which typically cause small changes in target gene expression in particular cell-types, conditions or stages of development (<xref ref-type="bibr" rid="bib22">GTEx Consortium, 2020</xref>; <xref ref-type="bibr" rid="bib67">Sobreira et al., 2021</xref>; <xref ref-type="bibr" rid="bib70">Strober et al., 2019</xref>; <xref ref-type="bibr" rid="bib86">Watanabe et al., 2019</xref>).</p><p>We found that the mouse orthologues of two noncoding regions studied here containing AF-associated variants in the <italic>TBX5</italic> locus harbor REs that independently controlled <italic>Tbx5</italic> expression in the heart in vivo. Deletion of either of the two RE-containing regions only affected <italic>Tbx5</italic> expression, consistent with the notion that <italic>Tbx5</italic> and surrounding RE regions are largely confined to one topologically associated domain not shared with adjacent genes (<xref ref-type="bibr" rid="bib80">van Weerd et al., 2014</xref>). The mechanism of the repressive action of the REs and cross-talk with the other REs in the locus (<xref ref-type="bibr" rid="bib66">Smemo et al., 2012</xref>) remain to be established. For RE(int), which showed the largest effect size in atria upon deletion, we identified two AF-associated SNPs that caused differential transcriptional activity of the RE sub fragment in HL1 atrial cardiomyocyte-like cells; one variant caused ~sixfold increase and the other minimally decreased activity. The risk allele of the first variant, rs7312625, disrupts a potential Lin54 motif, implying loss of interaction with the DREAM complex (<xref ref-type="bibr" rid="bib61">Sadasivam and DeCaprio, 2013</xref>), and thus suggesting possible cell cycle-dependent regulation that remains to be elucidated. We speculate that in individuals carrying the variant that increases the activity of RE(int) in HL-1 cells, the repressive activity of RE(int) is reduced in the context of the entire regulatory system, thus causing increased <italic>TBX5</italic> expression. The opposite could be true for the second variant, yet the small effect would likely be experimentally undetectable. On the other hand, the AF-associated variants in RE(down) may increase <italic>Tbx5</italic> expression in both the left atrium and pulmonary vein myocardium. The pulmonary veins have been strongly implicated in AF as they are the most common source of triggered activity (<xref ref-type="bibr" rid="bib23">HaÃ¯ssaguerre et al., 1998</xref>; <xref ref-type="bibr" rid="bib27">JaiÂ¨s et al., 1997</xref>). <italic>TBX5</italic> levels in pulmonary vein myocardium may influence gene regulation independently from the atrial <italic>TBX5</italic> levels (<xref ref-type="bibr" rid="bib69">Steimle et al., 2020</xref>). The variants in RE(down) segregate independently from those in RE(int), indicating these variant RE regions act through distinct tissue-specific transcriptional mechanisms that are influenced by AF-predisposing common variants. A further implication is they may cumulatively increase AF predisposition in a manner dependent on risk variant dose, in which homozygous carriers of risk haplotypes in RE(int) and RE(down) have the largest relative predisposition. These relations could be addressed in future genotype-phenotype analyses of human atrial and pulmonary vein samples.</p><p>Heart rates of the <italic>Tbx5<sup>RE(int)KO</sup></italic> mice were slower and more variable than of controls. In addition, PR interval was prolonged in <italic>Tbx5<sup>RE(int)KO</sup></italic> mice combination with increased Wenckebach cycle lengths. The latter is in line with the important role of Tbx5 in sinus node and AV node development and function (<xref ref-type="bibr" rid="bib47">Mori et al., 2006</xref>; <xref ref-type="bibr" rid="bib49">Moskowitz et al., 2007</xref>; <xref ref-type="bibr" rid="bib48">Moskowitz et al., 2004</xref>; <xref ref-type="bibr" rid="bib76">van Eif et al., 2018</xref>). Moreover, atrial arrhythmias could be more easily induced in <italic>Tbx5<sup>RE(int)KO</sup></italic> mice suggesting electrophysiological remodeling of the atria. It has been shown that mice haploinsufficient for <italic>Tbx5</italic> show atrial downregulation of genes encoding proteins involved in cardiac conduction (e.g. <italic>Gja1</italic>/Cx43 and <italic>Scn5a</italic>/Nav1.5) and Ca<sup>2+</sup> handling (e.g <italic>Atp2a2</italic>/Serca2a and <italic>Ryr2</italic>/Ryr2) (<xref ref-type="bibr" rid="bib50">Nadadur et al., 2016</xref>; <xref ref-type="bibr" rid="bib89">Zhu et al., 2008</xref>). This leads to slower conduction, reduced Ca<sup>2+</sup> concentration in the sarcoplasmic reticulum [Ca<sup>2+</sup>]<sub>SR</sub>, increased incidence of early and delayed afterdepolarization, and accordingly, increased AF propensity (<xref ref-type="bibr" rid="bib33">Laforest et al., 2019</xref>; <xref ref-type="bibr" rid="bib50">Nadadur et al., 2016</xref>). In the atria of our <italic>Tbx5<sup>RE(int)KO</sup></italic> mice, where expression of <italic>Tbx5</italic> was slightly elevated, transcriptomic analysis indicated upregulation of genes involved in cardiac conduction including <italic>Scn5a</italic> and <italic>Cx43</italic>. The Ca<sup>2+</sup> handling genes <italic>Atp2a2</italic>/Serca2a and <italic>Ryr2</italic>/Ryr2 were not differently expressed between <italic>Tbx5<sup>RE(int)KO</sup></italic> mice and controls. Accordingly, in our mice, we did not observe any changes in Ca<sup>2+</sup> transients and long decay constants as seen in <italic>Tbx5</italic> haploinsufficient mice (<xref ref-type="bibr" rid="bib33">Laforest et al., 2019</xref>). Expression of <italic>Cacna1c</italic> and <italic>Cacna2d2/Cacna2d3,</italic> encoding subunits of the L-type Ca<sup>2+</sup> channel, was upregulated in the atrium of <italic>Tbx5<sup>RE(int)KO</sup></italic> mice. This is consistent with the observed longer atrial APD in <italic>Tbx5<sup>RE(int)KO</sup></italic> mice compared to controls, which may predispose to increased arrhythmia inducibility, as seen in mice harboring the pathogenic TBX5-G125R variant or <italic>Prrx1</italic> enhancer deletion (<xref ref-type="bibr" rid="bib6">Bosada et al., 2021</xref>; <xref ref-type="bibr" rid="bib79">van Ouwerkerk et al., 2022</xref>). Although shortened APD is typically found in AF patients with sustained arrhythmia (<xref ref-type="bibr" rid="bib30">Kim et al., 2002</xref>; <xref ref-type="bibr" rid="bib87">Wu et al., 2001</xref>), prolonged APD has been previously associated with increased risk of developing AF (<xref ref-type="bibr" rid="bib6">Bosada et al., 2021</xref>; <xref ref-type="bibr" rid="bib35">Lee et al., 2016</xref>; <xref ref-type="bibr" rid="bib53">Olson et al., 2006</xref>; <xref ref-type="bibr" rid="bib65">Simpson et al., 1988</xref>; <xref ref-type="bibr" rid="bib79">van Ouwerkerk et al., 2022</xref>).</p><p>The molecular mechanisms underlying electrophysiological remodeling have remained unclear. For example, atrial cardiomyocytes of <italic>Tbx5</italic> iKO (<italic>Tbx5</italic> deletion induced in adult mice), of <italic>Tbx5</italic><sup>+/G125R</sup> (heterozygous for a gain of function missense mutation) and of <italic>Tbx5<sup>RE(int)KO</sup></italic> mice show APD prolongation (<xref ref-type="bibr" rid="bib50">Nadadur et al., 2016</xref>; <xref ref-type="bibr" rid="bib79">van Ouwerkerk et al., 2022</xref>). When comparing the transcriptional changes in left atria of these mouse models, we observed that it was unexpectedly divergent between the <italic>Tbx5<sup>RE(int)KO</sup></italic> and <italic>Tbx5</italic><sup>+/G125R</sup> models, whereas significantly differentially expressed genes common to both <italic>Tbx5<sup>RE(int)KO</sup></italic> and <italic>Tbx5</italic> iKO models were changed in opposite direction (<xref ref-type="fig" rid="fig5s2">Figure 5âfigure supplement 2</xref>, <xref ref-type="supplementary-material" rid="supp4 supp5">Supplementary files 4 and 5</xref>). This suggests that the degree and direction of change of expression of, for example, genes implicated in APD (including <italic>Cacna2d3</italic>, <italic>Camk2a</italic>, <italic>Kcnh2</italic>, and <italic>Ryr2</italic>) do not necessarily predict changes in APD. Furthermore, <italic>Pitx2</italic> was downregulated in left atria of <italic>Tbx5</italic> iKO mice and upregulated in right atria of <italic>Tbx5</italic><sup>+/G125R</sup> mice (<xref ref-type="bibr" rid="bib79">van Ouwerkerk et al., 2022</xref>), and Tbx5 and Pitx2 were found to work antagonistically in the left atrium to tightly regulate the expression of genes impacting on cardiac electrophysiology (<xref ref-type="bibr" rid="bib50">Nadadur et al., 2016</xref>). Yet, we did not detect a change in <italic>Pitx2</italic> expression in the atria of <italic>Tbx5<sup>RE(int)KO</sup></italic> mice. Together, these findings indicate that decreasing or increasing Tbx5 dose or changing Tbx5 function induces a large number of divergent transcriptional responses that disturb the balance in the genetic networks underlying functional (electrophysiological) properties of the atria, such as APD, leading to similar phenotypic outcomes.</p><p>The risk of developing complex diseases such as AF is strongly influenced by a large number of pleiotropic variants that each confers a small change in overall risk. We found that Tbx5 drives <italic>Prrx1</italic> expression, and that <italic>Tbx5</italic> levels are Prrx1-dependent (or Prrx1 target-dependent) in specific contexts. We then asked whether combining two alleles modeling the changes in gene expression conferred by AF-associated variant regions would cause a greater effect on heart phenotype, and by extension, arrhythmia predisposition, than each allele alone. Here, we found that introduction of this AF-susceptibility allele <italic>Tbx5<sup>RE(int)KO</sup></italic> mice rescued heart rate, PR interval, and atrioventricular node phenotypes. This example shows that two variant regions that are both independently associated with increased risk for a particular disease, do not necessarily cumulatively increase disease predisposing phenotype, but may neutralize each otherâs effect. Previously, the atrial electrophysiological phenotype of <italic>Tbx5</italic> haploinsufficient mice was observed to be rescued by haploinsufficiency of either <italic>Pitx2</italic> or <italic>Gata4</italic>, both of which have been associated with AF as well (<xref ref-type="bibr" rid="bib33">Laforest et al., 2019</xref>; <xref ref-type="bibr" rid="bib50">Nadadur et al., 2016</xref>). Although the direction of change of expression of the transcription factors in these models does not necessarily correspond to the direction of change in AF patients, this highlights the inherent robustness of the underlying gene regulatory networks, which in general remain stable when individual quantitative parameters such as transcription factor dose or binding sites affinity change (<xref ref-type="bibr" rid="bib1">Albergante et al., 2014</xref>). This also implies that evaluating specific interactions between AF risk loci will be necessary for ascertaining individual risk from genetic association data.</p><p>In conclusion, our data provide unique mechanistic insights into the biological effects of variant region-driven modest physiologically relevant changes in expression of crucial transcriptional regulators, and into the impact of interactions between transcriptional output-modulating risk loci on atrial biology.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Usage of epigenomic datasets</title><p>The following publicly available epigenomic datasets were used: Hi-C (<xref ref-type="bibr" rid="bib57">Rao et al., 2014</xref>), AF variants (<xref ref-type="bibr" rid="bib58">Roselli et al., 2018</xref>), promoter capture Hi-C maps from iPSC-derived cardiomyocytes (<xref ref-type="bibr" rid="bib46">Montefiori et al., 2018</xref>), accessible chromatin in human and mouse left atria (<xref ref-type="bibr" rid="bib77">van Ouwerkerk et al., 2019</xref>), cardiac H3K27ac and H3K4me1 ChIP-seq signatures in human (<xref ref-type="bibr" rid="bib19">Gilsbach et al., 2014</xref>), and EMERGE enhancer prediction signal (<xref ref-type="bibr" rid="bib75">van Duijvenboden et al., 2019</xref>; <xref ref-type="bibr" rid="bib77">van Ouwerkerk et al., 2019</xref>).</p></sec><sec id="s4-2"><title>Generation of mutant mice</title><p>Mutant mice were generated using CRISPR/Cas9. Guide RNA (sgRNA) constructs were designed with ZiFiT Targeter (<xref ref-type="bibr" rid="bib62">Sander et al., 2010</xref>). The sgRNA constructs were transcribed in vitro using MEGAshortscript T7 (Invitrogen AM1354) and mMessage Machine T7 transcription kit (Invitrogen AM1344) according to manufacturer instructions. One-cell FVB/NRj zygotes were microinjected with 10 ng/ÂµL each sgRNA and 25 ng/ÂµL Cas9 mRNA to generate mouse founders. Deletions were validated by PCR and Sanger sequencing. The sgRNA target sequences are the following: RE(int) guide 1 (<named-content content-type="sequence">GGGAAATCGCCTTACCTTTC</named-content>), guide 2 (<named-content content-type="sequence">GGACTGTTGGGTCACCTTGT</named-content>), and RE(down) guide 1 (<named-content content-type="sequence">GGCTCCTTCGTCAGTAAATA</named-content>), guide 2 (<named-content content-type="sequence">AAACAAGGGCTCTCTGGCGTTT</named-content>). The deleted coordinates are the following in mm10: RE(int) chr5:119,874,013â119,880,148, and RE(down) chr5:119,891,017â119,915,744. Founders were backcrossed with wildtype FVB/NJ mice to obtain stable lines. Downstream experiments were performed on F3-F7 mice, backcrossed with wild-type FVB mice. All transgenic mice were maintained on a FVB/NJ background commercially obtained from Jackson laboratory (stock number 100800).</p><p>For tissue harvest, animals were euthanized by 20% CO<sub>2</sub> inhalation followed by cervical dislocation.</p></sec><sec id="s4-3"><title>EdU cardiomyocyte proliferation assay</title><p>Timed pregnant female mice received intraperitoneal injection of 100 mg/kg EdU one hour before sacrifice by isoflurane and cervical dislocation. E14.5 fetuses were isolated in 1xPBS on ice, the head was removed and the body fixed in 4% PFA for 24 hr. 7 Î¼m sections were stained with mouse-anti-actin (1:400; Sigma A9357), goat-anti-nkx2.5 (1:150; Santa Cruz sc-14033), DAPI (1:1000) and EdU Click-IT (ThermoFisher, C10340) before imaging and counting. Nkx2.5 positive nuclei were designated cardiomyocytes, Nkx2.5 and EdU double positive nuclei were designated proliferating cardiomyocytes. Ratios were normalized within each litter.</p></sec><sec id="s4-4"><title>qPCR</title><p>Total RNA was isolated from atria, ventricle and lungs from P21 and left and right atria from adult male and female mice using ReliaPrep RNA Tissue Miniprep System (Promega, Z6112) according to the manufacturerâs protocol. cDNA was reverse transcribed with oligo dT primers from 500 ng of total RNA, or random hexamers from 500 pg of CM nuclear RNA, according to the manufacturerâs protocol of the Superscript II Reverse Transcriptase system (Thermo Fisher Scientific, 18064014). Expression levels of candidate target genes were determined by quantitative real-time PCR using a LightCycler 480 Instrument II (Roche Life Science, 05015243001). Expression levels were measured using LightCycler 480 SYBR Green I Master (Roche, 04887352001) and the primers had a concentration of 1 pmol/L. The amplification protocol consisted of 5 min 95 Â°C followed by 45 cycles of 10 s 95 Â°C, 20 s 60 Â°C and 20 s 72 Â°C. Relative start concentration (N0) was calculated using LinRegPCR (<xref ref-type="bibr" rid="bib59">Ruijter et al., 2009</xref>). Values were normalized to the geometric mean of two reference genes per experiment (Hprt, Ppia, or Rpl32) (<xref ref-type="bibr" rid="bib60">Ruiz-Villalba et al., 2017</xref>). The primer sequences are as follows: (all 3â to 5â) Hprt: <named-content content-type="sequence">TGTTGGATATGCCCTTGACT</named-content>, <named-content content-type="sequence">GATTCAACTTGCGCTCATCT</named-content>; Ppia: <named-content content-type="sequence">GGGTGGTGACTTTACACGCC</named-content>, <named-content content-type="sequence">CTTGCCATCCAGCCATTCAG</named-content>; Rpl32: <named-content content-type="sequence">GCCTCTGGTGAAGCCCAAG</named-content>, <named-content content-type="sequence">TTGTTGCTCCCATAACCGATGT</named-content>; Tbx5: <named-content content-type="sequence">CCCGGAGACAGCTTTTATCG</named-content>, <named-content content-type="sequence">TGGTTGGAGGTGACTTTGTG</named-content>; Prrx1: <named-content content-type="sequence">CACAAGCAGACGAAAGTGTGG</named-content>, <named-content content-type="sequence">GTTGTCCTGTTTCTCCGCTG</named-content>; Tbx3:<named-content content-type="sequence"> CGCCGTTACTGCCTATCAGAA</named-content>; <named-content content-type="sequence">GCCATTGCCAGTGTCTCGAA</named-content>.</p></sec><sec id="s4-5"><title>Cell culture and transfection luciferase assays</title><p>RE sub fragments were cloned into a modified pGL2-Basic plasmid containing an SV40 minimal promoter and an adjusted multiple cloning site for in vitro analysis by a transfection luciferase assay. HL1 cells (RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:CVCL_0303">CVCL_0303</ext-link>) were grown in 24-well plates in Claycomb medium (Sigma-Aldrich, 51,800 C) supplemented with chemically defined HL-1 FBS substitute (Lonza, 77227), Glutamax (ThermoFisher Scientific, 35050â061) and Pen/Strep (ThermoFisher Scientific, 15070â063). Cells were transfected using polyethylenimine 25 kDa (PEI, Brunschwig, 23966â2) at a 1:3 ratio (DNA:PEI). Standard transfections were carried out using 200 ng of reporter construct per well. 24 hr after transfection, cells were lysed using Renilla luciferase assay lysis buffer (Promega, E291A-C) and luciferase activity measured. Luciferase measurements were performed using a GloMax Explorer (Promega, GM3500). During the measurement, 100 ÂµL D-Luciferin (p.j.k, 102111) was injected (150 ÂµL/s) followed by a 1-s delay and 5 s of measurement. Transfections were carried out at least three times and measured in duplicates. HL-1 cell cultures were routinely tested negative for mycoplasma contamination. HL-1 cell lines were easily distinguished based on cellular morphology and contractility. HL-1 is not found in the database of commonly misidentified cell lines that is maintained by the International Cell Line Authentication Committee.</p></sec><sec id="s4-6"><title>In vivo electrophysiology</title><p>12â20 week old male mice were anesthetized with 5% Isoflurane (Pharmachemie B.V. 061756) and placed on thermostated mat (36 Â°C) with a steady flow of 1.5% isoflurane during all experiments. Electrodes were inserted subcutaneously in the limbs and connected to an ECG amplifier (Powerlab 26T, AD Instruments). The electrocardiogram (ECG) was measured for 5 min. ECG parameters were determined in Lead II (L-R) based on the last 60 s of the recording. For atrial stimulation, an octapolar CIBâer electrode (NuMED) was advanced through the esophagus to achieve atrial capture. Atrial capture thresholds were determined for each mouse, and all pacing protocols were performed at 2 x threshold. For sinus node recovery time (SNRT) measurements, a 4-s pacing train with a cycle length of 120 or 100ms was used. SNRT was defined as the interval between the last pacing stimulus and onset of the first P wave. To control for differences in sinus rate, SNRT was normalized to resting heart rate (cSNRT = SNRT â RR interval). To determine the Wenckebach cycle length (WBCL) we applied a 4s pacing train starting at a cycle length of 100ms, and decreasing by 2ms until atrioventricular (AV) block was first observed. Atrial arrhythmia (AA) was induced by 1 or 2 s bursts starting with a cycle length of 60ms, decreasing successively with a 2 ms decrement, down to a cycle length of 10ms. AA duration was the sum of time each mouse spent under and AA episode after completion of the two passes. Atrial arrhythmia (AA) inducibility was scored as the number of mice in which at least one episode lasting &gt;1 s of arrhythmia was induced after pacing. Mice of both sexes were used for atrial arrhythmia induction experiments.</p></sec><sec id="s4-7"><title>Cellular electrophysiology</title><p>Single cells were isolated from left atria of adult male mice by enzymatic dissociation. Therefore, excised hearts were perfused for 5 min in a Langendorff system with a modified Tyrodeâs solution containing (in mmol/L): NaCl 140, KCl 5.4, CaCl<sub>2</sub> 1.8, MgCl<sub>2</sub> 1.0, glucose 5.5, HEPES 5.0; pH 7.4 (set with NaOH). Subsequently, the hearts were perfused with Tyrodeâs solution containing a low Ca<sup>2+</sup>-concentration (10 Î¼mol/L) for 10 min, after which Liberase TM research grade (Roche Diagnostics, GmbH, Mannheim, Germany, 5401119001) and Elastase from porcine pancreas (Bio-Connect B.V., Huissen, Netherlands, W59168R) were added for 12 min at a concentration of 0.038 mg/mL and 0.01 mg/mL, respectively. All solutions were saturated with 100% O<sub>2</sub> and the temperature was maintained at 37 Â°C. To obtain single cells, the digested left atria was cut into small pieces which were triturated for 4 min through a pipette (tip diameter: 0.8 mm) in the low Ca<sup>2+</sup> Tyrodeâs solution, supplemented with 10 mg/ml Bovine Serum Albumin (Roche Diagnostics, essential fatty free, fraction V). Single cells were stored at room temperature for at least 45 min before they were used. Quiescent single rod-shaped cells with smooth surfaces were selected for electrophysiological measurements.</p><p>Action potentials (APs) were recorded with the amphotericin-B perforated patch-clamp technique using an Axopatch 200B amplifier (Molecular Devices Corporation, Sunnyvale, CA). Voltage control and data acquisition were performed as described previously (<xref ref-type="bibr" rid="bib28">Kamel et al., 2021</xref>), and APs were low-pass filtered at 5 kHz and digitized at 40 kHz. Potentials were corrected for the estimated liquid junction potentials (<xref ref-type="bibr" rid="bib3">Barry and Lynch, 1991</xref>).</p><p>APs were recorded at 36 Â± 0.2Â°C using the modified Tyrodeâs solution. Pipettes (borosilicate glass (Harvard Apparatus, UK)) were filled with solution containing (in mmol/l): K-gluc 125, KCl 20, NaCl 5, amphotericin-B 0.44, HEPES 10, pH 7.2 (KOH). APs were elicited at 2â8 Hz by 3ms,~1.2 Ã threshold current pulses through the patch pipette. We analyzed resting membrane potential (RMP), maximal AP amplitude (APA), maximum AP upstroke velocity, and AP duration at 20, 50, and 90% repolarization (APD<sub>20</sub>, APD<sub>50</sub>, and APD<sub>90</sub>, respectively). Parameters from 10 consecutive APs were averaged.</p></sec><sec id="s4-8"><title>Intracellular Ca<sup>2+</sup> measurements</title><p>Intracellular calcium concentrations: [Ca<sup>2+</sup>]<sub>i</sub> were measured at 25 Â°C in HEPES solution ((mmol/l): Na<sup>+</sup> 156, K<sup>+</sup> 4.7, Ca<sup>2+</sup> 1.3, Mg<sup>2+</sup> 2.0, Cl<sup>â</sup> 150.6, HCO<sub>3</sub> 4.3, HPO<sub>2</sub><sup>â</sup> 1.4, HEPES 17, Glucose 11 and 1% fatty acid free albumin, pH 7.3) using the fluorescent probe Indo-1 as described previously (<xref ref-type="bibr" rid="bib82">Verkerk et al., 2003</xref>). In brief, isolated myocytes were exposed to 5 Âµmol/l of the acetoxymethyl esters of indo-1 during 30 min at 37 Â°C. Myocytes were attached to a poly-D-lysine (0.1 g/l) treated cover slip placed on a temperature-controlled microscope stage of an inverted fluorescence microscope (Nikon Diaphot) with quartz optics. A temperature-controlled perfusion chamber (height 0.4 mm, diameter 10 mm, volume 30 ÂµL, temperature 37 Â°C), with two needles at opposite sides for perfusion purposes, was tightly positioned over the cover slip. The contents of the chamber could be replaced within 100ms. Bipolar square pulses for field stimulation (40 V/cm) were applied through two thin parallel platinum electrodes at a distance of 8 mm. One quiescent single myocyte was selected (myocytes with more than one spontaneous oscillation per 10 s were excluded) and the measuring area was adjusted to the cell surface with a rectangular diaphragm. The wavelength of excitation of Indo-1 was 340 nm, applied with a stabilized xenon-arc lamp (100 W). Fluorescence was measured in dual emission mode at 410 and 516 nm. Emitted light passed a barrier filter of 400 nm, a dichroic mirror (450 nm) and respective narrow band interference filters in front of two photomultipliers (Hamamatsu R-2949). Signals were digitized at 1 kHz and corrected for background signals recorded from Indo-1 free myocytes. Ten subsequent Ca<sup>2+</sup> transients were averaged from which apparent [Ca<sup>2+]</sup><sub>i</sub> was calculated according to the ratio equation (<xref ref-type="bibr" rid="bib21">Grynkiewicz et al., 1985</xref>).</p></sec><sec id="s4-9"><title>Isolation of CM nuclei</title><p>Nuclei isolation was performed as follows: snap frozen adult left and right atria from adult male and female mice were trimmed and homogenized in lysis buffer containing RNase inhibitor using an Ultra-Turrax homogenizer. Samples were further homogenized with a loose pestle douncer (10 strokes). After a 10 min incubation in the lysis buffer, an additional 10 strokes were performed with a tight pestle. The lysis procedure was monitored by light microscopy to ensure complete tissue and cell lysis and efficient nuclear extraction. The crude lysate was successively passed through 100â and 30 Âµm mesh filters. The final lysate was spun at 1000âÃâg for 5 âmin and the resulting pellet was resuspended in 500 âÂµl staining buffer (5% BSA in PBS) supplemented with RNAse inhibitor. Isolated nuclei were incubated with rabbit polyclonal antibodies specific for pericentriolar material 1 (PCM1) (Sigma-Aldrich; HPA023370) at a dilution of 1:400 for 1 âhr rotating at 4 âÂ°C. Next, Alexa Fluor 647-conjugated donkey-anti-rabbit 647 antibodies (ThermoFisher Scientific A-31573; 1:500 dilution), and DAPI (1:1000 dilution) were added and the incubation was continued for an additional hour. Samples were spun at 1000âÃâg for 10 âmin and washed with 500 âÂµl staining buffer before resuspension in 500 âÂµl staining buffer supplemented with RNAse inhibitor. Intact CM nuclei were sorted on a BD Influx FACS on the basis of DAPI and Alexa Fluor 647 positivity into cold BL +TG buffer from the ReliaPrep RNA Tissue Miniprep System (Promega, Z6112) for RNA isolation, and into resuspension buffer for ATACseq (<xref ref-type="bibr" rid="bib9">Buenrostro et al., 2015</xref>). RNA was isolated following a gDNA depletion step according to the manufacturerâs instructions. RNA yield and purity was assessed using an Agilent 2100 Bioanalyzer in combination with the RNA Pico chips.</p></sec><sec id="s4-10"><title>Library preparation and sequencing</title><p>For RNA isolated from left atria, 500 ng was used for library generation with the KAPA mRNA HyperPrep kit (Roche) and sequenced on the HiSeq4000 system (Illumina) with 50 bp single-end reads. RNAseq sample sizes are as follows: Whole adult left atria: 4 WT, 3 <italic>Tbx5<sup>RE(int)KO</sup></italic>, 3 <italic>Tbx5<sup>RE(down)KO</sup></italic>, 4 <italic>Prrx1<sup>(enh)KO</sup></italic>, and 3 <italic>Double homozygous</italic>.</p></sec><sec id="s4-11"><title>Differential expression analysis</title><p>Reads were mapped to the mm10 build of the mouse transcriptome using STAR (<xref ref-type="bibr" rid="bib17">Dobin et al., 2013</xref>). Differential expression analysis was performed using the DESeq2 package based on a negative binomial distribution model (<xref ref-type="bibr" rid="bib38">Love et al., 2014</xref>). p-Values were corrected for multiple testing using the false discovery rate (FDR) method of Benjamini-Hochberg. We have used 0.05 as FDR control level. Unsupervised hierarchical clustering was performed on differentially expressed genes using the R package pheatmap version 1.0.8. (<ext-link ext-link-type="uri" xlink:href="http://cran.rproject.org/web/packages/pheatmap/index.html">http://cran.rproject.org/web/packages/pheatmap/index.html</ext-link>). PANTHER (<xref ref-type="bibr" rid="bib45">Mi et al., 2019</xref>) was used for gene ontology (GO) biological process analysis. BenjaminiâHochberg correction was performed for multiple testing-controlled p values. Statistically significant enriched terms were functionally grouped and visualized.</p></sec><sec id="s4-12"><title>ATACseq on CM nuclei</title><p>ATACseq on FACS-sorted PCM1 +nuclei was performed and analyzed as described in <xref ref-type="bibr" rid="bib9">Buenrostro et al., 2015</xref>. Approximately 50 k nuclei were used as input. The library was sequenced (paired-end 125 bp) and data was collected on a HiSeq4000.</p></sec><sec id="s4-13"><title>Peak-calling and motif analysis of ATACseq</title><p>Reads from ATAC-seq data were mapped to mm10 build of the mouse genome using BWA (<xref ref-type="bibr" rid="bib37">Li and Durbin, 2009</xref>), the default settings were used. The BEDTools suite was used to distribute the genome wide signal into bins of 500 bp (<xref ref-type="bibr" rid="bib56">Quinlan and Hall, 2010</xref>). Bins with less than 89 cumulative tags across all 10 samples were discarded as noise. Differential accessibility was assessed using the DESeq2 package based on a model using the negative binomial distribution (<xref ref-type="bibr" rid="bib38">Love et al., 2014</xref>). p-Values were corrected for multiple testing using the false discovery rate (FDR) method of Benjamini-Hochberg. We have used 0.05 as FDR control level. Continuous bins with differential signal were subsequently merged together using the BEDTools suite.</p><p>200 bp summits were determined of ATAC-seq performed in atrial cells (<xref ref-type="bibr" rid="bib18">Fernandez-Perez et al., 2019</xref>). In total, HOMER (<xref ref-type="bibr" rid="bib24">Heinz et al., 2010</xref>) was performed on sequences of 2000 neutral called peaks (randomly sampled out of 85,570 peaks), 2000 peaks up (randomly sampled out of 3551 peaks), and 1776 peaks down in <italic>Tbx5<sup>RE(int)KO</sup></italic>, all with random genome as background in HOMER.</p><p>Unsupervised hierarchical clustering was performed on differentially detected peaks and genes in RNA-seq and ATAC-seq using the R package pheatmap, version 1.0.8. (<ext-link ext-link-type="uri" xlink:href="http://cran.r-project.org/web/packages/pheatmap/index.html">http://cran.r-project.org/web/packages/pheatmap/index.html</ext-link>).</p></sec><sec id="s4-14"><title>Usage of EMERGE</title><p>The genome-wide heart enhancer prediction track generated by EMERGE (<xref ref-type="bibr" rid="bib74">van Duijvenboden et al., 2016</xref>) was used as a proxy for the presence of putative heart enhancers. The particular prediction used aimed at identifying robustly active heart enhancers. This was accomplished by further annotating the available true positives (<xref ref-type="bibr" rid="bib83">Visel et al., 2007</xref>) to train the algorithm with on the basis of the consistency in heart activity patterns shown. Full details are outlined in <xref ref-type="bibr" rid="bib77">van Ouwerkerk et al., 2019</xref>.</p></sec><sec id="s4-15"><title>Statistics</title><p>The experimenters were blind to mouse genotype during all measurements and outcome assessment. Datasets were tested for normality using Shapiro-Wilk test unless specified otherwise. Whole tissue RT-qPCR fold change vs WT in fetal ventricles and adult whole left atria corrected expression changes were analyzed with unpaired t-tests and reference gene-corrected <italic>Tbx5</italic> in juvenile whole tissue was analyzed with Welchâs ANOVA followed by Dunnetâs T3 multiple comparison tests within each tissue type. Luciferase assays on HL1 cells were analyzed using Kruskal-Wallis test. In vivo electrophysiology was analyzed with Kruskal-Wallis followed by Dunnâs multiple comparison tests or one-way ANOVA followed by Tukeyâs multiple comparison tests. Significance of atrial arrhythmia (AA) duration was determined with Mann Whitney Wilcoxon test and differences in AA inducibility were tested using Fisherâs exact test. Conduction velocity was analyzed with unpaired t-tests with Welchâs correction. For single cell and whole tissue action potential (AP) duration (APD) normality and equal variance assumptions were tested with the Kolmogorov-Smirnov and the Levene median test, respectively. Two groups were compared with unpaired t-test or repeated measures ANOVA followed by pairwise comparison using the Student-Newman-Keuls test. Differences in Ca<sup>2+</sup> transient amplitude as well as changes in diastolic and systolic Ca<sup>2+</sup> concentrations in atria were tested using two-way ANOVA. Multiple testing corrections were performed independently within each hypothesis. Data are presented as individual data points and mean or mean Â± standard error of the mean (SEM) or standard deviation (SD), as indicated, and &lt;0.05 defines statistical significance. Statistical analysis was performed using GraphPad Prism 9.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Investigation, Visualization, Writing â original draft, Writing â review and editing</p></fn><fn fn-type="con" id="con2"><p>Data curation, Visualization, Writing â review and editing</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Investigation, Methodology</p></fn><fn fn-type="con" id="con4"><p>Formal analysis, Writing â review and editing</p></fn><fn fn-type="con" id="con5"><p>Data curation, Formal analysis, Writing â review and editing</p></fn><fn fn-type="con" id="con6"><p>Data curation, Formal analysis, Writing â review and editing</p></fn><fn fn-type="con" id="con7"><p>Data curation, Formal analysis, Supervision, Investigation, Methodology, Writing â original draft, Writing â review and editing</p></fn><fn fn-type="con" id="con8"><p>Conceptualization, Supervision, Funding acquisition, Writing â original draft, Writing â review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Housing, husbandry, all animal care and experimental protocols were in accordance with guidelines 310 from the Directive 2010/63/EU of the European Parliament and Dutch government. Protocols were 311 approved by the Animal Experimental Committee of the Amsterdam University Medical Centers. 312 Animal group sizes were determined based on previous experience.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>rs7312625 motif analysis +- 30 bp.</title><p>Changed motifs in red.</p></caption><media xlink:href="elife-80317-supp1-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>DESeq2 result WT vs <italic>Tbx5<sup>RE(int)KO</sup></italic> adult left atria.</title></caption><media xlink:href="elife-80317-supp2-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>DESeq2 result WT vs <italic>Tbx5<sup>RE(down)KO</sup></italic> adult left atria.</title></caption><media xlink:href="elife-80317-supp3-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp4"><label>Supplementary file 4.</label><caption><title>RNAseq comparison of <italic>Tbx5<sup>RE(down)KO</sup></italic> and <italic>Tbx5<sup>G125R/+</sup></italic> adult left atria.</title></caption><media xlink:href="elife-80317-supp4-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp5"><label>Supplementary file 5.</label><caption><title>RNAseq comparison of <italic>Tbx5<sup>RE(down)KO</sup></italic> and <italic>Tbx5iKO</italic> adult left atria.</title></caption><media xlink:href="elife-80317-supp5-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp6"><label>Supplementary file 6.</label><caption><title>DESeq2 result WT vs Double adult left atria.</title></caption><media xlink:href="elife-80317-supp6-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp7"><label>Supplementary file 7.</label><caption><title>DESeq2 result WT v <italic>Prrx1<sup>(enh)KO</sup></italic> adult left atria.</title></caption><media xlink:href="elife-80317-supp7-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp8"><label>Supplementary file 8.</label><caption><title>Deletion coordinates in mm10.</title></caption><media xlink:href="elife-80317-supp8-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-80317-mdarchecklist1-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>Adult left atrial RNAseq and ATACseq have been deposited under GEO accession numbers GSE189342 and GSE189498.</p><p>The following datasets were generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Bosada</surname><given-names>FM</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Tbx5 regulatory element controls atrial function and heart size</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE189342">GSE189342</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset2"><person-group person-group-type="author"><name><surname>Bosada</surname><given-names>FM</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Tbx5 regulatory element controls atrial function and heart size</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE189498">GSE189498</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank Berend de Jonge for technical assistance. This work was supported by CardioVasculair Onderzoek Nederland (CVON) project 2014â18 CONCOR-genes Young Talent Program (to FMB), CVON project 2014â18 CONCOR-genes (to VMC), Leducq Foundation 14CVD01 (to VMC), Dutch CardioVascular Alliance OUTREACH (to VMC) and ZonMW TOP 91217061 (to VMC).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albergante</surname><given-names>L</given-names></name><name><surname>Blow</surname><given-names>JJ</given-names></name><name><surname>Newman</surname><given-names>TJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Buffered qualitative stability explains the robustness and evolvability of transcriptional networks</article-title><source>eLife</source><volume>3</volume><elocation-id>e02863</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.02863</pub-id><pub-id pub-id-type="pmid">25182846</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bamshad</surname><given-names>M</given-names></name><name><surname>Lin</surname><given-names>RC</given-names></name><name><surname>Law</surname><given-names>DJ</given-names></name><name><surname>Watkins</surname><given-names>WC</given-names></name><name><surname>Krakowiak</surname><given-names>PA</given-names></name><name><surname>Moore</surname><given-names>ME</given-names></name><name><surname>Franceschini</surname><given-names>P</given-names></name><name><surname>Lala</surname><given-names>R</given-names></name><name><surname>Holmes</surname><given-names>LB</given-names></name><name><surname>Gebuhr</surname><given-names>TC</given-names></name><name><surname>Bruneau</surname><given-names>BG</given-names></name><name><surname>Schinzel</surname><given-names>A</given-names></name><name><surname>Seidman</surname><given-names>JG</given-names></name><name><surname>Seidman</surname><given-names>CE</given-names></name><name><surname>Jorde</surname><given-names>LB</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Mutations in human TBX3 alter limb, apocrine and genital development in Ulnar-Mammary syndrome</article-title><source>Nature Genetics</source><volume>16</volume><fpage>311</fpage><lpage>315</lpage><pub-id pub-id-type="doi">10.1038/ng0797-311</pub-id><pub-id pub-id-type="pmid">9207801</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barry</surname><given-names>PH</given-names></name><name><surname>Lynch</surname><given-names>JW</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Liquid junction potentials and small cell effects in patch-clamp analysis</article-title><source>The Journal of Membrane Biology</source><volume>121</volume><fpage>101</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1007/BF01870526</pub-id><pub-id pub-id-type="pmid">1715403</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basson</surname><given-names>CT</given-names></name><name><surname>Bachinsky</surname><given-names>DR</given-names></name><name><surname>Lin</surname><given-names>RC</given-names></name><name><surname>Levi</surname><given-names>T</given-names></name><name><surname>Elkins</surname><given-names>JA</given-names></name><name><surname>Soults</surname><given-names>J</given-names></name><name><surname>Grayzel</surname><given-names>D</given-names></name><name><surname>Kroumpouzou</surname><given-names>E</given-names></name><name><surname>Traill</surname><given-names>TA</given-names></name><name><surname>Leblanc-Straceski</surname><given-names>J</given-names></name><name><surname>Renault</surname><given-names>B</given-names></name><name><surname>Kucherlapati</surname><given-names>R</given-names></name><name><surname>Seidman</surname><given-names>JG</given-names></name><name><surname>Seidman</surname><given-names>CE</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Mutations in human Tbx5 [ corrected ] cause limb and cardiac malformation in Holt-Oram syndrome</article-title><source>Nature Genetics</source><volume>15</volume><fpage>30</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1038/ng0197-30</pub-id><pub-id pub-id-type="pmid">8988165</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berecki</surname><given-names>G</given-names></name><name><surname>Wilders</surname><given-names>R</given-names></name><name><surname>de Jonge</surname><given-names>B</given-names></name><name><surname>van Ginneken</surname><given-names>ACG</given-names></name><name><surname>Verkerk</surname><given-names>AO</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Re-Evaluation of the action potential upstroke velocity as a measure of the Na+ current in cardiac myocytes at physiological conditions</article-title><source>PLOS ONE</source><volume>5</volume><elocation-id>e15772</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0015772</pub-id><pub-id pub-id-type="pmid">21217835</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bosada</surname><given-names>FM</given-names></name><name><surname>Rivaud</surname><given-names>MR</given-names></name><name><surname>Uhm</surname><given-names>J-S</given-names></name><name><surname>Verheule</surname><given-names>S</given-names></name><name><surname>van Duijvenboden</surname><given-names>K</given-names></name><name><surname>Verkerk</surname><given-names>AO</given-names></name><name><surname>Christoffels</surname><given-names>VM</given-names></name><name><surname>Boukens</surname><given-names>BJ</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>A variant noncoding region regulates Prrx1 and predisposes to atrial arrhythmias</article-title><source>Circulation Research</source><volume>129</volume><fpage>420</fpage><lpage>434</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.121.319146</pub-id><pub-id pub-id-type="pmid">34092116</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruneau</surname><given-names>BG</given-names></name><name><surname>Logan</surname><given-names>M</given-names></name><name><surname>Davis</surname><given-names>N</given-names></name><name><surname>Levi</surname><given-names>T</given-names></name><name><surname>Tabin</surname><given-names>CJ</given-names></name><name><surname>Seidman</surname><given-names>JG</given-names></name><name><surname>Seidman</surname><given-names>CE</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Chamber-Specific cardiac expression of Tbx5 and heart defects in Holt-Oram syndrome</article-title><source>Developmental Biology</source><volume>211</volume><fpage>100</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1006/dbio.1999.9298</pub-id><pub-id pub-id-type="pmid">10373308</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruneau</surname><given-names>BG</given-names></name><name><surname>Nemer</surname><given-names>G</given-names></name><name><surname>Schmitt</surname><given-names>JP</given-names></name><name><surname>Charron</surname><given-names>F</given-names></name><name><surname>Robitaille</surname><given-names>L</given-names></name><name><surname>Caron</surname><given-names>S</given-names></name><name><surname>Conner</surname><given-names>DA</given-names></name><name><surname>Gessler</surname><given-names>M</given-names></name><name><surname>Nemer</surname><given-names>M</given-names></name><name><surname>Seidman</surname><given-names>CE</given-names></name><name><surname>Seidman</surname><given-names>JG</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor TBX5 in cardiogenesis and disease</article-title><source>Cell</source><volume>106</volume><fpage>709</fpage><lpage>721</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(01)00493-7</pub-id><pub-id pub-id-type="pmid">11572777</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buenrostro</surname><given-names>JD</given-names></name><name><surname>Wu</surname><given-names>B</given-names></name><name><surname>Chang</surname><given-names>HY</given-names></name><name><surname>Greenleaf</surname><given-names>WJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Atac-seq: a method for assaying chromatin accessibility genome-wide</article-title><source>Current Protocols in Molecular Biology</source><volume>109</volume><elocation-id>21</elocation-id><pub-id pub-id-type="doi">10.1002/0471142727.mb2129s109</pub-id><pub-id pub-id-type="pmid">25559105</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cenni</surname><given-names>C</given-names></name><name><surname>Andres</surname><given-names>S</given-names></name><name><surname>Hempel</surname><given-names>M</given-names></name><name><surname>Strom</surname><given-names>TM</given-names></name><name><surname>Thomas</surname><given-names>E</given-names></name><name><surname>Davies</surname><given-names>A</given-names></name><name><surname>Timoney</surname><given-names>N</given-names></name><name><surname>Frigiola</surname><given-names>A</given-names></name><name><surname>Logan</surname><given-names>M</given-names></name><name><surname>Holder-Espinasse</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Tbx3 and tbx5 duplication: a family with an atypical overlapping holt-oram/ulnar-mammary syndrome phenotype</article-title><source>European Journal of Medical Genetics</source><volume>64</volume><elocation-id>104213</elocation-id><pub-id pub-id-type="doi">10.1016/j.ejmg.2021.104213</pub-id><pub-id pub-id-type="pmid">33930582</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christophersen</surname><given-names>IE</given-names></name><name><surname>Rienstra</surname><given-names>M</given-names></name><name><surname>Roselli</surname><given-names>C</given-names></name><name><surname>Yin</surname><given-names>X</given-names></name><name><surname>Geelhoed</surname><given-names>B</given-names></name><name><surname>Barnard</surname><given-names>J</given-names></name><name><surname>Lin</surname><given-names>H</given-names></name><name><surname>Arking</surname><given-names>DE</given-names></name><name><surname>Smith</surname><given-names>AV</given-names></name><name><surname>Albert</surname><given-names>CM</given-names></name><name><surname>Chaffin</surname><given-names>M</given-names></name><name><surname>Tucker</surname><given-names>NR</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Klarin</surname><given-names>D</given-names></name><name><surname>Bihlmeyer</surname><given-names>NA</given-names></name><name><surname>Low</surname><given-names>SK</given-names></name><name><surname>Weeke</surname><given-names>PE</given-names></name><name><surname>MÃ¼ller-Nurasyid</surname><given-names>M</given-names></name><name><surname>Smith</surname><given-names>JG</given-names></name><name><surname>Brody</surname><given-names>JA</given-names></name><name><surname>Niemeijer</surname><given-names>MN</given-names></name><name><surname>DÃ¶rr</surname><given-names>M</given-names></name><name><surname>Trompet</surname><given-names>S</given-names></name><name><surname>Huffman</surname><given-names>J</given-names></name><name><surname>Gustafsson</surname><given-names>S</given-names></name><name><surname>Schurmann</surname><given-names>C</given-names></name><name><surname>Kleber</surname><given-names>ME</given-names></name><name><surname>LyytikÃ¤inen</surname><given-names>LP</given-names></name><name><surname>SeppÃ¤lÃ¤</surname><given-names>I</given-names></name><name><surname>Malik</surname><given-names>R</given-names></name><name><surname>Horimoto</surname><given-names>A</given-names></name><name><surname>Perez</surname><given-names>M</given-names></name><name><surname>Sinisalo</surname><given-names>J</given-names></name><name><surname>Aeschbacher</surname><given-names>S</given-names></name><name><surname>ThÃ©riault</surname><given-names>S</given-names></name><name><surname>Yao</surname><given-names>J</given-names></name><name><surname>Radmanesh</surname><given-names>F</given-names></name><name><surname>Weiss</surname><given-names>S</given-names></name><name><surname>Teumer</surname><given-names>A</given-names></name><name><surname>Choi</surname><given-names>SH</given-names></name><name><surname>Weng</surname><given-names>LC</given-names></name><name><surname>Clauss</surname><given-names>S</given-names></name><name><surname>Deo</surname><given-names>R</given-names></name><name><surname>Rader</surname><given-names>DJ</given-names></name><name><surname>Shah</surname><given-names>SH</given-names></name><name><surname>Sun</surname><given-names>A</given-names></name><name><surname>Hopewell</surname><given-names>JC</given-names></name><name><surname>Debette</surname><given-names>S</given-names></name><name><surname>Chauhan</surname><given-names>G</given-names></name><name><surname>Yang</surname><given-names>Q</given-names></name><name><surname>Worrall</surname><given-names>BB</given-names></name><name><surname>ParÃ©</surname><given-names>G</given-names></name><name><surname>Kamatani</surname><given-names>Y</given-names></name><name><surname>Hagemeijer</surname><given-names>YP</given-names></name><name><surname>Verweij</surname><given-names>N</given-names></name><name><surname>Siland</surname><given-names>JE</given-names></name><name><surname>Kubo</surname><given-names>M</given-names></name><name><surname>Smith</surname><given-names>JD</given-names></name><name><surname>Van Wagoner</surname><given-names>DR</given-names></name><name><surname>Bis</surname><given-names>JC</given-names></name><name><surname>Perz</surname><given-names>S</given-names></name><name><surname>Psaty</surname><given-names>BM</given-names></name><name><surname>Ridker</surname><given-names>PM</given-names></name><name><surname>Magnani</surname><given-names>JW</given-names></name><name><surname>Harris</surname><given-names>TB</given-names></name><name><surname>Launer</surname><given-names>LJ</given-names></name><name><surname>Shoemaker</surname><given-names>MB</given-names></name><name><surname>Padmanabhan</surname><given-names>S</given-names></name><name><surname>Haessler</surname><given-names>J</given-names></name><name><surname>Bartz</surname><given-names>TM</given-names></name><name><surname>Waldenberger</surname><given-names>M</given-names></name><name><surname>Lichtner</surname><given-names>P</given-names></name><name><surname>Arendt</surname><given-names>M</given-names></name><name><surname>Krieger</surname><given-names>JE</given-names></name><name><surname>KÃ¤hÃ¶nen</surname><given-names>M</given-names></name><name><surname>Risch</surname><given-names>L</given-names></name><name><surname>Mansur</surname><given-names>AJ</given-names></name><name><surname>Peters</surname><given-names>A</given-names></name><name><surname>Smith</surname><given-names>BH</given-names></name><name><surname>Lind</surname><given-names>L</given-names></name><name><surname>Scott</surname><given-names>SA</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Bottinger</surname><given-names>EB</given-names></name><name><surname>Hernesniemi</surname><given-names>J</given-names></name><name><surname>Lindgren</surname><given-names>CM</given-names></name><name><surname>Wong</surname><given-names>JA</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Eskola</surname><given-names>M</given-names></name><name><surname>Morris</surname><given-names>AP</given-names></name><name><surname>Ford</surname><given-names>I</given-names></name><name><surname>Reiner</surname><given-names>AP</given-names></name><name><surname>Delgado</surname><given-names>G</given-names></name><name><surname>Chen</surname><given-names>LY</given-names></name><name><surname>Chen</surname><given-names>YDI</given-names></name><name><surname>Sandhu</surname><given-names>RK</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Boerwinkle</surname><given-names>E</given-names></name><name><surname>Eisele</surname><given-names>L</given-names></name><name><surname>Lannfelt</surname><given-names>L</given-names></name><name><surname>Rost</surname><given-names>N</given-names></name><name><surname>Anderson</surname><given-names>CD</given-names></name><name><surname>Taylor</surname><given-names>KD</given-names></name><name><surname>Campbell</surname><given-names>A</given-names></name><name><surname>Magnusson</surname><given-names>PK</given-names></name><name><surname>Porteous</surname><given-names>D</given-names></name><name><surname>Hocking</surname><given-names>LJ</given-names></name><name><surname>Vlachopoulou</surname><given-names>E</given-names></name><name><surname>Pedersen</surname><given-names>NL</given-names></name><name><surname>Nikus</surname><given-names>K</given-names></name><name><surname>Orho-Melander</surname><given-names>M</given-names></name><name><surname>Hamsten</surname><given-names>A</given-names></name><name><surname>Heeringa</surname><given-names>J</given-names></name><name><surname>Denny</surname><given-names>JC</given-names></name><name><surname>Kriebel</surname><given-names>J</given-names></name><name><surname>Darbar</surname><given-names>D</given-names></name><name><surname>Newton-Cheh</surname><given-names>C</given-names></name><name><surname>Shaffer</surname><given-names>C</given-names></name><name><surname>Macfarlane</surname><given-names>PW</given-names></name><name><surname>Heilmann-Heimbach</surname><given-names>S</given-names></name><name><surname>Almgren</surname><given-names>P</given-names></name><name><surname>Huang</surname><given-names>PL</given-names></name><name><surname>Sotoodehnia</surname><given-names>N</given-names></name><name><surname>Soliman</surname><given-names>EZ</given-names></name><name><surname>Uitterlinden</surname><given-names>AG</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><name><surname>Franco</surname><given-names>OH</given-names></name><name><surname>VÃ¶lker</surname><given-names>U</given-names></name><name><surname>JÃ¶ckel</surname><given-names>KH</given-names></name><name><surname>Sinner</surname><given-names>MF</given-names></name><name><surname>Lin</surname><given-names>HJ</given-names></name><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Dichgans</surname><given-names>M</given-names></name><name><surname>Ingelsson</surname><given-names>E</given-names></name><name><surname>Kooperberg</surname><given-names>C</given-names></name><name><surname>Melander</surname><given-names>O</given-names></name><name><surname>Loos</surname><given-names>RJF</given-names></name><name><surname>Laurikka</surname><given-names>J</given-names></name><name><surname>Conen</surname><given-names>D</given-names></name><name><surname>Rosand</surname><given-names>J</given-names></name><name><surname>van der Harst</surname><given-names>P</given-names></name><name><surname>Lokki</surname><given-names>ML</given-names></name><name><surname>Kathiresan</surname><given-names>S</given-names></name><name><surname>Pereira</surname><given-names>A</given-names></name><name><surname>Jukema</surname><given-names>JW</given-names></name><name><surname>Hayward</surname><given-names>C</given-names></name><name><surname>Rotter</surname><given-names>JI</given-names></name><name><surname>MÃ¤rz</surname><given-names>W</given-names></name><name><surname>LehtimÃ¤ki</surname><given-names>T</given-names></name><name><surname>Stricker</surname><given-names>BH</given-names></name><name><surname>Chung</surname><given-names>MK</given-names></name><name><surname>Felix</surname><given-names>SB</given-names></name><name><surname>Gudnason</surname><given-names>V</given-names></name><name><surname>Alonso</surname><given-names>A</given-names></name><name><surname>Roden</surname><given-names>DM</given-names></name><name><surname>KÃ¤Ã¤b</surname><given-names>S</given-names></name><name><surname>Chasman</surname><given-names>DI</given-names></name><name><surname>Heckbert</surname><given-names>SR</given-names></name><name><surname>Benjamin</surname><given-names>EJ</given-names></name><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>Lunetta</surname><given-names>KL</given-names></name><name><surname>Lubitz</surname><given-names>SA</given-names></name><name><surname>Ellinor</surname><given-names>PT</given-names></name><collab>METASTROKE Consortium of the ISGC</collab><collab>Neurology Working Group of the CHARGE Consortium</collab><collab>AFGen Consortium</collab></person-group><year iso-8601-date="2017">2017</year><article-title>Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation</article-title><source>Nature Genetics</source><volume>49</volume><fpage>946</fpage><lpage>952</lpage><pub-id pub-id-type="doi">10.1038/ng.3843</pub-id><pub-id pub-id-type="pmid">28416818</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chugh</surname><given-names>SS</given-names></name><name><surname>Havmoeller</surname><given-names>R</given-names></name><name><surname>Narayanan</surname><given-names>K</given-names></name><name><surname>Singh</surname><given-names>D</given-names></name><name><surname>Rienstra</surname><given-names>M</given-names></name><name><surname>Benjamin</surname><given-names>EJ</given-names></name><name><surname>Gillum</surname><given-names>RF</given-names></name><name><surname>Kim</surname><given-names>Y-H</given-names></name><name><surname>McAnulty</surname><given-names>JH</given-names><suffix>Jr</suffix></name><name><surname>Zheng</surname><given-names>Z-J</given-names></name><name><surname>Forouzanfar</surname><given-names>MH</given-names></name><name><surname>Naghavi</surname><given-names>M</given-names></name><name><surname>Mensah</surname><given-names>GA</given-names></name><name><surname>Ezzati</surname><given-names>M</given-names></name><name><surname>Murray</surname><given-names>CJL</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study</article-title><source>Circulation</source><volume>129</volume><fpage>837</fpage><lpage>847</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.113.005119</pub-id><pub-id pub-id-type="pmid">24345399</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname><given-names>W</given-names></name><name><surname>Laforest</surname><given-names>B</given-names></name><name><surname>Tyan</surname><given-names>L</given-names></name><name><surname>Shen</surname><given-names>KM</given-names></name><name><surname>Nadadur</surname><given-names>RD</given-names></name><name><surname>Alvarado</surname><given-names>FJ</given-names></name><name><surname>Mazurek</surname><given-names>SR</given-names></name><name><surname>Lazarevic</surname><given-names>S</given-names></name><name><surname>Gadek</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Valdivia</surname><given-names>HH</given-names></name><name><surname>Shen</surname><given-names>L</given-names></name><name><surname>Broman</surname><given-names>MT</given-names></name><name><surname>Moskowitz</surname><given-names>IP</given-names></name><name><surname>Weber</surname><given-names>CR</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A calcium transport mechanism for atrial fibrillation in tbx5-mutant mice</article-title><source>eLife</source><volume>8</volume><elocation-id>e41814</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.41814</pub-id><pub-id pub-id-type="pmid">30896405</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Degtyareva</surname><given-names>AO</given-names></name><name><surname>Antontseva</surname><given-names>EV</given-names></name><name><surname>Merkulova</surname><given-names>TI</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Regulatory snps: altered transcription factor binding sites implicated in complex traits and diseases</article-title><source>International Journal of Molecular Sciences</source><volume>22</volume><elocation-id>6454</elocation-id><pub-id pub-id-type="doi">10.3390/ijms22126454</pub-id><pub-id pub-id-type="pmid">34208629</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deplancke</surname><given-names>B</given-names></name><name><surname>Alpern</surname><given-names>D</given-names></name><name><surname>Gardeux</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The genetics of transcription factor DNA binding variation</article-title><source>Cell</source><volume>166</volume><fpage>538</fpage><lpage>554</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.07.012</pub-id><pub-id pub-id-type="pmid">27471964</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dixon</surname><given-names>JR</given-names></name><name><surname>Selvaraj</surname><given-names>S</given-names></name><name><surname>Yue</surname><given-names>F</given-names></name><name><surname>Kim</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><name><surname>Hu</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>JS</given-names></name><name><surname>Ren</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Topological domains in mammalian genomes identified by analysis of chromatin interactions</article-title><source>Nature</source><volume>485</volume><fpage>376</fpage><lpage>380</lpage><pub-id pub-id-type="doi">10.1038/nature11082</pub-id><pub-id pub-id-type="pmid">22495300</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobin</surname><given-names>A</given-names></name><name><surname>Davis</surname><given-names>CA</given-names></name><name><surname>Schlesinger</surname><given-names>F</given-names></name><name><surname>Drenkow</surname><given-names>J</given-names></name><name><surname>Zaleski</surname><given-names>C</given-names></name><name><surname>Jha</surname><given-names>S</given-names></name><name><surname>Batut</surname><given-names>P</given-names></name><name><surname>Chaisson</surname><given-names>M</given-names></name><name><surname>Gingeras</surname><given-names>TR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Star: ultrafast universal RNA-seq aligner</article-title><source>Bioinformatics</source><volume>29</volume><fpage>15</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bts635</pub-id><pub-id pub-id-type="pmid">23104886</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandez-Perez</surname><given-names>A</given-names></name><name><surname>Sathe</surname><given-names>AA</given-names></name><name><surname>Bhakta</surname><given-names>M</given-names></name><name><surname>Leggett</surname><given-names>K</given-names></name><name><surname>Xing</surname><given-names>C</given-names></name><name><surname>Munshi</surname><given-names>NV</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Hand2 selectively reorganizes chromatin accessibility to induce pacemaker-like transcriptional reprogramming</article-title><source>Cell Reports</source><volume>27</volume><fpage>2354</fpage><lpage>2369</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.04.077</pub-id><pub-id pub-id-type="pmid">31116981</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilsbach</surname><given-names>R</given-names></name><name><surname>Preissl</surname><given-names>S</given-names></name><name><surname>GrÃ¼ning</surname><given-names>BA</given-names></name><name><surname>Schnick</surname><given-names>T</given-names></name><name><surname>Burger</surname><given-names>L</given-names></name><name><surname>Benes</surname><given-names>V</given-names></name><name><surname>WÃ¼rch</surname><given-names>A</given-names></name><name><surname>BÃ¶nisch</surname><given-names>U</given-names></name><name><surname>GÃ¼nther</surname><given-names>S</given-names></name><name><surname>Backofen</surname><given-names>R</given-names></name><name><surname>Fleischmann</surname><given-names>BK</given-names></name><name><surname>SchÃ¼beler</surname><given-names>D</given-names></name><name><surname>Hein</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Dynamic DNA methylation orchestrates cardiomyocyte development, maturation and disease</article-title><source>Nature Communications</source><volume>5</volume><elocation-id>5288</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms6288</pub-id><pub-id pub-id-type="pmid">25335909</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilsbach</surname><given-names>R</given-names></name><name><surname>Schwaderer</surname><given-names>M</given-names></name><name><surname>Preissl</surname><given-names>S</given-names></name><name><surname>GrÃ¼ning</surname><given-names>BA</given-names></name><name><surname>KranzhÃ¶fer</surname><given-names>D</given-names></name><name><surname>Schneider</surname><given-names>P</given-names></name><name><surname>NÃ¼hrenberg</surname><given-names>TG</given-names></name><name><surname>Mulero-Navarro</surname><given-names>S</given-names></name><name><surname>Weichenhan</surname><given-names>D</given-names></name><name><surname>Braun</surname><given-names>C</given-names></name><name><surname>DreÃen</surname><given-names>M</given-names></name><name><surname>Jacobs</surname><given-names>AR</given-names></name><name><surname>Lahm</surname><given-names>H</given-names></name><name><surname>Doenst</surname><given-names>T</given-names></name><name><surname>Backofen</surname><given-names>R</given-names></name><name><surname>Krane</surname><given-names>M</given-names></name><name><surname>Gelb</surname><given-names>BD</given-names></name><name><surname>Hein</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Distinct epigenetic programs regulate cardiac myocyte development and disease in the human heart in vivo</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>391</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-017-02762-z</pub-id><pub-id pub-id-type="pmid">29374152</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grynkiewicz</surname><given-names>G</given-names></name><name><surname>Poenie</surname><given-names>M</given-names></name><name><surname>Tsien</surname><given-names>RY</given-names></name></person-group><year iso-8601-date="1985">1985</year><article-title>A new generation of Ca2+ indicators with greatly improved fluorescence properties</article-title><source>The Journal of Biological Chemistry</source><volume>260</volume><fpage>3440</fpage><lpage>3450</lpage><pub-id pub-id-type="doi">10.1016/S0021-9258(19)83641-4</pub-id><pub-id pub-id-type="pmid">3838314</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>GTEx Consortium</collab></person-group><year iso-8601-date="2020">2020</year><article-title>The gtex Consortium atlas of genetic regulatory effects across human tissues</article-title><source>Science</source><volume>369</volume><fpage>1318</fpage><lpage>1330</lpage><pub-id pub-id-type="doi">10.1126/science.aaz1776</pub-id><pub-id pub-id-type="pmid">32913098</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>HaÃ¯ssaguerre</surname><given-names>M</given-names></name><name><surname>JaÃ¯s</surname><given-names>P</given-names></name><name><surname>Shah</surname><given-names>DC</given-names></name><name><surname>Takahashi</surname><given-names>A</given-names></name><name><surname>Hocini</surname><given-names>M</given-names></name><name><surname>Quiniou</surname><given-names>G</given-names></name><name><surname>Garrigue</surname><given-names>S</given-names></name><name><surname>Le Mouroux</surname><given-names>A</given-names></name><name><surname>Le MÃ©tayer</surname><given-names>P</given-names></name><name><surname>ClÃ©menty</surname><given-names>J</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins</article-title><source>The New England Journal of Medicine</source><volume>339</volume><fpage>659</fpage><lpage>666</lpage><pub-id pub-id-type="doi">10.1056/NEJM199809033391003</pub-id><pub-id pub-id-type="pmid">9725923</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heinz</surname><given-names>S</given-names></name><name><surname>Benner</surname><given-names>C</given-names></name><name><surname>Spann</surname><given-names>N</given-names></name><name><surname>Bertolino</surname><given-names>E</given-names></name><name><surname>Lin</surname><given-names>YC</given-names></name><name><surname>Laslo</surname><given-names>P</given-names></name><name><surname>Cheng</surname><given-names>JX</given-names></name><name><surname>Murre</surname><given-names>C</given-names></name><name><surname>Singh</surname><given-names>H</given-names></name><name><surname>Glass</surname><given-names>CK</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities</article-title><source>Molecular Cell</source><volume>38</volume><fpage>576</fpage><lpage>589</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2010.05.004</pub-id><pub-id pub-id-type="pmid">20513432</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hormozdiari</surname><given-names>F</given-names></name><name><surname>Zhu</surname><given-names>A</given-names></name><name><surname>Kichaev</surname><given-names>G</given-names></name><name><surname>Ju</surname><given-names>CJ-T</given-names></name><name><surname>SegrÃ¨</surname><given-names>AV</given-names></name><name><surname>Joo</surname><given-names>JWJ</given-names></name><name><surname>Won</surname><given-names>H</given-names></name><name><surname>Sankararaman</surname><given-names>S</given-names></name><name><surname>Pasaniuc</surname><given-names>B</given-names></name><name><surname>Shifman</surname><given-names>S</given-names></name><name><surname>Eskin</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Widespread allelic heterogeneity in complex traits</article-title><source>American Journal of Human Genetics</source><volume>100</volume><fpage>789</fpage><lpage>802</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2017.04.005</pub-id><pub-id pub-id-type="pmid">28475861</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hormozdiari</surname><given-names>F</given-names></name><name><surname>Gazal</surname><given-names>S</given-names></name><name><surname>van de Geijn</surname><given-names>B</given-names></name><name><surname>Finucane</surname><given-names>HK</given-names></name><name><surname>Ju</surname><given-names>CJ-T</given-names></name><name><surname>Loh</surname><given-names>P-R</given-names></name><name><surname>Schoech</surname><given-names>A</given-names></name><name><surname>Reshef</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>OâConnor</surname><given-names>L</given-names></name><name><surname>Gusev</surname><given-names>A</given-names></name><name><surname>Eskin</surname><given-names>E</given-names></name><name><surname>Price</surname><given-names>AL</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Leveraging molecular quantitative trait loci to understand the genetic architecture of diseases and complex traits</article-title><source>Nature Genetics</source><volume>50</volume><fpage>1041</fpage><lpage>1047</lpage><pub-id pub-id-type="doi">10.1038/s41588-018-0148-2</pub-id><pub-id pub-id-type="pmid">29942083</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>JaiÂ¨s</surname><given-names>P</given-names></name><name><surname>HaiÂ¨ssaguerre</surname><given-names>M</given-names></name><name><surname>Shah</surname><given-names>DC</given-names></name><name><surname>Chouairi</surname><given-names>S</given-names></name><name><surname>Gencel</surname><given-names>L</given-names></name><name><surname>Hocini</surname><given-names>M</given-names></name><name><surname>CleÂ´menty</surname><given-names>J</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>A focal source of atrial fibrillation treated by discrete radiofrequency ablation</article-title><source>Circulation</source><volume>95</volume><fpage>572</fpage><lpage>576</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.95.3.572</pub-id><pub-id pub-id-type="pmid">9024141</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamel</surname><given-names>SM</given-names></name><name><surname>van Opbergen</surname><given-names>CJM</given-names></name><name><surname>Koopman</surname><given-names>CD</given-names></name><name><surname>Verkerk</surname><given-names>AO</given-names></name><name><surname>Boukens</surname><given-names>BJD</given-names></name><name><surname>de Jonge</surname><given-names>B</given-names></name><name><surname>Onderwater</surname><given-names>YL</given-names></name><name><surname>van Alebeek</surname><given-names>E</given-names></name><name><surname>Chocron</surname><given-names>S</given-names></name><name><surname>Polidoro Pontalti</surname><given-names>C</given-names></name><name><surname>Weuring</surname><given-names>WJ</given-names></name><name><surname>Vos</surname><given-names>MA</given-names></name><name><surname>de Boer</surname><given-names>TP</given-names></name><name><surname>van Veen</surname><given-names>TAB</given-names></name><name><surname>Bakkers</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Istaroxime treatment ameliorates calcium dysregulation in a zebrafish model of phospholamban r14del cardiomyopathy</article-title><source>Nature Communications</source><volume>12</volume><elocation-id>7151</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-021-27461-8</pub-id><pub-id pub-id-type="pmid">34887420</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kathiriya</surname><given-names>IS</given-names></name><name><surname>Rao</surname><given-names>KS</given-names></name><name><surname>Iacono</surname><given-names>G</given-names></name><name><surname>Devine</surname><given-names>WP</given-names></name><name><surname>Blair</surname><given-names>AP</given-names></name><name><surname>Hota</surname><given-names>SK</given-names></name><name><surname>Lai</surname><given-names>MH</given-names></name><name><surname>Garay</surname><given-names>BI</given-names></name><name><surname>Thomas</surname><given-names>R</given-names></name><name><surname>Gong</surname><given-names>HZ</given-names></name><name><surname>Wasson</surname><given-names>LK</given-names></name><name><surname>Goyal</surname><given-names>P</given-names></name><name><surname>Sukonnik</surname><given-names>T</given-names></name><name><surname>Hu</surname><given-names>KM</given-names></name><name><surname>Akgun</surname><given-names>GA</given-names></name><name><surname>Bernard</surname><given-names>LD</given-names></name><name><surname>Akerberg</surname><given-names>BN</given-names></name><name><surname>Gu</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>K</given-names></name><name><surname>Speir</surname><given-names>ML</given-names></name><name><surname>Haeussler</surname><given-names>M</given-names></name><name><surname>Pu</surname><given-names>WT</given-names></name><name><surname>Stuart</surname><given-names>JM</given-names></name><name><surname>Seidman</surname><given-names>CE</given-names></name><name><surname>Seidman</surname><given-names>JG</given-names></name><name><surname>Heyn</surname><given-names>H</given-names></name><name><surname>Bruneau</surname><given-names>BG</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Modeling human TBX5 haploinsufficiency predicts regulatory networks for congenital heart disease</article-title><source>Developmental Cell</source><volume>56</volume><fpage>292</fpage><lpage>309</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2020.11.020</pub-id><pub-id pub-id-type="pmid">33321106</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>BS</given-names></name><name><surname>Kim</surname><given-names>YH</given-names></name><name><surname>Hwang</surname><given-names>GS</given-names></name><name><surname>Pak</surname><given-names>HN</given-names></name><name><surname>Lee</surname><given-names>SC</given-names></name><name><surname>Shim</surname><given-names>WJ</given-names></name><name><surname>Oh</surname><given-names>DJ</given-names></name><name><surname>Ro</surname><given-names>YM</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Action potential duration restitution kinetics in human atrial fibrillation</article-title><source>Journal of the American College of Cardiology</source><volume>39</volume><fpage>1329</fpage><lpage>1336</lpage><pub-id pub-id-type="doi">10.1016/S0735-1097(02)01760-6</pub-id><pub-id pub-id-type="pmid">11955851</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimura</surname><given-names>M</given-names></name><name><surname>Kikuchi</surname><given-names>A</given-names></name><name><surname>Ichinoi</surname><given-names>N</given-names></name><name><surname>Kure</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Novel Tbx5 duplication in a Japanese family with Holt-Oram syndrome</article-title><source>Pediatric Cardiology</source><volume>36</volume><fpage>244</fpage><lpage>247</lpage><pub-id pub-id-type="doi">10.1007/s00246-014-1028-x</pub-id><pub-id pub-id-type="pmid">25274398</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirchhof</surname><given-names>P</given-names></name><name><surname>Kahr</surname><given-names>PC</given-names></name><name><surname>Kaese</surname><given-names>S</given-names></name><name><surname>Piccini</surname><given-names>I</given-names></name><name><surname>Vokshi</surname><given-names>I</given-names></name><name><surname>Scheld</surname><given-names>H-H</given-names></name><name><surname>Rotering</surname><given-names>H</given-names></name><name><surname>Fortmueller</surname><given-names>L</given-names></name><name><surname>Laakmann</surname><given-names>S</given-names></name><name><surname>Verheule</surname><given-names>S</given-names></name><name><surname>Schotten</surname><given-names>U</given-names></name><name><surname>Fabritz</surname><given-names>L</given-names></name><name><surname>Brown</surname><given-names>NA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Pitx2C is expressed in the adult left atrium, and reducing Pitx2c expression promotes atrial fibrillation inducibility and complex changes in gene expression</article-title><source>Circulation. Cardiovascular Genetics</source><volume>4</volume><fpage>123</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1161/CIRCGENETICS.110.958058</pub-id><pub-id pub-id-type="pmid">21282332</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laforest</surname><given-names>B</given-names></name><name><surname>Dai</surname><given-names>W</given-names></name><name><surname>Tyan</surname><given-names>L</given-names></name><name><surname>Lazarevic</surname><given-names>S</given-names></name><name><surname>Shen</surname><given-names>KM</given-names></name><name><surname>Gadek</surname><given-names>M</given-names></name><name><surname>Broman</surname><given-names>MT</given-names></name><name><surname>Weber</surname><given-names>CR</given-names></name><name><surname>Moskowitz</surname><given-names>IP</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Atrial fibrillation risk loci interact to modulate Ca2+-dependent atrial rhythm homeostasis</article-title><source>The Journal of Clinical Investigation</source><volume>129</volume><fpage>4937</fpage><lpage>4950</lpage><pub-id pub-id-type="doi">10.1172/JCI124231</pub-id><pub-id pub-id-type="pmid">31609246</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lappalainen</surname><given-names>T</given-names></name><name><surname>MacArthur</surname><given-names>DG</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>From variant to function in human disease genetics</article-title><source>Science</source><volume>373</volume><fpage>1464</fpage><lpage>1468</lpage><pub-id pub-id-type="doi">10.1126/science.abi8207</pub-id><pub-id pub-id-type="pmid">34554789</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JM</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name><name><surname>Janardhan</surname><given-names>AH</given-names></name><name><surname>Park</surname><given-names>J</given-names></name><name><surname>Joung</surname><given-names>B</given-names></name><name><surname>Pak</surname><given-names>HN</given-names></name><name><surname>Lee</surname><given-names>MH</given-names></name><name><surname>Kim</surname><given-names>SS</given-names></name><name><surname>Hwang</surname><given-names>HJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Prolonged atrial refractoriness predicts the onset of atrial fibrillation: a 12-year follow-up study</article-title><source>Heart Rhythm</source><volume>13</volume><fpage>1575</fpage><lpage>1580</lpage><pub-id pub-id-type="doi">10.1016/j.hrthm.2016.03.037</pub-id><pub-id pub-id-type="pmid">27005930</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>QY</given-names></name><name><surname>Newbury-Ecob</surname><given-names>RA</given-names></name><name><surname>Terrett</surname><given-names>JA</given-names></name><name><surname>Wilson</surname><given-names>DI</given-names></name><name><surname>Curtis</surname><given-names>AR</given-names></name><name><surname>Yi</surname><given-names>CH</given-names></name><name><surname>Gebuhr</surname><given-names>T</given-names></name><name><surname>Bullen</surname><given-names>PJ</given-names></name><name><surname>Robson</surname><given-names>SC</given-names></name><name><surname>Strachan</surname><given-names>T</given-names></name><name><surname>Bonnet</surname><given-names>D</given-names></name><name><surname>Lyonnet</surname><given-names>S</given-names></name><name><surname>Young</surname><given-names>ID</given-names></name><name><surname>Raeburn</surname><given-names>JA</given-names></name><name><surname>Buckler</surname><given-names>AJ</given-names></name><name><surname>Law</surname><given-names>DJ</given-names></name><name><surname>Brook</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Holt-oram syndrome is caused by mutations in tbx5, a member of the brachyury (T) gene family</article-title><source>Nature Genetics</source><volume>15</volume><fpage>21</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1038/ng0197-21</pub-id><pub-id pub-id-type="pmid">8988164</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Durbin</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Fast and accurate short read alignment with burrows-wheeler transform</article-title><source>Bioinformatics</source><volume>25</volume><fpage>1754</fpage><lpage>1760</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp324</pub-id><pub-id pub-id-type="pmid">19451168</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname><given-names>MI</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name><name><surname>Anders</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Moderated estimation of fold change and dispersion for RNA-Seq data with deseq2</article-title><source>Genome Biology</source><volume>15</volume><elocation-id>550</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id><pub-id pub-id-type="pmid">25516281</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Low</surname><given-names>S-K</given-names></name><name><surname>Takahashi</surname><given-names>A</given-names></name><name><surname>Ebana</surname><given-names>Y</given-names></name><name><surname>Ozaki</surname><given-names>K</given-names></name><name><surname>Christophersen</surname><given-names>IE</given-names></name><name><surname>Ellinor</surname><given-names>PT</given-names></name><collab>AFGen Consortium</collab><name><surname>Ogishima</surname><given-names>S</given-names></name><name><surname>Yamamoto</surname><given-names>M</given-names></name><name><surname>Satoh</surname><given-names>M</given-names></name><name><surname>Sasaki</surname><given-names>M</given-names></name><name><surname>Yamaji</surname><given-names>T</given-names></name><name><surname>Iwasaki</surname><given-names>M</given-names></name><name><surname>Tsugane</surname><given-names>S</given-names></name><name><surname>Tanaka</surname><given-names>K</given-names></name><name><surname>Naito</surname><given-names>M</given-names></name><name><surname>Wakai</surname><given-names>K</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name><name><surname>Furukawa</surname><given-names>T</given-names></name><name><surname>Kubo</surname><given-names>M</given-names></name><name><surname>Ito</surname><given-names>K</given-names></name><name><surname>Kamatani</surname><given-names>Y</given-names></name><name><surname>Tanaka</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Identification of six new genetic loci associated with atrial fibrillation in the Japanese population</article-title><source>Nature Genetics</source><volume>49</volume><fpage>953</fpage><lpage>958</lpage><pub-id pub-id-type="doi">10.1038/ng.3842</pub-id><pub-id pub-id-type="pmid">28416822</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luna-Zurita</surname><given-names>L</given-names></name><name><surname>Stirnimann</surname><given-names>CU</given-names></name><name><surname>Glatt</surname><given-names>S</given-names></name><name><surname>Kaynak</surname><given-names>BL</given-names></name><name><surname>Thomas</surname><given-names>S</given-names></name><name><surname>Baudin</surname><given-names>F</given-names></name><name><surname>Samee</surname><given-names>MAH</given-names></name><name><surname>He</surname><given-names>D</given-names></name><name><surname>Small</surname><given-names>EM</given-names></name><name><surname>Mileikovsky</surname><given-names>M</given-names></name><name><surname>Nagy</surname><given-names>A</given-names></name><name><surname>Holloway</surname><given-names>AK</given-names></name><name><surname>Pollard</surname><given-names>KS</given-names></name><name><surname>MÃ¼ller</surname><given-names>CW</given-names></name><name><surname>Bruneau</surname><given-names>BG</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Complex interdependence regulates heterotypic transcription factor distribution and coordinates cardiogenesis</article-title><source>Cell</source><volume>164</volume><fpage>999</fpage><lpage>1014</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.01.004</pub-id><pub-id pub-id-type="pmid">26875865</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Machiela</surname><given-names>MJ</given-names></name><name><surname>Chanock</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants</article-title><source>Bioinformatics</source><volume>31</volume><fpage>3555</fpage><lpage>3557</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btv402</pub-id><pub-id pub-id-type="pmid">26139635</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marceau</surname><given-names>AH</given-names></name><name><surname>Felthousen</surname><given-names>JG</given-names></name><name><surname>Goetsch</surname><given-names>PD</given-names></name><name><surname>Iness</surname><given-names>AN</given-names></name><name><surname>Lee</surname><given-names>HW</given-names></name><name><surname>Tripathi</surname><given-names>SM</given-names></name><name><surname>Strome</surname><given-names>S</given-names></name><name><surname>Litovchick</surname><given-names>L</given-names></name><name><surname>Rubin</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Structural basis for LIN54 recognition of CHR elements in cell cycle-regulated promoters</article-title><source>Nature Communications</source><volume>7</volume><elocation-id>12301</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms12301</pub-id><pub-id pub-id-type="pmid">27465258</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maurano</surname><given-names>MT</given-names></name><name><surname>Humbert</surname><given-names>R</given-names></name><name><surname>Rynes</surname><given-names>E</given-names></name><name><surname>Thurman</surname><given-names>RE</given-names></name><name><surname>Haugen</surname><given-names>E</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Reynolds</surname><given-names>AP</given-names></name><name><surname>Sandstrom</surname><given-names>R</given-names></name><name><surname>Qu</surname><given-names>H</given-names></name><name><surname>Brody</surname><given-names>J</given-names></name><name><surname>Shafer</surname><given-names>A</given-names></name><name><surname>Neri</surname><given-names>F</given-names></name><name><surname>Lee</surname><given-names>K</given-names></name><name><surname>Kutyavin</surname><given-names>T</given-names></name><name><surname>Stehling-Sun</surname><given-names>S</given-names></name><name><surname>Johnson</surname><given-names>AK</given-names></name><name><surname>Canfield</surname><given-names>TK</given-names></name><name><surname>Giste</surname><given-names>E</given-names></name><name><surname>Diegel</surname><given-names>M</given-names></name><name><surname>Bates</surname><given-names>D</given-names></name><name><surname>Hansen</surname><given-names>RS</given-names></name><name><surname>Neph</surname><given-names>S</given-names></name><name><surname>Sabo</surname><given-names>PJ</given-names></name><name><surname>Heimfeld</surname><given-names>S</given-names></name><name><surname>Raubitschek</surname><given-names>A</given-names></name><name><surname>Ziegler</surname><given-names>S</given-names></name><name><surname>Cotsapas</surname><given-names>C</given-names></name><name><surname>Sotoodehnia</surname><given-names>N</given-names></name><name><surname>Glass</surname><given-names>I</given-names></name><name><surname>Sunyaev</surname><given-names>SR</given-names></name><name><surname>Kaul</surname><given-names>R</given-names></name><name><surname>Stamatoyannopoulos</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Systematic localization of common disease-associated variation in regulatory DNA</article-title><source>Science</source><volume>337</volume><fpage>1190</fpage><lpage>1195</lpage><pub-id pub-id-type="doi">10.1126/science.1222794</pub-id><pub-id pub-id-type="pmid">22955828</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meurer</surname><given-names>L</given-names></name><name><surname>Ferdman</surname><given-names>L</given-names></name><name><surname>Belcher</surname><given-names>B</given-names></name><name><surname>Camarata</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The six family of transcription factors: common themes integrating developmental and cancer biology</article-title><source>Frontiers in Cell and Developmental Biology</source><volume>9</volume><elocation-id>707854</elocation-id><pub-id pub-id-type="doi">10.3389/fcell.2021.707854</pub-id><pub-id pub-id-type="pmid">34490256</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mi</surname><given-names>H</given-names></name><name><surname>Muruganujan</surname><given-names>A</given-names></name><name><surname>Ebert</surname><given-names>D</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Thomas</surname><given-names>PD</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Panther version 14: more genomes, a new Panther GO-slim and improvements in enrichment analysis tools</article-title><source>Nucleic Acids Research</source><volume>47</volume><fpage>D419</fpage><lpage>D426</lpage><pub-id pub-id-type="doi">10.1093/nar/gky1038</pub-id><pub-id pub-id-type="pmid">30407594</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montefiori</surname><given-names>LE</given-names></name><name><surname>Sobreira</surname><given-names>DR</given-names></name><name><surname>Sakabe</surname><given-names>NJ</given-names></name><name><surname>Aneas</surname><given-names>I</given-names></name><name><surname>Joslin</surname><given-names>AC</given-names></name><name><surname>Hansen</surname><given-names>GT</given-names></name><name><surname>Bozek</surname><given-names>G</given-names></name><name><surname>Moskowitz</surname><given-names>IP</given-names></name><name><surname>McNally</surname><given-names>EM</given-names></name><name><surname>NÃ³brega</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A promoter interaction map for cardiovascular disease genetics</article-title><source>eLife</source><volume>7</volume><elocation-id>e35788</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.35788</pub-id><pub-id pub-id-type="pmid">29988018</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mori</surname><given-names>AD</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Vahora</surname><given-names>I</given-names></name><name><surname>Nieman</surname><given-names>B</given-names></name><name><surname>Koshiba-Takeuchi</surname><given-names>K</given-names></name><name><surname>Davidson</surname><given-names>L</given-names></name><name><surname>Pizard</surname><given-names>A</given-names></name><name><surname>Seidman</surname><given-names>JG</given-names></name><name><surname>Seidman</surname><given-names>CE</given-names></name><name><surname>Chen</surname><given-names>XJ</given-names></name><name><surname>Henkelman</surname><given-names>RM</given-names></name><name><surname>Bruneau</surname><given-names>BG</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Tbx5-dependent rheostatic control of cardiac gene expression and morphogenesis</article-title><source>Developmental Biology</source><volume>297</volume><fpage>566</fpage><lpage>586</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2006.05.023</pub-id><pub-id pub-id-type="pmid">16870172</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moskowitz</surname><given-names>IPG</given-names></name><name><surname>Pizard</surname><given-names>A</given-names></name><name><surname>Patel</surname><given-names>VV</given-names></name><name><surname>Bruneau</surname><given-names>BG</given-names></name><name><surname>Kim</surname><given-names>JB</given-names></name><name><surname>Kupershmidt</surname><given-names>S</given-names></name><name><surname>Roden</surname><given-names>D</given-names></name><name><surname>Berul</surname><given-names>CI</given-names></name><name><surname>Seidman</surname><given-names>CE</given-names></name><name><surname>Seidman</surname><given-names>JG</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>The T-box transcription factor tbx5 is required for the patterning and maturation of the murine cardiac conduction system</article-title><source>Development</source><volume>131</volume><fpage>4107</fpage><lpage>4116</lpage><pub-id pub-id-type="doi">10.1242/dev.01265</pub-id><pub-id pub-id-type="pmid">15289437</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moskowitz</surname><given-names>IPG</given-names></name><name><surname>Kim</surname><given-names>JB</given-names></name><name><surname>Moore</surname><given-names>ML</given-names></name><name><surname>Wolf</surname><given-names>CM</given-names></name><name><surname>Peterson</surname><given-names>MA</given-names></name><name><surname>Shendure</surname><given-names>J</given-names></name><name><surname>Nobrega</surname><given-names>MA</given-names></name><name><surname>Yokota</surname><given-names>Y</given-names></name><name><surname>Berul</surname><given-names>C</given-names></name><name><surname>Izumo</surname><given-names>S</given-names></name><name><surname>Seidman</surname><given-names>JG</given-names></name><name><surname>Seidman</surname><given-names>CE</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>A molecular pathway including id2, tbx5, and nkx2-5 required for cardiac conduction system development</article-title><source>Cell</source><volume>129</volume><fpage>1365</fpage><lpage>1376</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2007.04.036</pub-id><pub-id pub-id-type="pmid">17604724</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nadadur</surname><given-names>RD</given-names></name><name><surname>Broman</surname><given-names>MT</given-names></name><name><surname>Boukens</surname><given-names>B</given-names></name><name><surname>Mazurek</surname><given-names>SR</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>van den Boogaard</surname><given-names>M</given-names></name><name><surname>Bekeny</surname><given-names>J</given-names></name><name><surname>Gadek</surname><given-names>M</given-names></name><name><surname>Ward</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Qiao</surname><given-names>Y</given-names></name><name><surname>Martin</surname><given-names>JF</given-names></name><name><surname>Seidman</surname><given-names>CE</given-names></name><name><surname>Seidman</surname><given-names>J</given-names></name><name><surname>Christoffels</surname><given-names>V</given-names></name><name><surname>Efimov</surname><given-names>IR</given-names></name><name><surname>McNally</surname><given-names>EM</given-names></name><name><surname>Weber</surname><given-names>CR</given-names></name><name><surname>Moskowitz</surname><given-names>IP</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Pitx2 modulates a tbx5-dependent gene regulatory network to maintain atrial rhythm</article-title><source>Science Translational Medicine</source><volume>8</volume><elocation-id>354ra115</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.aaf4891</pub-id><pub-id pub-id-type="pmid">27582060</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nielsen</surname><given-names>JB</given-names></name><name><surname>Thorolfsdottir</surname><given-names>RB</given-names></name><name><surname>Fritsche</surname><given-names>LG</given-names></name><name><surname>Zhou</surname><given-names>W</given-names></name><name><surname>Skov</surname><given-names>MW</given-names></name><name><surname>Graham</surname><given-names>SE</given-names></name><name><surname>Herron</surname><given-names>TJ</given-names></name><name><surname>McCarthy</surname><given-names>S</given-names></name><name><surname>Schmidt</surname><given-names>EM</given-names></name><name><surname>Sveinbjornsson</surname><given-names>G</given-names></name><name><surname>Surakka</surname><given-names>I</given-names></name><name><surname>Mathis</surname><given-names>MR</given-names></name><name><surname>Yamazaki</surname><given-names>M</given-names></name><name><surname>Crawford</surname><given-names>RD</given-names></name><name><surname>Gabrielsen</surname><given-names>ME</given-names></name><name><surname>Skogholt</surname><given-names>AH</given-names></name><name><surname>Holmen</surname><given-names>OL</given-names></name><name><surname>Lin</surname><given-names>M</given-names></name><name><surname>Wolford</surname><given-names>BN</given-names></name><name><surname>Dey</surname><given-names>R</given-names></name><name><surname>Dalen</surname><given-names>H</given-names></name><name><surname>Sulem</surname><given-names>P</given-names></name><name><surname>Chung</surname><given-names>JH</given-names></name><name><surname>Backman</surname><given-names>JD</given-names></name><name><surname>Arnar</surname><given-names>DO</given-names></name><name><surname>Thorsteinsdottir</surname><given-names>U</given-names></name><name><surname>Baras</surname><given-names>A</given-names></name><name><surname>OâDushlaine</surname><given-names>C</given-names></name><name><surname>Holst</surname><given-names>AG</given-names></name><name><surname>Wen</surname><given-names>X</given-names></name><name><surname>Hornsby</surname><given-names>W</given-names></name><name><surname>Dewey</surname><given-names>FE</given-names></name><name><surname>Boehnke</surname><given-names>M</given-names></name><name><surname>Kheterpal</surname><given-names>S</given-names></name><name><surname>Mukherjee</surname><given-names>B</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Kang</surname><given-names>HM</given-names></name><name><surname>Holm</surname><given-names>H</given-names></name><name><surname>Kitzman</surname><given-names>J</given-names></name><name><surname>Shavit</surname><given-names>JA</given-names></name><name><surname>Jalife</surname><given-names>J</given-names></name><name><surname>Brummett</surname><given-names>CM</given-names></name><name><surname>Teslovich</surname><given-names>TM</given-names></name><name><surname>Carey</surname><given-names>DJ</given-names></name><name><surname>Gudbjartsson</surname><given-names>DF</given-names></name><name><surname>Stefansson</surname><given-names>K</given-names></name><name><surname>Abecasis</surname><given-names>GR</given-names></name><name><surname>Hveem</surname><given-names>K</given-names></name><name><surname>Willer</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Biobank-driven genomic discovery yields new insight into atrial fibrillation biology</article-title><source>Nature Genetics</source><volume>50</volume><fpage>1234</fpage><lpage>1239</lpage><pub-id pub-id-type="doi">10.1038/s41588-018-0171-3</pub-id><pub-id pub-id-type="pmid">30061737</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nora</surname><given-names>EP</given-names></name><name><surname>Lajoie</surname><given-names>BR</given-names></name><name><surname>Schulz</surname><given-names>EG</given-names></name><name><surname>Giorgetti</surname><given-names>L</given-names></name><name><surname>Okamoto</surname><given-names>I</given-names></name><name><surname>Servant</surname><given-names>N</given-names></name><name><surname>Piolot</surname><given-names>T</given-names></name><name><surname>van Berkum</surname><given-names>NL</given-names></name><name><surname>Meisig</surname><given-names>J</given-names></name><name><surname>Sedat</surname><given-names>J</given-names></name><name><surname>Gribnau</surname><given-names>J</given-names></name><name><surname>Barillot</surname><given-names>E</given-names></name><name><surname>BlÃ¼thgen</surname><given-names>N</given-names></name><name><surname>Dekker</surname><given-names>J</given-names></name><name><surname>Heard</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Spatial partitioning of the regulatory landscape of the X-inactivation centre</article-title><source>Nature</source><volume>485</volume><fpage>381</fpage><lpage>385</lpage><pub-id pub-id-type="doi">10.1038/nature11049</pub-id><pub-id pub-id-type="pmid">22495304</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olson</surname><given-names>TM</given-names></name><name><surname>Alekseev</surname><given-names>AE</given-names></name><name><surname>Liu</surname><given-names>XKK</given-names></name><name><surname>Park</surname><given-names>S</given-names></name><name><surname>Zingman</surname><given-names>LV</given-names></name><name><surname>Bienengraeber</surname><given-names>M</given-names></name><name><surname>Sattiraju</surname><given-names>S</given-names></name><name><surname>Ballew</surname><given-names>JD</given-names></name><name><surname>Jahangir</surname><given-names>A</given-names></name><name><surname>Terzic</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation</article-title><source>Human Molecular Genetics</source><volume>15</volume><fpage>2185</fpage><lpage>2191</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddl143</pub-id><pub-id pub-id-type="pmid">16772329</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>C</given-names></name><name><surname>Silcock</surname><given-names>L</given-names></name><name><surname>McMullan</surname><given-names>D</given-names></name><name><surname>Brueton</surname><given-names>L</given-names></name><name><surname>Cox</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Tbx5 intragenic duplication: a family with an atypical holtâoram syndrome phenotype</article-title><source>European Journal of Human Genetics</source><volume>20</volume><fpage>863</fpage><lpage>869</lpage><pub-id pub-id-type="doi">10.1038/ejhg.2012.16</pub-id><pub-id pub-id-type="pmid">22333898</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Postma</surname><given-names>AV</given-names></name><name><surname>van de Meerakker</surname><given-names>JBA</given-names></name><name><surname>Mathijssen</surname><given-names>IB</given-names></name><name><surname>Barnett</surname><given-names>P</given-names></name><name><surname>Christoffels</surname><given-names>VM</given-names></name><name><surname>Ilgun</surname><given-names>A</given-names></name><name><surname>Lam</surname><given-names>J</given-names></name><name><surname>Wilde</surname><given-names>AAM</given-names></name><name><surname>Lekanne Deprez</surname><given-names>RH</given-names></name><name><surname>Moorman</surname><given-names>AFM</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>A gain-of-function Tbx5 mutation is associated with atypical Holt-Oram syndrome and paroxysmal atrial fibrillation</article-title><source>Circulation Research</source><volume>102</volume><fpage>1433</fpage><lpage>1442</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.107.168294</pub-id><pub-id pub-id-type="pmid">18451335</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quinlan</surname><given-names>AR</given-names></name><name><surname>Hall</surname><given-names>IM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>BEDTools: a flexible suite of utilities for comparing genomic features</article-title><source>Bioinformatics</source><volume>26</volume><fpage>841</fpage><lpage>842</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btq033</pub-id><pub-id pub-id-type="pmid">20110278</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>SSP</given-names></name><name><surname>Huntley</surname><given-names>MH</given-names></name><name><surname>Durand</surname><given-names>NC</given-names></name><name><surname>Stamenova</surname><given-names>EK</given-names></name><name><surname>Bochkov</surname><given-names>ID</given-names></name><name><surname>Robinson</surname><given-names>JT</given-names></name><name><surname>Sanborn</surname><given-names>AL</given-names></name><name><surname>Machol</surname><given-names>I</given-names></name><name><surname>Omer</surname><given-names>AD</given-names></name><name><surname>Lander</surname><given-names>ES</given-names></name><name><surname>Aiden</surname><given-names>EL</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping</article-title><source>Cell</source><volume>159</volume><fpage>1665</fpage><lpage>1680</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.11.021</pub-id><pub-id pub-id-type="pmid">25497547</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roselli</surname><given-names>C</given-names></name><name><surname>Chaffin</surname><given-names>MD</given-names></name><name><surname>Weng</surname><given-names>L-C</given-names></name><name><surname>Aeschbacher</surname><given-names>S</given-names></name><name><surname>Ahlberg</surname><given-names>G</given-names></name><name><surname>Albert</surname><given-names>CM</given-names></name><name><surname>Almgren</surname><given-names>P</given-names></name><name><surname>Alonso</surname><given-names>A</given-names></name><name><surname>Anderson</surname><given-names>CD</given-names></name><name><surname>Aragam</surname><given-names>KG</given-names></name><name><surname>Arking</surname><given-names>DE</given-names></name><name><surname>Barnard</surname><given-names>J</given-names></name><name><surname>Bartz</surname><given-names>TM</given-names></name><name><surname>Benjamin</surname><given-names>EJ</given-names></name><name><surname>Bihlmeyer</surname><given-names>NA</given-names></name><name><surname>Bis</surname><given-names>JC</given-names></name><name><surname>Bloom</surname><given-names>HL</given-names></name><name><surname>Boerwinkle</surname><given-names>E</given-names></name><name><surname>Bottinger</surname><given-names>EB</given-names></name><name><surname>Brody</surname><given-names>JA</given-names></name><name><surname>Calkins</surname><given-names>H</given-names></name><name><surname>Campbell</surname><given-names>A</given-names></name><name><surname>Cappola</surname><given-names>TP</given-names></name><name><surname>Carlquist</surname><given-names>J</given-names></name><name><surname>Chasman</surname><given-names>DI</given-names></name><name><surname>Chen</surname><given-names>LY</given-names></name><name><surname>Chen</surname><given-names>Y-DI</given-names></name><name><surname>Choi</surname><given-names>E-K</given-names></name><name><surname>Choi</surname><given-names>SH</given-names></name><name><surname>Christophersen</surname><given-names>IE</given-names></name><name><surname>Chung</surname><given-names>MK</given-names></name><name><surname>Cole</surname><given-names>JW</given-names></name><name><surname>Conen</surname><given-names>D</given-names></name><name><surname>Cook</surname><given-names>J</given-names></name><name><surname>Crijns</surname><given-names>HJ</given-names></name><name><surname>Cutler</surname><given-names>MJ</given-names></name><name><surname>Damrauer</surname><given-names>SM</given-names></name><name><surname>Daniels</surname><given-names>BR</given-names></name><name><surname>Darbar</surname><given-names>D</given-names></name><name><surname>Delgado</surname><given-names>G</given-names></name><name><surname>Denny</surname><given-names>JC</given-names></name><name><surname>Dichgans</surname><given-names>M</given-names></name><name><surname>DÃ¶rr</surname><given-names>M</given-names></name><name><surname>Dudink</surname><given-names>EA</given-names></name><name><surname>Dudley</surname><given-names>SC</given-names></name><name><surname>Esa</surname><given-names>N</given-names></name><name><surname>Esko</surname><given-names>T</given-names></name><name><surname>Eskola</surname><given-names>M</given-names></name><name><surname>Fatkin</surname><given-names>D</given-names></name><name><surname>Felix</surname><given-names>SB</given-names></name><name><surname>Ford</surname><given-names>I</given-names></name><name><surname>Franco</surname><given-names>OH</given-names></name><name><surname>Geelhoed</surname><given-names>B</given-names></name><name><surname>Grewal</surname><given-names>RP</given-names></name><name><surname>Gudnason</surname><given-names>V</given-names></name><name><surname>Guo</surname><given-names>X</given-names></name><name><surname>Gupta</surname><given-names>N</given-names></name><name><surname>Gustafsson</surname><given-names>S</given-names></name><name><surname>Gutmann</surname><given-names>R</given-names></name><name><surname>Hamsten</surname><given-names>A</given-names></name><name><surname>Harris</surname><given-names>TB</given-names></name><name><surname>Hayward</surname><given-names>C</given-names></name><name><surname>Heckbert</surname><given-names>SR</given-names></name><name><surname>Hernesniemi</surname><given-names>J</given-names></name><name><surname>Hocking</surname><given-names>LJ</given-names></name><name><surname>Hofman</surname><given-names>A</given-names></name><name><surname>Horimoto</surname><given-names>ARVR</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>PL</given-names></name><name><surname>Huffman</surname><given-names>J</given-names></name><name><surname>Ingelsson</surname><given-names>E</given-names></name><name><surname>Ipek</surname><given-names>EG</given-names></name><name><surname>Ito</surname><given-names>K</given-names></name><name><surname>Jimenez-Conde</surname><given-names>J</given-names></name><name><surname>Johnson</surname><given-names>R</given-names></name><name><surname>Jukema</surname><given-names>JW</given-names></name><name><surname>KÃ¤Ã¤b</surname><given-names>S</given-names></name><name><surname>KÃ¤hÃ¶nen</surname><given-names>M</given-names></name><name><surname>Kamatani</surname><given-names>Y</given-names></name><name><surname>Kane</surname><given-names>JP</given-names></name><name><surname>Kastrati</surname><given-names>A</given-names></name><name><surname>Kathiresan</surname><given-names>S</given-names></name><name><surname>Katschnig-Winter</surname><given-names>P</given-names></name><name><surname>Kavousi</surname><given-names>M</given-names></name><name><surname>Kessler</surname><given-names>T</given-names></name><name><surname>Kietselaer</surname><given-names>BL</given-names></name><name><surname>Kirchhof</surname><given-names>P</given-names></name><name><surname>Kleber</surname><given-names>ME</given-names></name><name><surname>Knight</surname><given-names>S</given-names></name><name><surname>Krieger</surname><given-names>JE</given-names></name><name><surname>Kubo</surname><given-names>M</given-names></name><name><surname>Launer</surname><given-names>LJ</given-names></name><name><surname>Laurikka</surname><given-names>J</given-names></name><name><surname>LehtimÃ¤ki</surname><given-names>T</given-names></name><name><surname>Leineweber</surname><given-names>K</given-names></name><name><surname>Lemaitre</surname><given-names>RN</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Lim</surname><given-names>HE</given-names></name><name><surname>Lin</surname><given-names>HJ</given-names></name><name><surname>Lin</surname><given-names>H</given-names></name><name><surname>Lind</surname><given-names>L</given-names></name><name><surname>Lindgren</surname><given-names>CM</given-names></name><name><surname>Lokki</surname><given-names>M-L</given-names></name><name><surname>London</surname><given-names>B</given-names></name><name><surname>Loos</surname><given-names>RJF</given-names></name><name><surname>Low</surname><given-names>S-K</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>LyytikÃ¤inen</surname><given-names>L-P</given-names></name><name><surname>Macfarlane</surname><given-names>PW</given-names></name><name><surname>Magnusson</surname><given-names>PK</given-names></name><name><surname>Mahajan</surname><given-names>A</given-names></name><name><surname>Malik</surname><given-names>R</given-names></name><name><surname>Mansur</surname><given-names>AJ</given-names></name><name><surname>Marcus</surname><given-names>GM</given-names></name><name><surname>Margolin</surname><given-names>L</given-names></name><name><surname>Margulies</surname><given-names>KB</given-names></name><name><surname>MÃ¤rz</surname><given-names>W</given-names></name><name><surname>McManus</surname><given-names>DD</given-names></name><name><surname>Melander</surname><given-names>O</given-names></name><name><surname>Mohanty</surname><given-names>S</given-names></name><name><surname>Montgomery</surname><given-names>JA</given-names></name><name><surname>Morley</surname><given-names>MP</given-names></name><name><surname>Morris</surname><given-names>AP</given-names></name><name><surname>MÃ¼ller-Nurasyid</surname><given-names>M</given-names></name><name><surname>Natale</surname><given-names>A</given-names></name><name><surname>Nazarian</surname><given-names>S</given-names></name><name><surname>Neumann</surname><given-names>B</given-names></name><name><surname>Newton-Cheh</surname><given-names>C</given-names></name><name><surname>Niemeijer</surname><given-names>MN</given-names></name><name><surname>Nikus</surname><given-names>K</given-names></name><name><surname>Nilsson</surname><given-names>P</given-names></name><name><surname>Noordam</surname><given-names>R</given-names></name><name><surname>Oellers</surname><given-names>H</given-names></name><name><surname>Olesen</surname><given-names>MS</given-names></name><name><surname>Orho-Melander</surname><given-names>M</given-names></name><name><surname>Padmanabhan</surname><given-names>S</given-names></name><name><surname>Pak</surname><given-names>H-N</given-names></name><name><surname>ParÃ©</surname><given-names>G</given-names></name><name><surname>Pedersen</surname><given-names>NL</given-names></name><name><surname>Pera</surname><given-names>J</given-names></name><name><surname>Pereira</surname><given-names>A</given-names></name><name><surname>Porteous</surname><given-names>D</given-names></name><name><surname>Psaty</surname><given-names>BM</given-names></name><name><surname>Pulit</surname><given-names>SL</given-names></name><name><surname>Pullinger</surname><given-names>CR</given-names></name><name><surname>Rader</surname><given-names>DJ</given-names></name><name><surname>Refsgaard</surname><given-names>L</given-names></name><name><surname>RibasÃ©s</surname><given-names>M</given-names></name><name><surname>Ridker</surname><given-names>PM</given-names></name><name><surname>Rienstra</surname><given-names>M</given-names></name><name><surname>Risch</surname><given-names>L</given-names></name><name><surname>Roden</surname><given-names>DM</given-names></name><name><surname>Rosand</surname><given-names>J</given-names></name><name><surname>Rosenberg</surname><given-names>MA</given-names></name><name><surname>Rost</surname><given-names>N</given-names></name><name><surname>Rotter</surname><given-names>JI</given-names></name><name><surname>Saba</surname><given-names>S</given-names></name><name><surname>Sandhu</surname><given-names>RK</given-names></name><name><surname>Schnabel</surname><given-names>RB</given-names></name><name><surname>Schramm</surname><given-names>K</given-names></name><name><surname>Schunkert</surname><given-names>H</given-names></name><name><surname>Schurman</surname><given-names>C</given-names></name><name><surname>Scott</surname><given-names>SA</given-names></name><name><surname>SeppÃ¤lÃ¤</surname><given-names>I</given-names></name><name><surname>Shaffer</surname><given-names>C</given-names></name><name><surname>Shah</surname><given-names>S</given-names></name><name><surname>Shalaby</surname><given-names>AA</given-names></name><name><surname>Shim</surname><given-names>J</given-names></name><name><surname>Shoemaker</surname><given-names>MB</given-names></name><name><surname>Siland</surname><given-names>JE</given-names></name><name><surname>Sinisalo</surname><given-names>J</given-names></name><name><surname>Sinner</surname><given-names>MF</given-names></name><name><surname>Slowik</surname><given-names>A</given-names></name><name><surname>Smith</surname><given-names>AV</given-names></name><name><surname>Smith</surname><given-names>BH</given-names></name><name><surname>Smith</surname><given-names>JG</given-names></name><name><surname>Smith</surname><given-names>JD</given-names></name><name><surname>Smith</surname><given-names>NL</given-names></name><name><surname>Soliman</surname><given-names>EZ</given-names></name><name><surname>Sotoodehnia</surname><given-names>N</given-names></name><name><surname>Stricker</surname><given-names>BH</given-names></name><name><surname>Sun</surname><given-names>A</given-names></name><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Svendsen</surname><given-names>JH</given-names></name><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>Tanriverdi</surname><given-names>K</given-names></name><name><surname>Taylor</surname><given-names>KD</given-names></name><name><surname>Teder-Laving</surname><given-names>M</given-names></name><name><surname>Teumer</surname><given-names>A</given-names></name><name><surname>ThÃ©riault</surname><given-names>S</given-names></name><name><surname>Trompet</surname><given-names>S</given-names></name><name><surname>Tucker</surname><given-names>NR</given-names></name><name><surname>Tveit</surname><given-names>A</given-names></name><name><surname>Uitterlinden</surname><given-names>AG</given-names></name><name><surname>Van Der Harst</surname><given-names>P</given-names></name><name><surname>Van Gelder</surname><given-names>IC</given-names></name><name><surname>Van Wagoner</surname><given-names>DR</given-names></name><name><surname>Verweij</surname><given-names>N</given-names></name><name><surname>Vlachopoulou</surname><given-names>E</given-names></name><name><surname>VÃ¶lker</surname><given-names>U</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Weeke</surname><given-names>PE</given-names></name><name><surname>Weijs</surname><given-names>B</given-names></name><name><surname>Weiss</surname><given-names>R</given-names></name><name><surname>Weiss</surname><given-names>S</given-names></name><name><surname>Wells</surname><given-names>QS</given-names></name><name><surname>Wiggins</surname><given-names>KL</given-names></name><name><surname>Wong</surname><given-names>JA</given-names></name><name><surname>Woo</surname><given-names>D</given-names></name><name><surname>Worrall</surname><given-names>BB</given-names></name><name><surname>Yang</surname><given-names>P-S</given-names></name><name><surname>Yao</surname><given-names>J</given-names></name><name><surname>Yoneda</surname><given-names>ZT</given-names></name><name><surname>Zeller</surname><given-names>T</given-names></name><name><surname>Zeng</surname><given-names>L</given-names></name><name><surname>Lubitz</surname><given-names>SA</given-names></name><name><surname>Lunetta</surname><given-names>KL</given-names></name><name><surname>Ellinor</surname><given-names>PT</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Multi-Ethnic genome-wide association study for atrial fibrillation</article-title><source>Nature Genetics</source><volume>50</volume><fpage>1225</fpage><lpage>1233</lpage><pub-id pub-id-type="doi">10.1038/s41588-018-0133-9</pub-id><pub-id pub-id-type="pmid">29892015</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruijter</surname><given-names>JM</given-names></name><name><surname>Ramakers</surname><given-names>C</given-names></name><name><surname>Hoogaars</surname><given-names>WMH</given-names></name><name><surname>Karlen</surname><given-names>Y</given-names></name><name><surname>Bakker</surname><given-names>O</given-names></name><name><surname>van den Hoff</surname><given-names>MJB</given-names></name><name><surname>Moorman</surname><given-names>AFM</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data</article-title><source>Nucleic Acids Research</source><volume>37</volume><elocation-id>e45</elocation-id><pub-id pub-id-type="doi">10.1093/nar/gkp045</pub-id><pub-id pub-id-type="pmid">19237396</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruiz-Villalba</surname><given-names>A</given-names></name><name><surname>van Pelt-Verkuil</surname><given-names>E</given-names></name><name><surname>Gunst</surname><given-names>QD</given-names></name><name><surname>Ruijter</surname><given-names>JM</given-names></name><name><surname>van den Hoff</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Amplification of nonspecific products in quantitative polymerase chain reactions (qPCR)</article-title><source>Biomolecular Detection and Quantification</source><volume>14</volume><fpage>7</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1016/j.bdq.2017.10.001</pub-id><pub-id pub-id-type="pmid">29255685</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sadasivam</surname><given-names>S</given-names></name><name><surname>DeCaprio</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The DREAM complex: master coordinator of cell cycle-dependent gene expression</article-title><source>Nature Reviews. Cancer</source><volume>13</volume><fpage>585</fpage><lpage>595</lpage><pub-id pub-id-type="doi">10.1038/nrc3556</pub-id><pub-id pub-id-type="pmid">23842645</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sander</surname><given-names>JD</given-names></name><name><surname>Maeder</surname><given-names>ML</given-names></name><name><surname>Reyon</surname><given-names>D</given-names></name><name><surname>Voytas</surname><given-names>DF</given-names></name><name><surname>Joung</surname><given-names>JK</given-names></name><name><surname>Dobbs</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>ZiFiT (zinc finger targeter): an updated zinc finger engineering tool</article-title><source>Nucleic Acids Research</source><volume>38</volume><fpage>W462</fpage><lpage>W468</lpage><pub-id pub-id-type="doi">10.1093/nar/gkq319</pub-id><pub-id pub-id-type="pmid">20435679</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaub</surname><given-names>MA</given-names></name><name><surname>Boyle</surname><given-names>AP</given-names></name><name><surname>Kundaje</surname><given-names>A</given-names></name><name><surname>Batzoglou</surname><given-names>S</given-names></name><name><surname>Snyder</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Linking disease associations with regulatory information in the human genome</article-title><source>Genome Research</source><volume>22</volume><fpage>1748</fpage><lpage>1759</lpage><pub-id pub-id-type="doi">10.1101/gr.136127.111</pub-id><pub-id pub-id-type="pmid">22955986</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simmons</surname><given-names>AR</given-names></name><name><surname>Davies</surname><given-names>KA</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Bergmann</surname><given-names>DC</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>SOL1 and SOL2 regulate fate transition and cell divisions in the arabidopsis stomatal lineage</article-title><source>Development</source><volume>146</volume><elocation-id>dev171066</elocation-id><pub-id pub-id-type="doi">10.1242/dev.171066</pub-id><pub-id pub-id-type="pmid">30665887</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simpson</surname><given-names>RJ</given-names></name><name><surname>Amara</surname><given-names>I</given-names></name><name><surname>Foster</surname><given-names>JR</given-names></name><name><surname>Woelfel</surname><given-names>A</given-names></name><name><surname>Gettes</surname><given-names>LS</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>Thresholds, refractory periods, and conduction times of the normal and diseased human atrium</article-title><source>American Heart Journal</source><volume>116</volume><fpage>1080</fpage><lpage>1090</lpage><pub-id pub-id-type="doi">10.1016/0002-8703(88)90163-9</pub-id><pub-id pub-id-type="pmid">2459948</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smemo</surname><given-names>S</given-names></name><name><surname>Campos</surname><given-names>LC</given-names></name><name><surname>Moskowitz</surname><given-names>IP</given-names></name><name><surname>Krieger</surname><given-names>JE</given-names></name><name><surname>Pereira</surname><given-names>AC</given-names></name><name><surname>Nobrega</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Regulatory variation in a TBX5 enhancer leads to isolated congenital heart disease</article-title><source>Human Molecular Genetics</source><volume>21</volume><fpage>3255</fpage><lpage>3263</lpage><pub-id pub-id-type="doi">10.1093/hmg/dds165</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sobreira</surname><given-names>DR</given-names></name><name><surname>Joslin</surname><given-names>AC</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Williamson</surname><given-names>I</given-names></name><name><surname>Hansen</surname><given-names>GT</given-names></name><name><surname>Farris</surname><given-names>KM</given-names></name><name><surname>Sakabe</surname><given-names>NJ</given-names></name><name><surname>Sinnott-Armstrong</surname><given-names>N</given-names></name><name><surname>Bozek</surname><given-names>G</given-names></name><name><surname>Jensen-Cody</surname><given-names>SO</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Extensive pleiotropism and allelic heterogeneity mediate metabolic effects of IRX3 and IRX5</article-title><source>Science</source><volume>372</volume><fpage>1085</fpage><lpage>1091</lpage><pub-id pub-id-type="doi">10.1126/science.abf1008</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Staerk</surname><given-names>L</given-names></name><name><surname>Sherer</surname><given-names>JA</given-names></name><name><surname>Ko</surname><given-names>D</given-names></name><name><surname>Benjamin</surname><given-names>EJ</given-names></name><name><surname>Helm</surname><given-names>RH</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes</article-title><source>Circulation Research</source><volume>120</volume><fpage>1501</fpage><lpage>1517</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.117.309732</pub-id><pub-id pub-id-type="pmid">28450367</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Steimle</surname><given-names>J</given-names></name><name><surname>Nadadur</surname><given-names>RD</given-names></name><name><surname>Broman</surname><given-names>MT</given-names></name><name><surname>Moskowitz</surname><given-names>IP</given-names></name></person-group><year iso-8601-date="2020">2020</year><source>Molecular Mechanism of Congenital Heart Disease and Pulmonary Hypertension</source><publisher-name>Springer</publisher-name><pub-id pub-id-type="doi">10.1007/978-981-15-1185-1</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strober</surname><given-names>BJ</given-names></name><name><surname>Elorbany</surname><given-names>R</given-names></name><name><surname>Rhodes</surname><given-names>K</given-names></name><name><surname>Krishnan</surname><given-names>N</given-names></name><name><surname>Tayeb</surname><given-names>K</given-names></name><name><surname>Battle</surname><given-names>A</given-names></name><name><surname>Gilad</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Dynamic genetic regulation of gene expression during cellular differentiation</article-title><source>Science</source><volume>364</volume><fpage>1287</fpage><lpage>1290</lpage><pub-id pub-id-type="doi">10.1126/science.aaw0040</pub-id><pub-id pub-id-type="pmid">31249060</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tao</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Bai</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Moon</surname><given-names>AM</given-names></name><name><surname>Kaminski</surname><given-names>HJ</given-names></name><name><surname>Martin</surname><given-names>JF</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Pitx2, an atrial fibrillation predisposition gene, directly regulates ion transport and intercalated disc genes</article-title><source>Circulation. Cardiovascular Genetics</source><volume>7</volume><fpage>23</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1161/CIRCGENETICS.113.000259</pub-id><pub-id pub-id-type="pmid">24395921</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Timpson</surname><given-names>NJ</given-names></name><name><surname>Greenwood</surname><given-names>CMT</given-names></name><name><surname>Soranzo</surname><given-names>N</given-names></name><name><surname>Lawson</surname><given-names>DJ</given-names></name><name><surname>Richards</surname><given-names>JB</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Genetic architecture: the shape of the genetic contribution to human traits and disease</article-title><source>Nature Reviews. Genetics</source><volume>19</volume><fpage>110</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1038/nrg.2017.101</pub-id><pub-id pub-id-type="pmid">29225335</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tucker</surname><given-names>NR</given-names></name><name><surname>McLellan</surname><given-names>MA</given-names></name><name><surname>Hu</surname><given-names>D</given-names></name><name><surname>Ye</surname><given-names>J</given-names></name><name><surname>Parsons</surname><given-names>VA</given-names></name><name><surname>Mills</surname><given-names>RW</given-names></name><name><surname>Clauss</surname><given-names>S</given-names></name><name><surname>Dolmatova</surname><given-names>E</given-names></name><name><surname>Shea</surname><given-names>MA</given-names></name><name><surname>Milan</surname><given-names>DJ</given-names></name><name><surname>Scott</surname><given-names>NS</given-names></name><name><surname>Lindsay</surname><given-names>M</given-names></name><name><surname>Lubitz</surname><given-names>SA</given-names></name><name><surname>Domian</surname><given-names>IJ</given-names></name><name><surname>Stone</surname><given-names>JR</given-names></name><name><surname>Lin</surname><given-names>H</given-names></name><name><surname>Ellinor</surname><given-names>PT</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Novel mutation in <italic>flnc</italic> (filamin c) causes familial restrictive cardiomyopathy</article-title><source>Circulation. Cardiovascular Genetics</source><volume>10</volume><elocation-id>e001780</elocation-id><pub-id pub-id-type="doi">10.1161/CIRCGENETICS.117.001780</pub-id><pub-id pub-id-type="pmid">29212899</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Duijvenboden</surname><given-names>K</given-names></name><name><surname>de Boer</surname><given-names>BA</given-names></name><name><surname>Capon</surname><given-names>N</given-names></name><name><surname>Ruijter</surname><given-names>JM</given-names></name><name><surname>Christoffels</surname><given-names>VM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Emerge: a flexible modelling framework to predict genomic regulatory elements from genomic signatures</article-title><source>Nucleic Acids Research</source><volume>44</volume><elocation-id>e42</elocation-id><pub-id pub-id-type="doi">10.1093/nar/gkv1144</pub-id><pub-id pub-id-type="pmid">26531828</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Duijvenboden</surname><given-names>K</given-names></name><name><surname>de Bakker</surname><given-names>DEM</given-names></name><name><surname>Man</surname><given-names>JCK</given-names></name><name><surname>Janssen</surname><given-names>R</given-names></name><name><surname>GÃ¼nthel</surname><given-names>M</given-names></name><name><surname>Hill</surname><given-names>MC</given-names></name><name><surname>Hooijkaas</surname><given-names>IB</given-names></name><name><surname>van der Made</surname><given-names>I</given-names></name><name><surname>van der Kraak</surname><given-names>PH</given-names></name><name><surname>Vink</surname><given-names>A</given-names></name><name><surname>Creemers</surname><given-names>EE</given-names></name><name><surname>Martin</surname><given-names>JF</given-names></name><name><surname>Barnett</surname><given-names>P</given-names></name><name><surname>Bakkers</surname><given-names>J</given-names></name><name><surname>Christoffels</surname><given-names>VM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Conserved NPPB+ border zone switches from MEF2- to AP-1-driven gene program</article-title><source>Circulation</source><volume>140</volume><fpage>864</fpage><lpage>879</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.118.038944</pub-id><pub-id pub-id-type="pmid">31259610</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Eif</surname><given-names>VWW</given-names></name><name><surname>Devalla</surname><given-names>HD</given-names></name><name><surname>Boink</surname><given-names>GJJ</given-names></name><name><surname>Christoffels</surname><given-names>VM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Transcriptional regulation of the cardiac conduction system</article-title><source>Nature Reviews Cardiology</source><volume>15</volume><fpage>617</fpage><lpage>630</lpage><pub-id pub-id-type="doi">10.1038/s41569-018-0031-y</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Ouwerkerk</surname><given-names>AF</given-names></name><name><surname>Bosada</surname><given-names>FM</given-names></name><name><surname>van Duijvenboden</surname><given-names>K</given-names></name><name><surname>Hill</surname><given-names>MC</given-names></name><name><surname>Montefiori</surname><given-names>LE</given-names></name><name><surname>Scholman</surname><given-names>KT</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>de Vries</surname><given-names>AAF</given-names></name><name><surname>Boukens</surname><given-names>BJ</given-names></name><name><surname>Ellinor</surname><given-names>PT</given-names></name><name><surname>Goumans</surname><given-names>MJTH</given-names></name><name><surname>Efimov</surname><given-names>IR</given-names></name><name><surname>Nobrega</surname><given-names>MA</given-names></name><name><surname>Barnett</surname><given-names>P</given-names></name><name><surname>Martin</surname><given-names>JF</given-names></name><name><surname>Christoffels</surname><given-names>VM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Identification of atrial fibrillation associated genes and functional non-coding variants</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>4755</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-12721-5</pub-id><pub-id pub-id-type="pmid">31628324</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Ouwerkerk</surname><given-names>AF</given-names></name><name><surname>Hall</surname><given-names>AW</given-names></name><name><surname>Kadow</surname><given-names>ZA</given-names></name><name><surname>Lazarevic</surname><given-names>S</given-names></name><name><surname>Reyat</surname><given-names>JS</given-names></name><name><surname>Tucker</surname><given-names>NR</given-names></name><name><surname>Nadadur</surname><given-names>RD</given-names></name><name><surname>Bosada</surname><given-names>FM</given-names></name><name><surname>Bianchi</surname><given-names>V</given-names></name><name><surname>Ellinor</surname><given-names>PT</given-names></name><name><surname>Fabritz</surname><given-names>L</given-names></name><name><surname>Martin</surname><given-names>JF</given-names></name><name><surname>de Laat</surname><given-names>W</given-names></name><name><surname>Kirchhof</surname><given-names>P</given-names></name><name><surname>Moskowitz</surname><given-names>IP</given-names></name><name><surname>Christoffels</surname><given-names>VM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Epigenetic and transcriptional networks underlying atrial fibrillation</article-title><source>Circulation Research</source><volume>127</volume><fpage>34</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.120.316574</pub-id><pub-id pub-id-type="pmid">32717170</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Ouwerkerk</surname><given-names>AF</given-names></name><name><surname>Bosada</surname><given-names>FM</given-names></name><name><surname>van Duijvenboden</surname><given-names>K</given-names></name><name><surname>Houweling</surname><given-names>AC</given-names></name><name><surname>Scholman</surname><given-names>KT</given-names></name><name><surname>Wakker</surname><given-names>V</given-names></name><name><surname>Allaart</surname><given-names>CP</given-names></name><name><surname>Uhm</surname><given-names>J-S</given-names></name><name><surname>Mathijssen</surname><given-names>IB</given-names></name><name><surname>Baartscheer</surname><given-names>T</given-names></name><name><surname>Postma</surname><given-names>AV</given-names></name><name><surname>Barnett</surname><given-names>P</given-names></name><name><surname>Verkerk</surname><given-names>AO</given-names></name><name><surname>Boukens</surname><given-names>BJ</given-names></name><name><surname>Christoffels</surname><given-names>VM</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Patient-Specific TBX5-G125R variant induces profound transcriptional deregulation and atrial dysfunction</article-title><source>Circulation</source><volume>145</volume><fpage>606</fpage><lpage>619</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.121.054347</pub-id><pub-id pub-id-type="pmid">35113653</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Weerd</surname><given-names>JH</given-names></name><name><surname>Badi</surname><given-names>I</given-names></name><name><surname>van den Boogaard</surname><given-names>M</given-names></name><name><surname>Stefanovic</surname><given-names>S</given-names></name><name><surname>van de Werken</surname><given-names>HJG</given-names></name><name><surname>Gomez-Velazquez</surname><given-names>M</given-names></name><name><surname>Badia-Careaga</surname><given-names>C</given-names></name><name><surname>Manzanares</surname><given-names>M</given-names></name><name><surname>de Laat</surname><given-names>W</given-names></name><name><surname>Barnett</surname><given-names>P</given-names></name><name><surname>Christoffels</surname><given-names>VM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A large permissive regulatory domain exclusively controls TBX3 expression in the cardiac conduction system</article-title><source>Circulation Research</source><volume>115</volume><fpage>432</fpage><lpage>441</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.115.303591</pub-id><pub-id pub-id-type="pmid">24963028</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verheule</surname><given-names>S</given-names></name><name><surname>Sato</surname><given-names>T</given-names></name><name><surname>Everett</surname><given-names>T</given-names></name><name><surname>Engle</surname><given-names>SK</given-names></name><name><surname>Otten</surname><given-names>D</given-names></name><name><surname>Rubart-von der Lohe</surname><given-names>M</given-names></name><name><surname>Nakajima</surname><given-names>HO</given-names></name><name><surname>Nakajima</surname><given-names>H</given-names></name><name><surname>Field</surname><given-names>LJ</given-names></name><name><surname>Olgin</surname><given-names>JE</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-beta1</article-title><source>Circulation Research</source><volume>94</volume><fpage>1458</fpage><lpage>1465</lpage><pub-id pub-id-type="doi">10.1161/01.RES.0000129579.59664.9d</pub-id><pub-id pub-id-type="pmid">15117823</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verkerk</surname><given-names>AO</given-names></name><name><surname>Tan</surname><given-names>HL</given-names></name><name><surname>Kirkels</surname><given-names>JH</given-names></name><name><surname>Ravesloot</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Role of Ca2+-activated Cl- current during proarrhythmic early afterdepolarizations in sheep and human ventricular myocytes</article-title><source>Acta Physiologica Scandinavica</source><volume>179</volume><fpage>143</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1046/j.1365-201X.2003.01190.x</pub-id><pub-id pub-id-type="pmid">14510777</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Visel</surname><given-names>A</given-names></name><name><surname>Minovitsky</surname><given-names>S</given-names></name><name><surname>Dubchak</surname><given-names>I</given-names></name><name><surname>Pennacchio</surname><given-names>LA</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Vista enhancer browser -- a database of tissue-specific human enhancers</article-title><source>Nucleic Acids Research</source><volume>35</volume><fpage>D88</fpage><lpage>D92</lpage><pub-id pub-id-type="doi">10.1093/nar/gkl822</pub-id><pub-id pub-id-type="pmid">17130149</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Visscher</surname><given-names>PM</given-names></name><name><surname>Wray</surname><given-names>NR</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Sklar</surname><given-names>P</given-names></name><name><surname>McCarthy</surname><given-names>MI</given-names></name><name><surname>Brown</surname><given-names>MA</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>10 years of GWAS discovery: biology, function, and translation</article-title><source>American Journal of Human Genetics</source><volume>101</volume><fpage>5</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2017.06.005</pub-id><pub-id pub-id-type="pmid">28686856</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Klysik</surname><given-names>E</given-names></name><name><surname>Sood</surname><given-names>S</given-names></name><name><surname>Johnson</surname><given-names>RL</given-names></name><name><surname>Wehrens</surname><given-names>XHT</given-names></name><name><surname>Martin</surname><given-names>JF</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Pitx2 prevents susceptibility to atrial arrhythmias by inhibiting left-sided pacemaker specification</article-title><source>PNAS</source><volume>107</volume><fpage>9753</fpage><lpage>9758</lpage><pub-id pub-id-type="doi">10.1073/pnas.0912585107</pub-id><pub-id pub-id-type="pmid">20457925</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>K</given-names></name><name><surname>Stringer</surname><given-names>S</given-names></name><name><surname>Frei</surname><given-names>O</given-names></name><name><surname>UmiÄeviÄ Mirkov</surname><given-names>M</given-names></name><name><surname>de Leeuw</surname><given-names>C</given-names></name><name><surname>Polderman</surname><given-names>TJC</given-names></name><name><surname>van der Sluis</surname><given-names>S</given-names></name><name><surname>Andreassen</surname><given-names>OA</given-names></name><name><surname>Neale</surname><given-names>BM</given-names></name><name><surname>Posthuma</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A global overview of pleiotropy and genetic architecture in complex traits</article-title><source>Nature Genetics</source><volume>51</volume><fpage>1339</fpage><lpage>1348</lpage><pub-id pub-id-type="doi">10.1038/s41588-019-0481-0</pub-id><pub-id pub-id-type="pmid">31427789</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>TJ</given-names></name><name><surname>Kim</surname><given-names>YH</given-names></name><name><surname>Yashima</surname><given-names>M</given-names></name><name><surname>Athill</surname><given-names>CA</given-names></name><name><surname>Ting</surname><given-names>CT</given-names></name><name><surname>Karagueuzian</surname><given-names>HS</given-names></name><name><surname>Chen</surname><given-names>PS</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Progressive action potential duration shortening and the conversion from atrial flutter to atrial fibrillation in the isolated canine right atrium</article-title><source>Journal of the American College of Cardiology</source><volume>38</volume><fpage>1757</fpage><lpage>1765</lpage><pub-id pub-id-type="doi">10.1016/s0735-1097(01)01606-0</pub-id><pub-id pub-id-type="pmid">11704392</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Hill</surname><given-names>MC</given-names></name><name><surname>Kadow</surname><given-names>ZA</given-names></name><name><surname>Suh</surname><given-names>JH</given-names></name><name><surname>Tucker</surname><given-names>NR</given-names></name><name><surname>Hall</surname><given-names>AW</given-names></name><name><surname>Tran</surname><given-names>TT</given-names></name><name><surname>Swinton</surname><given-names>PS</given-names></name><name><surname>Leach</surname><given-names>JP</given-names></name><name><surname>Margulies</surname><given-names>KB</given-names></name><name><surname>Ellinor</surname><given-names>PT</given-names></name><name><surname>Li</surname><given-names>N</given-names></name><name><surname>Martin</surname><given-names>JF</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Long-range pitx2c enhancer-promoter interactions prevent predisposition to atrial fibrillation</article-title><source>PNAS</source><volume>116</volume><fpage>22692</fpage><lpage>22698</lpage><pub-id pub-id-type="doi">10.1073/pnas.1907418116</pub-id><pub-id pub-id-type="pmid">31636200</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Gramolini</surname><given-names>AO</given-names></name><name><surname>Walsh</surname><given-names>MA</given-names></name><name><surname>Zhou</surname><given-names>YQ</given-names></name><name><surname>Slorach</surname><given-names>C</given-names></name><name><surname>Friedberg</surname><given-names>MK</given-names></name><name><surname>Takeuchi</surname><given-names>JK</given-names></name><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Henkelman</surname><given-names>RM</given-names></name><name><surname>Backx</surname><given-names>PH</given-names></name><name><surname>Redington</surname><given-names>AN</given-names></name><name><surname>Maclennan</surname><given-names>DH</given-names></name><name><surname>Bruneau</surname><given-names>BG</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Tbx5-dependent pathway regulating diastolic function in congenital heart disease</article-title><source>PNAS</source><volume>105</volume><fpage>5519</fpage><lpage>5524</lpage><pub-id pub-id-type="doi">10.1073/pnas.0801779105</pub-id><pub-id pub-id-type="pmid">18378906</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.80317.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Shivkumar</surname><given-names>Kalyanam</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01d88se56</institution-id><institution>UCLA Health</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2022.05.14.491627" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2022.05.14.491627"/></front-stub><body><p>Molecular mechanisms of atrial fibrillation, a highly prevalent arrhythmia, have been challenging to contextualize. The investigators, in a series of experiments using the deletion of two loci in TBX5 (one intronic and one downstream), achieved a modest increase in Tbx5 in the atria. In a series of elegant experiments they show that this increase in TbX5 in turn impacted the cardiac gene regulatory network that resulted in a higher susceptibility to AF. These results will provide useful insights into the mechanisms of disease especially the variable phenotypes observed with functional variants of a gene.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.80317.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Shivkumar</surname><given-names>Kalyanam</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01d88se56</institution-id><institution>UCLA Health</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Shivkumar</surname><given-names>Kalyanam</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01d88se56</institution-id><institution>UCLA Health</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Bruneau</surname><given-names>Benoit</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/043mz5j54</institution-id><institution>University of California, San Francisco</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2022.05.14.491627">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2022.05.14.491627v1">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;An atrial fibrillation-associated regulatory region modulates cardiac <italic>Tbx5</italic> levels and arrhythmia susceptibility&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, including Kalyanam Shivkumar as the Reviewing Editor and Reviewer #1, and the evaluation has been overseen by a Senior Editor. The following individual involved in the review of your submission has agreed to reveal their identity: Benoit Bruneau (Reviewer #2).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>Please address the discussion points raised by reviewers # 1 and 2.</p><p>1. Please provide data for this comment by reviewer # 2-Does the increase in Tbx5 gene expression result in an increase in protein expression?</p><p>2. Please address the extra data sought by reviewer # 3 in the detailed comments.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>1. Why is the assumption that the regulatory elements &quot;modulate the expression of TBX5 only&quot; as opposed to have trans effects on distant gene encoding regions? For example, in reference 41 on the topic of promoter capture Hi-C maps, &quot;Remarkably, more than 90% of SNP-target gene interactions did not involve the nearest gene, while 40% of SNPs interacted with at least two genes, demonstrating the importance of considering long-range chromatin interactions when interpreting functional targets of disease loci.&quot; Aside from the two regions for selected to study, were additional regions identified?</p><p>2. As &quot;13790 and 13564 different transcripts in RE(int)-/- and RE (down)-/-&quot; were identified, how is it known that the transcriptional changes are from increased TBX5 levels as opposed to a direct, trans effects due to the deletion of the two loci at TBX5? This seems at odds with the claim that &quot;[d]eletion of either of the two RE-containing regions only affected Tbx5 expression&quot;.</p><p>3. As the SNP of interest rs7312625 has been identified as a variant associated with the electrocardiographic P wave (https://pubmed.ncbi.nlm.nih.gov/28794112/) and the transgenic mice in this study had slower heart rates, sinus pauses, inverted P waves (presumably ectopic atrial rhythm), PR prolongation, corrected sinus node recovery time, and Wenckebach cycle length, could the findings be more explanatory for nodal (sinus and atrioventricular) function and the cardiac conduction system more generally rather than atrial fibrillation in particular? The study seems as though it could have been re-framed as an evaluation of nodal function rather than atrial fibrillation. Of note, these findings were of note in the RE(down)-/- mice, which did not have increased atrial arrhythmia inducibility.</p><p>4. The authors cite reference 19 as showing a &quot;slight increaseâ¦in cardiac TBX5 expression in human heart tissues [as being] associated with AF&quot;. What was the magnitude of the increase? Challenging to gather this information on this reviewer's review of reference 19.</p><p>5. Of all the genes that are modulated by changes in TBX5 expression, why was Prrx1 chosen? How do the authors explain that lack of change noted for Pitx2?</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>The rationale for focusing on RE(down) is not clearly appreciated based on Figure 1. This is in contrast to the apparent evidence in support of RE(int). Promoter Hi-C data shows DNA interactions in human that appears to span beyond the presumptive syntenic region of RE(down) in mouse, as well as a lack of chromatin accessibility, histone marks or EMERGE prediction for RE(down). Perhaps highlighting relevant features for RE(down) more explicitly would address this minor concern.</p><p>For supplemental figure 1, please define LD as &quot;linkage disequilibrium&quot; prior to abbreviation, as appropriate, and list the abbreviation at the beginning of the manuscript. As well, a scale bar is not apparent.</p><p>Does the increase in Tbx5 gene expression result in an increase in protein expression?</p><p>It would be interesting to compare these mouse models to the recently published TBX5 gain of function model.</p><p>For Figure 3, please define RR as &quot;R-R interval&quot; in legend and SDNN as &quot;standard deviation of normal to normal R-R intervals&quot;, as appropriate, and add to abbreviation list.</p><p>In Figure 5, where is Prrx1 highlighted in the transcriptomic analysis?</p><p>For Figure 6C, how does Prrx1(enh)-/- compare in the PCA analysis? Please display it.</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>1. TBX5 mutations in humans and animal models are known to generate congenital heart defects and upper limb/radial malformations. Perhaps of relevance to this manuscript, human patients with TBX5 duplications also show many of these same phenotypes (Heinritz et al. 2005 Heart; Patel et al. 2012 Eur J Hum Genet; Kimura et al. 2015 Pedatr Cardiol; Cenni et al. 2021 Eur J Hum Genet). Do RE(int) and RE(down) homozygous mutations result in congenital heart or limb malformations? Structural heart defects can certainly impact cardiac electrophysiology and reporting structural defects, or lack of them can help put the phenotype into context.</p><p>2. The RE(int) deletion appears to be more severe than the RE(down) deletion. Does the RE(int) deletion interfere with the splicing of the last two exons? Depending on library construction, perhaps the RNA-seq can address this.</p><p>3. In Figure 2E, the authors report that rs7312625 A&gt;G appears to be the functional SNP as it alone results in increased Tbx5 expression in vitro. As this is a predicted regulatory element, what transcription factor binding motif(s) is this SNP predicted to interfere or generate? Does this motif change make sense with gained Tbx5 expression in cardiomyocytes/HL1 cells?</p><p>4. In Figure 3C, the authors report RE(int) mutants have an increased PR interval and in Figure 4C, the authors report RE(int) have an increased APD20, 50, and 90. Single-copy loss of Tbx5 in mice has been reported to cause these same phenotypes (e.g. Bruneau et al. 2001 Cell; Nadadur et al. 2016 Sci Trans Med). Would you not expect the opposite phenotype, i.e., decreased PR interval and APD20/50/90? What is the explanation for these paradoxical results?</p><p>5. Several transcriptional profiling datasets have been generated for various Tbx5 mutations in mouse and human including a few by the authors (by cursory search of GEO for &quot;TBX5&quot;). How do the gene expression changes seen in the current datasets compare with previously generated datasets? Are the changes largely consistent with expectations of increased Tbx5 levels in RE(int) and RE(down)? It appears most public datasets are in Tbx5/TBX5 loss-of-function contexts, so we are expecting the opposite results. Does this data support that hypothesis or is there something else going on?</p><p>6. Figures 2A and 2C report that RE(down) demonstrated increased expression of Tbx5 in the adult left atria and P21 lungs, specifically, but there is little to no mention of this in the text or discussion. Given the importance of the pulmonary veins in the development of atrial fibrillation and prior publication history from the authors and colleagues on the topic of left atrial Tbx5, can the authors expand their discussion on the RE(down) related SNPs? The SNPs associated with RE(down) are independently segregating and the differences observed in this manuscript may hint at an independent, tissue-dependent function for that regulatory element.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.80317.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>Please address the discussion points raised by reviewers # 1 and 2.</p><p>1. Please provide data for this comment by reviewer # 2-Does the increase in Tbx5 gene expression result in an increase in protein expression?</p><p>2. Please address the extra data sought by reviewer # 3 in the detailed comments.</p></disp-quote><p>We would like to thank the reviewers for their constructive criticism and suggestions. In our revised manuscript, we have addressed all comments and questions raised as detailed below. We believe that the incorporated changes have greatly improved the manuscript.</p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>1. Why is the assumption that the regulatory elements &quot;modulate the expression of TBX5 only&quot; as opposed to have trans effects on distant gene encoding regions? For example, in reference 41 on the topic of promoter capture Hi-C maps, &quot;Remarkably, more than 90% of SNP-target gene interactions did not involve the nearest gene, while 40% of SNPs interacted with at least two genes, demonstrating the importance of considering long-range chromatin interactions when interpreting functional targets of disease loci.&quot; Aside from the two regions for selected to study, were additional regions identified?</p></disp-quote><p>Although a regulatory element, potentially containing SNP(s), usually shares the topologically associating domain (TAD) with its target genes, it does not necessarily interact with the nearest gene. In the referred study, promoter capture Hi-C identified only a fraction of the interactions, and showed a bias against detecting proximal interactions because of the high background signal associated with genomic locations close to each other. Moreover, the interactions reflect conformation (3D structure) of the chromatin and do not necessarily imply functional interactions. Nevertheless, our group has previously shown that the <italic>Tbx5</italic> regulatory region is confined to its own TAD (Weerd et al., 2014). Additionally, we examined the expression of genes adjacent to the Tbx5 TAD, <italic>Rbm19</italic>, <italic>Tbx3</italic> and <italic>Med13l,</italic> in atria and ventricles of mice with deletions by RT-qPCR, and found no changes in their expression (Figure 2âfigure supplement 1). These data confirm that the deleted regulatory regions target <italic>Tbx5</italic> and not genes in adjacent TADs.</p><p>We identified at least one additional AF-associated variant region with regulatory potential in the <italic>TBX5/Tbx5</italic> locus, namely, in the second to last intron, which can be seen in Figure 1. However, we chose not to study this region because of the decreased accessibility in atrial tissue (ATACseq) and the comparably lower degree of conservation across species (GERP).</p><disp-quote content-type="editor-comment"><p>2. As &quot;13790 and 13564 different transcripts in RE(int)-/- and RE (down)-/-&quot; were identified, how is it known that the transcriptional changes are from increased TBX5 levels as opposed to a direct, trans effects due to the deletion of the two loci at TBX5? This seems at odds with the claim that &quot;[d]eletion of either of the two RE-containing regions only affected Tbx5 expression&quot;.</p></disp-quote><p>Although we cannot fully rule out that the deleted regulatory regions target other genes in addition to <italic>Tbx5</italic>, we anticipate that the transcriptional changes are a result of increased <italic>Tbx5</italic> levels rather than a consequence of the deletion of the variant regions. As mentioned above in response to comment 1 of the reviewer, previous research indicated that the regulatory elements of <italic>Tbx5</italic> are restricted to the <italic>Tbx5</italic> TAD (Weerd et al., 2014), and we confirmed that nearby genes in adjacent TADs were not influenced by the deletions (see Figure 2âfigure supplement 1 in the revised manuscript). Regulatory element-target promoter interactions are generally assumed to be confined to the same TAD (Dixon et al., 2012; Nora et al., 2012; Sexton et al., 2012), and it is considered very unlikely that these interactions span multiple TADs or chromosomes. Furthermore, we observed the upregulation of several well established TBX5 target genes (e.g. <italic>Gja5</italic>, <italic>Ryr2</italic>), suggesting that increased <italic>Tbx5</italic> dose is causal. Finally, we compared the transcriptomes of left atria of RE(int)<sup>-/-</sup> mice (deletion in the last intron of <italic>Tbx5</italic>; increased <italic>Tbx5</italic> expression in atria) to the reported transcriptome of left atria of mice in which <italic>Tbx5</italic> was inactivated (Nadadur et al., 2016). We observed a strikingly opposite transcriptional response (see new Figure 5âfigure supplement 2), indicating that the Tbx5-dependent regulatory network responds in opposite direction to increased and decreased Tbx5 dose, respectively.</p><disp-quote content-type="editor-comment"><p>3. As the SNP of interest rs7312625 has been identified as a variant associated with the electrocardiographic P wave (https://pubmed.ncbi.nlm.nih.gov/28794112/) and the transgenic mice in this study had slower heart rates, sinus pauses, inverted P waves (presumably ectopic atrial rhythm), PR prolongation, corrected sinus node recovery time, and Wenckebach cycle length, could the findings be more explanatory for nodal (sinus and atrioventricular) function and the cardiac conduction system more generally rather than atrial fibrillation in particular? The study seems as though it could have been re-framed as an evaluation of nodal function rather than atrial fibrillation. Of note, these findings were of note in the RE(down)-/- mice, which did not have increased atrial arrhythmia inducibility.</p></disp-quote><p>We thank the reviewer for this comment. The study the reviewer refers to states: âThe P wave on an ECG is a measure of atrial electric function, and its characteristics may serve as predictors for atrial arrhythmias.â Therefore, the SNPs identified in this study may impact on expression of genes, including <italic>TBX5</italic> and <italic>SCN5A</italic>, involved in atrial cardiomyocyte electrophysiology. We addressed this aspect here, and found that atrial cardiomyocytes showed altered electrophysiological properties facilitating arrhythmia. The observed inverted P waves, changed SAN recovery times and changed WCL indeed suggest that SAN and AVN function may be affected in addition. Therefore, it is possible that the atrial arrhythmia is a culmination of multiple triggers, including changes in nodal and working cardiomyocytes. While we certainly want to further investigate a role of Tbx5 in SAN function, we feel that further characterization of nodal function remains outside the scope of this study.</p><disp-quote content-type="editor-comment"><p>4. The authors cite reference 19 as showing a &quot;slight increaseâ¦in cardiac TBX5 expression in human heart tissues [as being] associated with AF&quot;. What was the magnitude of the increase? Challenging to gather this information on this reviewer's review of reference 19.</p></disp-quote><p>We thank the reviewer for pointing this out. We have amended the text in the revised manuscript to clarify a 30% increase in cardiac <italic>TBX5</italic> expression in lines 96-98 and 144-145.</p><disp-quote content-type="editor-comment"><p>5. Of all the genes that are modulated by changes in TBX5 expression, why was Prrx1 chosen?</p></disp-quote><p>In GWAS studies, the <italic>PRRX1</italic> locus has been strongly associated with AF. <italic>PRRX1</italic> encodes a transcription factor that we and others have shown to be causally linked to atrial fibrillation susceptibility. Therefore, we chose to intercross RE(int)<sup>-/-</sup> and Prrx1(enh)<sup>-/-</sup> mice to test whether the two established AF-risk alleles would aggravated the arrhythmogenic phenotype. Strikingly, we found a partial rescue of the phenotypes instead. We later determined that <italic>Prrx1</italic> was upregulated in RE(int)<sup>-/-</sup> specifically in cardiomyocytes, but not in bulk RNAseq, likely because <italic>Prrx1</italic> is most highly expressed in non-cardiomyocyte cell populations.</p><p>We have changed the revised manuscript to clarify this in 229-2243, as follows:</p><p>âWe considered whether the presence of two AF-risk alleles would exacerbate the phenotype(s) consistent with AF. <italic>PRRX1</italic>, encoding the transcription factor Paired Related Homeobox 1, has been linked to AF-predisposition (19, 24, 25). Reduced <italic>PRRX1</italic> expression in human cardiac tissues has been associated with AF (19). We previously deleted the mouse orthologous variant region near <italic>PRRX1</italic> (<italic>Prrx1(enh)</italic>) to investigate its role in gene regulation and rhythm control (25). <italic>Prrx1(enh)<sup>-/-</sup></italic> mice express less <italic>Prrx1</italic> specifically in cardiomyocytes compared to controls, and show atrial conduction slowing, lower AP upstroke velocity (indicative for lower Na<sup>+</sup> current densities) (58), as well as increased systolic and diastolic [ca<sup>2+</sup>]<sub>i</sub> concentration that culminate in increased susceptibility to atrial arrhythmia induction (25). To explore whether and how these two AF-risk genes may interact, we intercrossed <italic>RE(int)<sup>-/</sup></italic><sup>-</sup> with <italic>Prrx1(enh)<sup>-/-</sup></italic> mice (decreased <italic>Prrx1</italic> in cardiomyocytes), and investigated cardiac transcriptomes and phenotypes across genotypes.â</p><disp-quote content-type="editor-comment"><p>How do the authors explain that lack of change noted for Pitx2?</p></disp-quote><p>We did not observe a change in <italic>Pitx2</italic> expression in the left atria of our mutant mice. We surmise that this is because a 30-35% increase of <italic>Tbx5</italic> expression is not sufficient to induce a proportional increase in <italic>Pitx2</italic>. We recently characterized a <italic>Tbx5</italic> gain-of-function mouse model (van Ouwerkerk et al., 2022) in which <italic>Pitx2</italic> was increased in the right atrium, while the left atrium remained unaffected. We therefore examined whether <italic>Pitx2</italic> expression was changed in the right atria of RE(int)<sup>-/-</sup> by RT-qPCR and found that it is indeed not affected, thus suggesting that the modest increase in <italic>Tbx5</italic> level does not influence <italic>Pitx2</italic> expression.</p><p>We included this result in lines 215-216, new Figure 5âfigure supplement 3, and discussion in lines 348-356.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>The rationale for focusing on RE(down) is not clearly appreciated based on Figure 1. This is in contrast to the apparent evidence in support of RE(int). Promoter Hi-C data shows DNA interactions in human that appears to span beyond the presumptive syntenic region of RE(down) in mouse, as well as a lack of chromatin accessibility, histone marks or EMERGE prediction for RE(down). Perhaps highlighting relevant features for RE(down) more explicitly would address this minor concern.</p></disp-quote><p>We would like to thank the reviewer for this suggestion. While the absence of interactions as assayed in Promoter Capture Hi-C does not necessarily indicate a lack of interaction, the interactions beyond the RE(down) region indeed indicate possible distal downstream regulatory elements. Consistently, Smemo et al. (Smemo et al., 2012) identified multiple enhancer candidates downstream of the REdown region, one of which was found to harbor a SNP associated with CHD (non-HOS). We chose to include the RE(down) region in our study because it harbors AF-associated variants, and H3K4me1 modifications in cardiomyocytes. We have clarified this in lines 125-126 of the revised manuscript.</p><disp-quote content-type="editor-comment"><p>For supplemental figure 1, please define LD as &quot;linkage disequilibrium&quot; prior to abbreviation, as appropriate, and list the abbreviation at the beginning of the manuscript. As well, a scale bar is not apparent.</p></disp-quote><p>We thank the reviewer for pointing out these oversights. We have changed the text in the supplement as indicated.</p><disp-quote content-type="editor-comment"><p>Does the increase in Tbx5 gene expression result in an increase in protein expression?</p></disp-quote><p>We attempted to quantify protein expression in adult atria of RE(int)<sup>-/-</sup> and WT mice by Western Blot. However, we were unable to detect Tbx5 protein. We performed immunofluorescence staining on adult atria to show that indeed Tbx5 protein is detected in the atria of mutant and control mice, even though a 30% increase is not quantifiable using this method. However, the analysis shows that Tbx5 remains selectively expressed in PCM-1<sup>+</sup> cardiomyocyte nuclei in RE(int)<sup>-/-</sup> atria (see new Figure 2âfigure supplement 2).</p><disp-quote content-type="editor-comment"><p>It would be interesting to compare these mouse models to the recently published TBX5 gain of function model.</p></disp-quote><p>We thank the reviewer for this valuable suggestion. We now include an additional table and a scatter plot showing a comparison between adult left atria from RE(int)<sup>-/-</sup> and Tbx5<sup>G125R/+</sup> as Supplementary file 4 and in Figure 5âfigure supplement 2, respectively. Surprisingly, we found very few differentially expressed genes (DEGs) common to both models, while their electrophysiological phenotypes were more alike- inverted P-waves, slower and more variable heart rates, increased atrial arrhythmia induction, and prolonged APD. Conspicuously, an inducible loss-of-function <italic>Tbx5</italic> mouse model (Nadadur et al., 2016) also displays irregular RR, prolonged APD and arrhythmia. We have also compared transcriptomes of left atria of our RE(int) model to those of this induced adult <italic>Tbx5</italic> deletion model (Supplementary file 5 and in Figure 5âfigure supplement 2) and found opposite response of many of the same DEGs, as expected. Together, this suggests that perturbation of a Tbx5âdependent network independently of direction of change of many of the network genes results in overlapping phenotypic changes culminating in atrial dysfunction.</p><p>We have included this comparison in lines 204-208.</p><disp-quote content-type="editor-comment"><p>For Figure 3, please define RR as &quot;R-R interval&quot; in legend and SDNN as &quot;standard deviation of normal to normal R-R intervals&quot;, as appropriate, and add to abbreviation list.</p></disp-quote><p>We apologize for the oversight. The definitions have been added to the revised manuscript as indicated.</p><disp-quote content-type="editor-comment"><p>In Figure 5, where is Prrx1 highlighted in the transcriptomic analysis?</p></disp-quote><p><italic>Prrx1</italic> was, in fact, not found to be differentially expressed in left atrial RNAseq data. We found that the induction of <italic>Prrx1</italic> occurs only in atrial cardiomyocytes of RE(int)<sup>-/-</sup> mice, consistent with cardiomyocyte-specific expression-, and thereby induction in RE(int)<sup>-/-</sup>, of <italic>Tbx5</italic> (see also immunofluorescence analysis mentioned above). We surmise that this change was not detectable in bulk RNAseq because <italic>Prrx1</italic> is mostly expressed in non-cardiomyocytes, which is likely not affected in our mutants.</p><p>We understand that the rationale for studying the interaction between <italic>Tbx5</italic> and <italic>Prrx1</italic> is muddled without this observation. Therefore, we have changed the text in lines 229-238, as specified in reviewer 1 point 5.</p><disp-quote content-type="editor-comment"><p>For Figure 6C, how does Prrx1(enh)-/- compare in the PCA analysis? Please display it.</p></disp-quote><p>Unfortunately, we are unable to directly compare the Prrx1(enh)<sup>-/-</sup> RNAseq dataset in the PCA because it was obtained, along with its own WT control group, in a different session (months in between experiments; all experiments performed with alleles on same FVB background though). It appeared that this difference in session greatly influences the PCs. However, we compared the L2FC (and p(adj)) values in each transcriptomic comparison (WT vs RE(int)<sup>-/-</sup>, WT vs Prrx1(enh)<sup>-/-</sup>, WT vs RE(int)<sup>-/-</sup>;Prrx1(enh)<sup>-/-</sup> (Double mutant)), as these parameters are relatively unaffected by inter-session variation. We observed that (1) the number of genes differentially expressed between mutant and WT decreased going from RE(int)<sup>-/-</sup>, Double mutant, Prrx1(enh)<sup>-/-</sup>, (2) the direction of change of DEGs was similar between RE(int)<sup>-/-</sup> and Double mutant, but different from Prrx1(enh)<sup>-/-</sup>, (3) the distribution of the L2FCs was slightly smaller in Double mutant than RE(int)<sup>-/-</sup>. This is shown in the revised Supplemental figure 10. Together, these analyses suggest that RE(int)<sup>-/-</sup> has a much larger effect on the atrial transcriptome than Prrx1(enh)<sup>-/-</sup>, and that the effect of RE(int)<sup>-/-</sup> is slightly normalized by the inclusion of Prrx1(enh)<sup>-/-</sup> in RE(int)<sup>-/-</sup>.</p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Recommendations for the authors):</p><p>1. TBX5 mutations in humans and animal models are known to generate congenital heart defects and upper limb/radial malformations. Perhaps of relevance to this manuscript, human patients with TBX5 duplications also show many of these same phenotypes (Heinritz et al. 2005 Heart; Patel et al. 2012 Eur J Hum Genet; Kimura et al. 2015 Pedatr Cardiol; Cenni et al. 2021 Eur J Hum Genet). Do RE(int) and RE(down) homozygous mutations result in congenital heart or limb malformations? Structural heart defects can certainly impact cardiac electrophysiology and reporting structural defects, or lack of them can help put the phenotype into context.</p></disp-quote><p>We thank the reviewer for this suggestion. We have included the notion of CHD in patients with duplications and these references in the Introduction section of the revised manuscript in lines 85-86. We did not observe any structural defects of limbs or heart. <italic>Tbx5</italic> expression in RE(down)<sup>-/-</sup> mice is selectively induced in atrial and lung tissue after birth, and therefore limb defects are not expected. Similarly, atrial induction in RE(int)<sup>-/-</sup> mice is observed after birth. However, we noted a mild induction of <italic>Tbx5</italic> expression in prenatal ventricles of RE(int)<sup>-/-</sup> mice (not in RE(down)<sup>-/-</sup> mice). While this does not lead to structural defects, the ventricles may be slightly larger. We are currently investigating this possible phenotype.</p><disp-quote content-type="editor-comment"><p>2. The RE(int) deletion appears to be more severe than the RE(down) deletion. Does the RE(int) deletion interfere with the splicing of the last two exons? Depending on library construction, perhaps the RNA-seq can address this.</p></disp-quote><p>This is a very insightful suggestion. Inspection of the RNAseq data sets revealed that the exon read coverage of exons relative to each other, including the ones flanking the intra-intronic deletion, is highly similar between WT and RE(int)<sup>-/-</sup> (see new Figure 2âfigure supplement 3). Moreover, when zooming in on the intronic region, we clearly see absence of reads mapped to the deleted region, validating the absence of this genomic sequence. Furthermore, when we performed RT-qPCR of WT and RE(int)<sup>-/-</sup> atrial samples using intron/exon-spanning primers in exons 6-8, 7-9 and 8-9, respectively, we obtained the same result for both groups, and the obtained amplicons did not include fragments in which exon 8 was skipped (new Figure 2âfigure supplement 3).</p><disp-quote content-type="editor-comment"><p>3. In Figure 2E, the authors report that rs7312625 A&gt;G appears to be the functional SNP as it alone results in increased Tbx5 expression in vitro. As this is a predicted regulatory element, what transcription factor binding motif(s) is this SNP predicted to interfere or generate? Does this motif change make sense with gained Tbx5 expression in cardiomyocytes/HL1 cells?</p></disp-quote><p>We analyzed whether the rs7312625 substitution interfered/changed predicted binding motifs and found that the risk allele disrupts motifs for SOL1/2 (TCX/TCX2/CHC), which are homologues of the animal CHC protein LIN54 that binds DNA in a sequence-specific manner and is a component of DREAM complexes regulating cell cycle-dependent transcription. Furthermore, we observed gain of a <italic>sine oculis</italic> (SIX) homeodomain transcription factor binding motif with the risk allele (new Supplementary file 1). SIX transcription factors can act as transcriptional activators or repressors depending on interactions with other highly conserved regulators including Paired-box (Pax), Eyes absent (Eya), Dachshund (Dach), and Groucho (Grg) proteins (Meurer et al., 2021). Both Six4 and Six5 are expressed in atrial tissue of mice (see Supplementary table 1) and human (see (Meurer et al., 2021)). We speculate the SNP could create a SIX binding site, causing loss of repressive activity of the RE. We have added this information to the revised manuscript in lines 152-159 of the Results section and 295-298 in the discussion.</p><disp-quote content-type="editor-comment"><p>4. In Figure 3C, the authors report RE(int) mutants have an increased PR interval and in Figure 4C, the authors report RE(int) have an increased APD20, 50, and 90. Single-copy loss of Tbx5 in mice has been reported to cause these same phenotypes (e.g. Bruneau et al. 2001 Cell; Nadadur et al. 2016 Sci Trans Med). Would you not expect the opposite phenotype, i.e., decreased PR interval and APD20/50/90? What is the explanation for these paradoxical results?</p></disp-quote><p>This observation is puzzling to us as well, and may reflect the complexity of responses to either decreased or increased levels of <italic>Tbx5</italic>. When comparing the transcriptional response of increased <italic>Tbx5</italic> in left atria (RE(int)<sup>-/-</sup>) to that of Tbx5<sup>G125R/+</sup> (gain of function missense mutation; (van Ouwerkerk et al., 2022) (new Supplementary file 4, Figure 5âfigure supplement 2)) we observed that it was unexpectedly divergent. When comparing the published left atrial transcriptomes of Tbx5 iKO ((Nadadur et al., 2016); <italic>Tbx5</italic> deletion induced in adult mice) with that of RE(int)<sup>-/-</sup>, we found, as expected, that most significantly differentially expressed genes (DEGs) common to both datasets were changed in opposite direction (new Supplementary file 5, Figure 5âfigure supplement 2). Remarkably, all three <italic>Tbx5</italic> mouse models display APD prolongation. This suggests that a (probably) large number of transcriptional changes occur in RE(int)<sup>-/-</sup> that disturb the balance between AP duration-increasing and -decreasing gene expression, leading to phenotypic outcome similar to that of both <italic>Tbx5</italic> loss of function and Tbx5 G125R missense variant. This further indicates that the response to Tbx5 dose is complex. Moreover, as indicated by the reviewer, loss- and gain of TBX5 gene copy results in CHD phenotypes, consistent with the notion that both reduced and increased Tbx5 levels can result in similar phenotypic outcomes.</p><disp-quote content-type="editor-comment"><p>5. Several transcriptional profiling datasets have been generated for various Tbx5 mutations in mouse and human including a few by the authors (by cursory search of GEO for &quot;TBX5&quot;). How do the gene expression changes seen in the current datasets compare with previously generated datasets? Are the changes largely consistent with expectations of increased Tbx5 levels in RE(int) and RE(down)? It appears most public datasets are in Tbx5/TBX5 loss-of-function contexts, so we are expecting the opposite results. Does this data support that hypothesis or is there something else going on?</p></disp-quote><p>We have included a new supplemental figure and accompanying tables in which we compare transcriptional profiles of left atria of RE(int)<sup>-/-</sup> mice to those of a Tbx5 gain-of-function variant mouse model (van Ouwerkerk et al., 2022) and an adult-specific knockout mouse model (Nadadur et al., 2016). Please see reviewer 2 point 4, and the response this reviewer above.</p><disp-quote content-type="editor-comment"><p>6. Figures 2A and 2C report that RE(down) demonstrated increased expression of Tbx5 in the adult left atria and P21 lungs, specifically, but there is little to no mention of this in the text or discussion. Given the importance of the pulmonary veins in the development of atrial fibrillation and prior publication history from the authors and colleagues on the topic of left atrial Tbx5, can the authors expand their discussion on the RE(down) related SNPs? The SNPs associated with RE(down) are independently segregating and the differences observed in this manuscript may hint at an independent, tissue-dependent function for that regulatory element.</p></disp-quote><p>This is an excellent suggestion. We have addressed this point in the Discussion lines 302-313 as follows:</p><p>ââ¦the AF-associated variants in <italic>RE(down)</italic> may increase <italic>Tbx5</italic> expression in both the left atrium and pulmonary vein myocardium. The pulmonary veins have been strongly implicated in AF as they are the most common source of triggered activity (64, 65). <italic>TBX5</italic> levels in pulmonary vein myocardium may influence gene regulation independently from the atrial <italic>TBX5</italic> levels (66). The variants in <italic>RE(down)</italic> segregate independently from those in <italic>RE(int)</italic>, indicating these variant RE regions act through distinct tissue-specific transcriptional mechanisms that are influenced by AF-predisposing common variants. A further implication is they may cumulatively increase AF predisposition in a manner dependent on risk variant dose, in which homozygous carriers of risk haplotypes in <italic>RE(int)</italic> and <italic>RE(down)</italic> have the largest relative predisposition. These relations could be addressed in future genotype-phenotype analyses of human atrial and pulmonary vein samples.â</p><p>References</p><p>Dixon, J.R., Selvaraj, S., Yue, F., Kim, A., Li, Y., Shen, Y., Hu, M., Liu, J.S., Ren, B., 2012. Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature 485, 376â80. https://doi.org/10.1038/nature11082</p><p>Meurer, L., Ferdman, L., Belcher, B., Camarata, T., 2021. The SIX Family of Transcription Factors: Common Themes Integrating Developmental and Cancer Biology. Front. Cell Dev. Biol. 9.</p><p>Nadadur, R.D., Broman, M.T., Boukens, B., Mazurek, S.R., Yang, X., Van Den Boogaard, M., Bekeny, J., Gadek, M., Ward, T., Zhang, M., Qiao, Y., Martin, J.F., Seidman, C.E., Seidman, J., Christoffels, V., Efimov, I.R., McNally, E.M., Weber, C.R., Moskowitz, I.P., 2016. Pitx2 modulates a Tbx5-dependent gene regulatory network to maintain atrial rhythm. Sci. Transl. Med. 8. https://doi.org/10.1126/scitranslmed.aaf4891</p><p>Nora, E.P., Lajoie, B.R., Schulz, E.G., Giorgetti, L., Okamoto, I., Servant, N., Piolot, T., Van Berkum, N.L., Meisig, J., Sedat, J., Gribnau, J., Barillot, E., BlÃ¼thgen, N., Dekker, J., Heard, E., 2012. Spatial partitioning of the regulatory landscape of the X-inactivation centre. Nature 485, 381â385. https://doi.org/10.1038/nature11049</p><p>Sexton, T., Yaffe, E., Kenigsberg, E., Bantignies, F., Leblanc, B., Hoichman, M., Parrinello, H., Tanay, A., Cavalli, G., 2012. Three-dimensional folding and functional organization principles of the <italic>Drosophila</italic> genome. Cell 148, 458â472. https://doi.org/10.1016/j.cell.2012.01.010</p><p>Smemo, S., Campos, L.C., Moskowitz, I.P., Krieger, J.E., Pereira, A.C., Nobrega, M.A., 2012. Regulatory variation in a TBX5 enhancer leads to isolated congenital heart disease. Hum. Mol. Genet. 21, 3255â63. https://doi.org/10.1093/hmg/dds165</p><p>van Ouwerkerk, A.F., Bosada, F.M., van Duijvenboden, K., Houweling, A.C., Scholman, K.T., Wakker, V., Allaart, C.P., Uhm, J.-S., Mathijssen, I.B., Baartscheer, T., Postma, A.V., Barnett, P., Verkerk, A.O., Boukens, B.J., Christoffels, V.M., 2022. Patient-Specific TBX5-G125R Variant Induces Profound Transcriptional Deregulation and Atrial Dysfunction. Circulation 145, 606â619. https://doi.org/10.1161/CIRCULATIONAHA.121.054347</p><p>Weerd, J.H. van, Badi, I., Boogaard, M. van den, Stefanovic, S., Werken, H.J.G. van de, Gomez-Velazquez, M., Badia-Careaga, C., Manzanares, M., Laat, W. de, Barnett, P., Christoffels, V.M., 2014. A Large Permissive Regulatory Domain Exclusively Controls Tbx3 Expression in the Cardiac Conduction System. Circ. Res. 115, 432â441. https://doi.org/10.1161/CIRCRESAHA.115.303591</p></body></sub-article></article>